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ABSTRACT 
P2X7 is an ATP-gated ion channel in the plasma membrane of a number of cell 
types. Previous in vitro studies show that P2X7 plays a role in regulating the 
differentiation of osteoblasts and adipocytes from mesenchymal precursors, as well as 
cellular metabolism and energy homeostasis. Furthermore, P2X7 has been implicated in 
mediating the effects of mechanical stimuli in bone. Our objective was to investigate the 
roles of P2X7, mechanical vibration, and their possible interaction in regulating body 
composition in vivo. We developed a novel method to monitor body composition during 
growth and aging in mice using micro-computed tomography (Chapter 2). This method 
permits rapid and reproducible quantification of adipose, lean and skeletal tissues in a 
non-invasive manner. We then applied this methodology to monitor the body 
composition of wild-type and P2X7 knockout mice (Chapter 3). Loss of P2X7 function 
led to greater adiposity and ectopic lipid accumulation in older male mice. We next 
investigated the effects of low-magnitude, high-frequency vibration on wild-type and 
P2X7 knockout mice (Chapter 4). Under our conditions, vibration does not induce 
changes in body composition or bone microarchitecture. Together, our studies provide an 
effective tool for characterizing whole-body composition of mice and establish novel in 
vivo roles for the P2X7 receptor in regulating adipogenesis and lipid metabolism. Finally, 
our findings and those of others highlight the need to re-evaluate current thinking on the 
effects of low-magnitude, high-frequency vibration on body composition in vivo.   
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1.1  Chapter Summary 
In this chapter, basic skeletal physiology will be described including an overview 
of bone structure, function and development. The different types of bone cells, and their 
functions as a team to build and maintain bones will be elaborated upon. This chapter will 
also describe the interactions between skeletal and adipose tissues, and their roles in 
systemic metabolic diseases. Additionally, purinergic receptor physiology with emphasis 
on a specific receptor (P2X7) will be discussed, along with the role of P2X7 in bone and 
adipose tissues. Furthermore, this Chapter reviews the possibilities for interplay among 
P2X7, bone and adipose tissues, and mechanical loading, and the potential to harness 
these effects to build bone and reduce adiposity in vivo. The rationale and specific 
objectives of the studies presented in Chapters 2-4 then follow. 
 
1.2  Bone Physiology 
1.2.1  Bone Structure and Function 
In the past, bone was perceived to be a relatively inactive tissue that functioned 
solely to provide support for other organ systems within the body. However, studies 
conducted over the last few decades have challenged this perception. It is clear now that 
bone is a highly specialized and complex connective tissue that provides physical 
protection to vital organs, serves as a site for muscle attachment to support locomotion, 
contributes to regulation of calcium and phosphate mineral homeostasis and supplies a 
source of hematopoietic and mesenchymal stem cells (Clarke, 2008; Muruganandan, 
2009). Adding to this complexity is the emerging idea that bone itself regulates energy 
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metabolism (Wei et al., 2014), emphasizing that there is still much to learn about this 
dynamic tissue.  
Bone shares similarities to other connective tissues in that the cells are separated 
by extracellular matrix. However, bone is composed of both organic and inorganic 
components, which accounts for its extraordinary physical properties (Marieb et al., 
2011). The organic portion of bone is primarily composed of type 1 collagen (ColI) fibers 
and proteoglycans, and makes up approximately 35% of bone mass (Marieb et al., 2011). 
The organization of collagen into parallel layers and angles provides bone with its tensile 
strength and flexibility, allowing it to resist forces such as twisting and stretching 
(Clarke, 2008; Marieb et al., 2011). Non-collagenous proteins, such as bone sialoprotein 
(BSP), osteocalcin (OCN), and osteopontin (OPN), are also present and are thought to 
regulate the mineralization process (Clarke, 2008). The inorganic components of bone are 
more abundant than the organic portion (making up approximately 65% of bone mass), 
and consists of hydroxyapatite crystals [Ca10(PO4)6(OH)2] (Hadjidakis and Androulakis, 
2006; Marieb et al., 2011). These crystals pack tightly around collagen in the 
extracellular matrix, contributing to the hardness and resistance to compressive loading in 
bone (Marieb et al., 2011). 
Bones are present in a variety of shapes and sizes, which fit into four general 
categories: long bones, short bones, flat bones and irregular bones (Clarke, 2008; Marieb 
et al., 2011). In general, nearly every bone in the skeleton consists of an external layer of 
compact bone, an internal network of trabecular bone and bone marrow that resides 
within the trabecular spaces (Marieb et al., 2011). At the same time, the shape of each 
bone in the body is unique owing to differences in both formation and function. Flat 
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bones are thin and flattened, such as the cranial bones, sternum, ribs and scapula (Clarke, 
2008). Long bones include most bones in the limbs and include the humerus, radius, ulna, 
femur, tibia and fibula. These bones are longer than they are wide and consist of a long 
shaft with two distinct ends. The hollow shaft forming the long axis of the bone is 
referred to as the diaphysis (Marieb et al., 2011). At both proximal and distal ends of the 
diaphysis, the long bones flare outward to form the cone-shaped metaphyses below the 
growth plate; and are then followed by the rounded bone ends above the growth plate 
referred to as the epiphyses (Clarke, 2008; Marieb et al., 2011).  
The epiphyses and metaphyses are comprised of a trabecular network, while the 
diaphysis is made of dense compact bone. With the exception of the epiphyses, a 
connective tissue membrane called the periosteum covers the external surface of each 
bone (Marieb et al., 2011). The periosteum has two layers: a deep osteogenic layer that 
remodels the perimeter of the bone and a superficial outer layer that protects the bone by 
resisting tension due to bending forces. The periosteum is secured to the bone with thick 
collagenous perforating fibres, called Sharpey’s fibres. Within the bone, the inner 
surfaces are also lined with an osteogenic connective tissue membrane, called the 
endosteum. The endosteum covers the trabeculae and the central canal of osteons. 
Osteons (the Haversian system) are the long cylindrical structures running longitudinally 
and parallel throughout compact bone, which contribute structural strength and resistance 
to torsional stresses imposed upon compact bone (Marieb et al., 2011). 
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1.2.2  Skeletal Development  
In vertebrate organisms, two distinct methods of bone formation have been 
described. The mechanism regulating the development of flat bones is termed 
intramembranous ossification, where mesenchymal cells directly differentiate into 
osteoblasts (Wagner and Karsenty, 2001). The second mechanism accounts for the 
development of the majority of bones in the axial and appendicular skeleton, and is 
referred to as endochondral ossification. In this process, mesenchymal cells form 
condensations and differentiate into chondrocytes (cartilage forming cells), which 
produce a cartilaginous template that defines the shape and site of future skeletal 
elements (Kronenberg, 2003; Wagner and Karsenty, 2001). The chondrocyte-directed 
matrix production regulates the size of the skeletal element being formed. Osteoblasts 
then differentiate from the perichondral cells adjacent to the hypertrophic chondrocytes to 
form the bone collar, while the cartilaginous template directs the invasion of vasculature 
and the formation of mineralized matrix along with chondrocyte apoptosis (Kronenberg, 
2003). The mineralization process forms a primary ossification centre, where osteoblasts 
continue to accompany the vascular invasion of the newly forming bone. Chondrocytes 
continue to proliferate to lengthen the bone in a polarized manner, and the bone collar 
begins to form cortical bone (Kronenberg, 2003). Next, the secondary ossification centre 
forms at the bone ends through cycles of chondrocyte hypertrophy accompanied by 
vascular invasion and osteoblast activity, except that this forms the growth plate between 
the metaphyses and epiphyses (Kronenberg, 2003). Interestingly, human growth plates 
fuse after the completion of puberty (Emons et al., 2009), but growth plates in mice do 
not fuse and the mouse continues to grow throughout a lifetime (Bagi et al., 2011). 
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1.3  Bone Cells and Their Functions 
1.3.1  Osteoblasts 
As the cells responsible for bone formation, osteoblasts serve a vital role in bone 
growth and remodelling (Figure 1.1). In this regard, the functions of osteoblasts are 
controlled by various hormones and growth factors, which regulate formation, function 
and survival.     
Osteoblasts develop from mesenchymal stem cells (MSCs), and cell lineage 
commitment is controlled by several master transcription factors and signalling cascades 
(Figure 1.2). Early stage commitment to the osteoblast lineage from MSCs is regulated 
by runt-related transcription factor-2 (RUNX2, known in past literature as Cbfa1). Mice 
lacking RUNX2 (Runx2-/-) are incapable of bone formation due to the absence of 
osteoblasts; thus, these mice have only a cartilaginous skeletal template (Komori et al., 
1997; Otto et al., 1997). Without proper ossification, maturation of the skeletal elements 
does not occur resulting in death of Runx2-/- mice at birth due to respiratory failure 
(Komori et al., 1997; Otto et al., 1997). This genetically-modified mouse model clearly 
demonstrates the critical role of RUNX2 in regulating early osteoblast lineage 
commitment. Moreover, RUNX2 also plays a part in promoting the expression of bone 
matrix protein genes, alkaline phosphatase (ALP) activity (an early osteoblast marker), as 
well as in vitro mineralization of osteoblast-like cells and immature mesenchymal cells 
(Banerjee et al., 1997; Ducy et al., 1997; Harada et al., 1999).  
Commitment to the late-stage mature osteoblast is regulated by the transcription 
factor Osterix (OSX). Similar to the Runx2-/- mice, genetically-modified mice lacking the 
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Figure 1.1 The basic multicellular unit and bone remodelling. 
 Skeletal integrity depends on the maintenance of bone by teams of cells working 
closely together to turnover bone over a period of approximately 4 months. To initiate 
bone remodelling, an activation event of localized damage occurs such as microfractures, 
and this recruits osteoclast precursors to the surface area where the basic multicellular 
unit will form to remodel bone. Osteoclasts mature from these precursors and begin to 
adhere and resorb the bone. The activation and resorption phases together take 
approximately 3 weeks from beginning to end. The reversal phase then follows, where 
bone lining cells are recruited to the site by the osteoclasts and factors released from the 
bone matrix, and these precursors differentiate into osteoblasts. The osteoblasts secrete 
organic matrix called osteoid, which subsequently mineralizes during the formation phase 
to fill the resorbed area formed by the osteoclasts. A small subset of osteoblasts become 
embedded within the matrix, and will then terminally differentiate into mature osteocytes. 
Figure courtesy of Dr. M.W. Grol. 
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Figure 1.2 Signalling pathways involved in osteoblastogenesis and adipogenesis.  
As both osteoblasts and adipocytes arise from the same mesenchymal progenitors 
(bone marrow stromal cells), several key transcriptional events direct the commitment 
toward either lineage. The osteoblast master transcription factor RUNX2 and the 
canonical Wnt transcriptional coactivator β-catenin are expressed in all stages of 
osteoblastogenesis to direct commitment during osteoblastogenesis. OSX appears at a 
later stage and directs the commitment of pre-osteoblasts towards mature osteoblasts.  
β-catenin also serves a dual role to inhibit PPARγ, the master transcription factor for 
adipogenesis. PPARγ also exhibits dual roles as it functions to also partially inhibit 
RUNX2, β-catenin and osteogenesis. In adipogenesis, C/EBPβ and C/EBPδ are present 
for the early commitment of pre-adipocytes, where at later stages PPARγ and C/EBPα 
synergize to enable the commitment towards the mature adipocyte. 
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OSX gene (Osx-/-) develop a completely cartilaginous skeleton, and die at birth due to 
respiratory failure (Nakashima et al., 2002). However, these Osx-/- mice exhibit 
expression of RUNX2 precursor cells, suggesting their differentiation is arrested and 
cannot progress past the early osteoblast without OSX. Furthermore, studies show that 
OSX is also critical for postnatal bone formation and growth (Zhou et al., 2010). 
Therefore, OSX is essential for mature osteoblast differentiation and the development and 
growth of healthy bones. 
Other signalling pathways that also play important roles in developing bone 
include Wnt/β-catenin, Indian hedgehog and vascular endothelial growth factors, which 
are required for osteoblast differentiation (Kronenberg, 2003; Mak et al., 2006). 
Moreover, transcription factors such as nuclear factor of activated T-cells (NFAT)-c1, 
cytokines, growth factors and bone morphogenic proteins (BMPs) act to modify the 
actions of the aforementioned key players in osteoblastogenesis (Grol et al., 2009; 
Robling et al., 2006; Zhou et al., 2010). Thus, it is evident that multiple signalling 
pathways play a role in regulation of osteoblast differentiation and commitment. When 
osteoblasts mature, they begin to secrete non-mineralized osteoid consisting of matrix 
proteins expressing ColI, OCN, and ALP which is a key enzyme in mineralization to 
yield mature bone (Robling et al., 2006). 
 
1.3.2  Osteocytes  
As osteoblasts continue to secrete osteoid, a small subpopulation of osteoblasts 
becomes embedded within the non-mineralized bone matrix (Bonewald, 2011)  (Figure 
1.1). These osteoblasts then begin to undergo a dramatic transformation as they 
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terminally differentiate into osteocytes. The early osteocyte is marked by greater 
expression of E11, and, as the matrix matures and mineralizes, the osteocyte begins to 
express markers of mature osteocytes such as dentin matrix protein-1 (DMP-1), sclerostin 
(SOST) and matrix extracellular phosphoglycoprotein (MEPE) (Bonewald, 2011; 
Robling et al., 2006). The most abundant cell type in bone, osteocytes are characterized 
by long cytoplasmic processes (dendrites) that extend outward from the cell body 
(Bonewald and Johnson, 2008; Marks and Popoff, 1988).  The osteocyte cell body lives 
within the mineralized matrix in cave-like lacunae, while these dendritic processes extend 
along tiny channels throughout the bone called canaliculi. The network of these dendritic 
processes are used for communication with neighbouring osteocytes via gap junctions, 
and are also believed to play a role in bone mechanotransduction (Bonewald, 2006; 
Robling et al., 2006). Additionally, canaliculi permit osteocytes to connect with cells 
lining the bone surface, including osteoblasts and osteoclasts (Bonewald and Johnson, 
2008). In this regard, new bone produced by osteoblast has been shown to be maintained 
by the osteocytes and bone-lining cells (Robling et al., 2006). Additionally, the dendritic 
processes of osteocytes reach into the marrow cavity, allowing for not only recruitment of 
osteoclasts but also regulation of mesenchymal stem cell differentiation (Bonewald and 
Johnson, 2008). Consequently, these channels provide a means for communication, fluid 
flow and nutrient diffusion to cells deep within the dense matrix (Marks and Popoff, 
1988). 
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1.3.3  Osteoclasts 
Osteoclasts are multinucleated cells of hematopoietic origin that differentiate 
from progenitors of the monocyte-macrophage lineage (Kobayashi et al., 2009). Once 
matured, these specialized cells attach and spread on bone surfaces, and resorb bone by 
creating an acidic microenvironment through the secretion of acids and proteases 
(Robling et al., 2006) (Figure 1.1). Interestingly, osteoclast activity is controlled by cells 
of the osteoblast lineage and, during remodelling, bone resorbed by osteoclasts is 
replaced by the actions of osteoblasts (Martin et al., 2009). Osteoclast differentiation is 
initiated by mechanisms that are activated by macrophage-colony stimulating factor (M-
CSF) and the transcription factor nuclear factor-κB ligand (NF-κB). Osteoblasts express 
receptor activator for nuclear factor-κB ligand (RANKL), and the binding of RANKL to 
its receptor, RANK in the monocyte-macrophage lineage initiates commitment to the 
osteoclast lineage. Osteoblasts also secrete osteoprotegerin (OPG), a decoy receptor for 
RANKL, acting to inhibit osteoclastogenesis and osteoclast function by blocking the 
interaction of RANKL with RANK (Kobayashi et al., 2009; Korcok et al., 2004). On the 
other hand, more recent studies have shown that osteoclasts can act to recruit osteoblasts 
and enhance osteogenesis by providing a source of soluble and membrane bound factors 
(Pederson et al., 2008; Zhao et al., 2006). Moreover, osteocytes have also been shown to 
communicate with and regulate osteoclast cells through RANKL expression (Xiong et al., 
2011). Thus, crosstalk between bone cells regulates the fine balance maintaining the 
status quo in healthy adult bone.  
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1.3.4  Regulation of Bone Remodelling  
Osteoclasts and osteoblasts have lifespans of a few weeks to months, respectively 
(Figure 1.1). On the other hand, the osteocyte life span can range from months to 
decades, depending on their anatomical location (Almeida and O'Brien, 2013). 
Osteoclasts have high activity levels over a short period of time due to the rapid nature of 
resorption, occurring over the course of a few weeks. The process of organic matrix 
secretion and mineralization by the osteoblast is an inherently longer process, taking 
upwards of a few months. Although the duration of these processes seem quite different, 
establishing equilibrium between the amount of bone resorbed and formed is critical for 
the maintenance of bone. When osteoclast activity exceeds that of osteoblast activity, the 
net result is bone loss due to increased bone resorption, resulting in reduced bone mass 
and strength (Almeida and O'Brien, 2013). Thus, the continual maintenance throughout a 
lifetime is imperative for proper structural integrity of bone.  
Much of what we know about how bone maintains its structural properties at the 
microscopic level is attributed to the work of Harold Frost in the 1960s (Sims and Martin, 
2014). Frost described two ways that bone cells work together to accomplish skeletal 
formation and/or renewal: bone modelling and bone remodelling (Robling et al., 2006). 
The addition or removal of bone can occur at four locations: trabeculae, Haversian 
(intracortical) envelopes, and endocortical and periosteal surfaces. Bone modelling is 
responsible for the spatial distribution and accumulation of bone during growth involving 
osteoclast activation and resorption, as well as osteoblast activation and formation, but 
not concomitantly at the same location. Once the skeleton reaches maturity after puberty 
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modeling contributes little to the maintenance of bone; unless the disease state of the 
bone or the mechanical loading of the bone has changed drastically (Robling et al., 2006).  
The preventive maintenance and repair mechanism for damaged bone is referred 
to as bone remodelling, and involves a coordinated balance between bone formation and 
bone resorption by specialized osteoblasts and osteoclasts (Grol et al., 2009; Robling et 
al., 2006; Sims and Martin, 2014). Remodelling also allows access to ions for metabolic 
homeostasis (Parfitt, 1979). Remodelling is accomplished cyclically by the removal and 
replacement of areas of bone (for repair and preventive maintenance) through activation, 
resorption, reversal and formation phases in this respective sequence (Robling et al., 
2006) (Figure 1.1). In this remodelling event, activation begins with localized damage to 
bone, which initiates the remodelling sequence by recruitment of osteoclasts (Parfitt, 
1994; Sims and Gooi, 2008). Osteoclasts adhere to the bone surface and spread to begin 
resorption. This is followed by a reversal phase, whereby mononuclear lining cells (of 
unknown lineage) then prepare the bone surface by depositing a substance denoted as the 
cement (reversal) line. This thin layer of matrix allows for recruitment of osteoblast 
precursors to begin proliferation and differentiation into mature osteoblasts, filling the 
space that has been resorbed with newly formed bone (Parfitt, 1994; Sims and Gooi, 
2008; Sims and Martin, 2014). Thus, teams of osteoblasts and osteoclasts temporarily 
arrange themselves to remodel bone in what is referred to as a basic multicellular unit 
(BMU) (Robling et al., 2006).  
Trabecular and intracortical bone BMUs differ in structure and the process by 
which they replace bone (Sims and Martin, 2014), but both methods are the mechanistic 
bridges between cellular activity and bone morphology (Robling et al., 2006). In the 
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trabeculae, the BMU is located on the bone surface and is covered by a canopy of osteal 
macrophages (osteomacs) at the site of bone formation (Sims and Martin, 2014). Under 
this canopy, the surface is resorbed by osteoclasts and osteoblast precursors are recruited 
to form bone in the space that has been resorbed (Sims and Martin, 2014). Intracortical, 
periosteal and endocortical BMUs have a distinct three-dimensional structure, where the 
osteoclasts lead the way by resorbing bone and excavating a longitudinal tunnel (referred 
to as Howship’s lacunae) and defining the size and amount of bone that will be replaced. 
Osteoclast resorption initiates the remodelling cycle, recruiting osteoblasts to follow 
behind and refill the resorbed area through bone formation and subsequent mineralization 
of osteoid produced by osteoblasts (Grol et al., 2009; Robling et al., 2006). Thus, 
coupling between osteoclasts and osteoblasts in bone remodelling is controlled to ensure 
that bone is replaced in the region where it had been removed. 
Remodelling by BMUs occurs continuously at multiple loci throughout the 
growth and maintenance of bones in the body (Robling et al., 2006). Bone remodelling is 
regulated by local and systemic factors, as well as mechanical stimuli (Grol et al., 2009). 
It is well known that in the absence of bone loading (a form of mechanical stimuli), bone 
strength and quality rapidly depreciate as seen in patients on bed rest for extended periods 
of time (attenuated muscle atrophy) (Prisby et al., 2008; Robling et al., 2006) and in 
astronauts (microgravity) (Robling et al., 2006; Rubin et al., 2001b). Thus, achieving a 
balance between the processes of resorption and formation is essential to maintain normal 
bone density and bone mass. A disruption in this equilibrium can lead to pathological 
bone phenotypes and metabolic bone diseases, such as osteoporosis (Rosen, 2000). 
Therefore, the possibility of tipping the equilibrium favourably towards bone formation to 
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prevent or mitigate bone loss in osteoporosis may be possible by initiating bone 
remodelling events. 
 
1.4  Stromal Cell Plasticity in the Skeleton 
1.4.1  Bone Marrow Stromal Cell Plasticity 
  A reserve of bone marrow stromal cells (BMSCs) resides in the marrow cavity of 
adult long bones (Pittenger et al., 1999). These BMSCs are a mesenchymal progenitor 
cell population exhibiting multipotency, with the capacity to differentiate into other cell 
types, such as osteoblasts, adipocytes, chondrocytes and fibroblasts (Pittenger et al., 
1999). BMSC differentiation is regulated by a multitude of signalling cascades alongside 
transcriptional events, which ensure that lineage determination is either inhibited or 
enhanced to obtain the desired specific cell-type (Harada, 2003). An imbalance in 
differentiation of osteoblasts from mesenchymal stem cells and osteoclasts from 
macrophage/monocyte precursors result in skeletal diseases such as osteoporosis and 
contribute to the pathogenesis of inflammatory autoimmune diseases such as rheumatoid 
arthritis (Soltanoff, 2009). The plasticity seen among cells derived from BMSCs is 
evident in diseases such as osteoporosis, where increased marrow adiposity is coupled 
with decreased bone formation (Rosen and Bouxsein, 2006). The factors that increase 
osteoblast differentiation at the expense of adipogenesis remain poorly understood. As 
such, research into the mechanisms governing BMSC plasticity is essential for 
understanding systemic degenerative bone diseases. 
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1.4.2  Adipocytes and Adipogenesis 
The principal cell type responsible for formation and maintenance of adipose 
tissue is the adipocyte (also known as the fat cell). Adipogenesis is the process in which 
adipocytes are formed. The specific stages governing adipogenesis are determination and 
terminal differentiation. Just as osteoblast differentiation is regulated by several 
transcription factors, adipocyte differentiation is regulated by an adipocyte-specific 
transcription factor, peroxisome proliferator-activated receptor γ (PPARγ) (Figure 1.2).  
Playing a key role in energy metabolism, inflammation, cell proliferation, hyperlipidemia 
and gluconeogenesis, it is of no surprise that PPARγ is expressed in adipose tissue where 
it is responsible for adipogenesis and lipogenesis. Two members of the 
CCAAT/enhancer-binding protein (C/EBP) family, C/EBPβ and C/EBPδ, are expressed 
early in adipogenesis, both of which are involved in inducing PPARγ (Cao et al., 1991; 
Lefterova et al., 2008). There is increasing evidence that PPARγ and other PPARs play 
an important role in regulating obesity (Kersten, 2002). Additionally, studies have shown 
that PPARγ exhibits a reciprocal relationship with β-catenin, where by PPARγ suppresses 
β-catenin, and increased β-catenin levels inhibit PPARγ gene expression (Kawai et al., 
2007; Moldes et al., 2003; Rosen and MacDougald, 2006). Furthermore, C/EBPα is 
another important transcription factor in late stages of adipogenesis (Cao et al., 1991; 
Lefterova et al., 2008). When co-expressed, PPARγ and C/EBPα synergize, promoting 
the differentiation of adipocytes even in the absence of exogenous PPAR activators 
(Tontonoz et al., 1994). Aside from master transcription factors, circulating blood 
glucose levels, insulin, LDL (cholesterol), triglycerides, adipocytokines (also referred to 
as adipokines such as leptin, adiponectin and resistin) undoubtedly play important roles 
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as biomarkers of fat regulation and energy metabolism. 
 
1.4.3  Relationship between Osteoblast and Adipocyte Determination 
Studies have shown that Pparγ-deficient embryonic stem cells fail to differentiate 
into adipocytes, and show enhanced osteogenesis (Akune et al., 2004). Interestingly, 
PPARγ and adipogenesis are inhibited by β -catenin (Rosen and MacDougald, 2006), 
which is in contrast to osteoblastogenesis where β -catenin plays a positive role (Figure 
1.2). Furthermore, enhanced osteoblastogenesis and high bone mass has been 
demonstrated in Pparγ-/- mice (Akune et al., 2004). Whereas PPAR-γ stimulates 
adipogenesis in the mesenchymal stem cells (MSCs) of bone marrow, it also acts to 
suppress osteoblastogenesis through partial inhibition of RUNX2 while enhancing 
osteoclastogenesis through enhancing gene expression in osteoclast precursors (Gourine 
et al., 2009). Thus, PPARγ is a master regulator of adipocyte differentiation whose 
expression is both necessary and sufficient for maintenance of the adipogenic phenotype 
and inhibition of osteoblastogenesis. Interestingly, it has previously been noted that 
increased rates of marrow adipogenesis in humans is associated with aging as well as 
chronic diseases such as diabetes mellitus and osteoporosis (Gourine et al., 2009). Thus, 
increased bone marrow adiposity seen in degenerative bone diseases suggests that cells of 
mesenchymal origin are not static in their determination and differentiation.  
The plasticity seen among cells derived from MSCs is evident in diseases such as 
osteoporosis, where increased marrow adiposity is coupled with decreased bone 
formation. An imbalance in differentiation of osteoblasts from mesenchymal stem cells 
and osteoclasts from macrophage/monocyte precursors result in skeletal diseases such as 
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osteoporosis, and contribute to the pathogenesis of diseases such as rheumatoid arthritis 
(Soltanoff, 2009). The signalling pathways that regulate osteoblast-lineage commitment 
in vivo have yet to be entirely understood. Therefore, understanding the factors that 
increase osteoblast differentiation at the expense of adipogenesis may be essential in the 
prevention and treatment of degenerative bone diseases, and is one of issues explored in 
my thesis.  
 
1.4.4  Bone-fat Crosstalk 
Research over the past decade has been working towards revealing integrative 
signalling pathways referred to as crosstalk among cell and tissue types. The emergence 
of these signalling pathways will be crucial for understanding physiological properties of 
organs and tissues (Confavreux et al., 2009). Although bone and fat have been 
traditionally thought of as static and inert tissues, complex pathways link bone 
remodelling to fat metabolism (de Paula et al., 2010). As bone also has energy reserves of 
marrow fat, the determination of MSC lineage fate plays an important role in modulating 
the microenvironment of bone and its immediate energy metabolism (Lecka-Czernik, 
2010).  
The complexity of this crosstalk is apparent; adipocytes have been shown to 
secrete bone-active hormones (such as leptin and estrogens), and fat-mass has been 
shown to influence secretion of hormones from pancreatic beta cells (such as insulin) 
(Reid, 2008).  Insulin has a central role in carbohydrate and fat metabolism, and has 
recently been shown to signal in osteoblasts by favouring osteoclast differentiation and 
resorption. The acidic environment created by this upregulated osteoclast activity has 
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been shown to activate OCN by decarboxylation (Wei et al., 2014). OCN is the most 
abundant non-collagenous protein in bone matrix (Patti et al., 2013), and is secreted 
exclusively by osteoblasts. OCN activation favours insulin secretion from pancreatic ß-
cells and enhancing insulin sensitivity in white adipose tissues, muscle and liver, 
contributing to whole-body glucose homeostasis (Wei et al., 2014). Moreover, circulating 
uncarboxylated fraction of OCN has been correlated with increased insulin sensitivity 
and reduced blood glucose and visceral fat, while both uncarboxylated and total OCN 
have been associated are increased with physical activity (Patti et al., 2013). Thus, the 
study of crosstalk between bone and fat is becoming a prominent area of skeletal biology, 
with important implications for metabolic diseases such as obesity, diabetes mellitus and 
osteoporosis (de Paula et al., 2010). 
 
1.4.5  Skeletal Aging 
Even with intricate and continuous self-renewal system inherent to bone, it cannot 
escape the effects of aging over a lifetime. Bone aging presents with an imbalance 
between the amount of bone resorbed by osteoclasts, and the amount of bone that 
osteoblasts can form to restore the resorption. This shift in the equilibrium results in both 
the loss of bone mass and strength (Almeida and O'Brien, 2013). At the morphological 
level, structural changes in bone such as reduced cortical bone thickness and density, 
accompanied by an increase in porosity contributes to the reduction of bone strength 
(Almeida and O'Brien, 2013; Halloran et al., 2002). At a histological level, a reduction in 
bone formation has been associated with inadequate numbers of osteoblasts due to 
apoptosis, and reduced osteocyte quantity (Almeida and O'Brien, 2013). Moreover, 
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decreased MSCs numbers in bone marrow are due in part to preferential adipogenic 
commitment over osteoblastogenesis, drastically increasing the number of adipocytes 
present with age (Almeida and O'Brien, 2013). Moreover, trabecular bone aging is 
associated with diminished bone volume and osteoclast numbers, reduced trabecular 
number (Tb.N) and thickness (Tb.Th), and increased spacing between trabeculae (Tb.Sp) 
(Almeida and O'Brien, 2013; Halloran et al., 2002). Taken together, the decline in 
functional bone contributes to the systemic bone loss observed in skeletal aging. 
 
1.4.6  Diseases of Systemic Bone Loss 
 Musculoskeletal diseases are highly prevalent and pose a great burden, affecting 
millions of people globally. The prevalence of these diseases increases with age and 
becomes a greater concern with the aging population. In fact, among older age groups 
musculoskeletal diseases have been reported as the main cause of disability, imparting 
diminished quality of life due to reduced social function and mental health issues 
associated with pain and physical disability (Woolf and Pfleger, 2003).  
Osteoporosis is a common skeletal disorder, characterized by compromised bone 
quality (reduced bone mineral density), primarily caused by bone resorption exceeding 
bone formation resulting in an increased fracture risk (Pietschmann et al., 2009; Rosen, 
2000). Age- and gender-specific factors in bone density play a role in predisposition to 
the disease. However, other lifestyle factors such as smoking, alcohol consumption, 
calcium and vitamin D intake, and bone loading (such as mobility and exercise) play 
critical roles in bone health throughout a lifetime (Pietschmann et al., 2009). The 
prevalence of osteoporosis is on the rise, with an estimated 40% of women expected to 
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experience an osteoporotic fracture in their lifetime (Melton et al., 1992). The limited 
therapeutic interventions available for treatment of osteoporosis are only marginally 
successful and primarily anti-resorptive in their properties (Akesson, 2003). Currently, no 
pharmacologic or non-invasive treatment options exist for the prevention of osteoporosis. 
This emphasizes the importance of elucidating the mechanisms that regulate bone 
remodelling to determine potential therapeutic targets for prevention and treatment. 
Metabolic syndrome encompasses a myriad of diseases including obesity and 
dyslipidemia (Klop et al., 2013), has been associated with altered hormone levels, and is 
more prevalent with age (Dulloo and Montani, 2012). The global obesity epidemic is a 
contributing factor to musculoskeletal disease progression and prevalence. Interestingly, 
studies have begun to correlate the incidence of diabetic patients with increased risk of 
fracture due to decreased bone quality (type II diabetes) and reduced bone mineral 
density (type I diabetes) (Isidro and Ruano, 2010; Rakel et al., 2008). However, the 
signalling pathways that regulate osteoblast-lineage and adipocyte-lineage commitment 
in vivo have yet to be entirely elucidated. Therefore, understanding the factors that 
increase osteoblast differentiation at the expense of adipogenesis may prove to be an 
innovative approach to the prevention and treatment of musculoskeletal diseases 
including osteoporosis. 
 
1.5  Purinergic Receptor Physiology 
1.5.1 P2 Receptors 
Purinergic receptors (purinoceptors) are a family of cell surface receptors 
activated by nucleotides or nucleosides (Burnstock, 1976), eliciting an array of 
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physiological responses. This family of receptors consists of the P1, P2X and P2Y 
subclasses (Fredholm et al., 1997). P1 receptors are a family of G protein-coupled 
receptors activated by extracellular adenosine. P2 receptors are activated by nucleotides 
and are subdivided into two classes: P2X (ATP-gated cation channels) and P2Y (G 
protein-coupled receptors). In mammals, eight P2Y receptor subtypes are known, 
P2Y1,2,4,6,11-14, whereas seven members of the P2X family, P2X1-7, are known to exist. 
With regards to the P2X subfamily, these receptors consist of either homo- or 
heterotrimeric channels that are permeable to Na+, K+, and Ca2+ (Khakh and North, 
2006). Each P2X subunit possesses intracellular carboxyl and amino termini containing 
consensus binding motifs for protein kinases; two transmembrane domains, one involved 
in channel gating and the other that lines the ion pore; and a large extracellular loop that 
participates in ATP binding (Burnstock, 2007).  
P2 receptors play important roles in regulating cellular physiology and pathology. 
Extracellular nucleotides such as ATP signal through P2 nucleotide receptors expressed 
in many cell types, including osteoblasts and osteoclasts (Dixon and Sims, 2000). It is 
well known that both osteoblasts and osteoclasts express multiple P2 receptor subtypes 
(Lenertz et al., 2011; Orriss et al., 2010). Nucleotides are released from cells 
constitutively and in response to mechanical stimulation, osmotic swelling, shear stress 
and inflammation (Bodin and Burnstock, 2001; Burnstock, 2007), and are thought to be 
key mediators in skeletal cell responses to mechanical stimuli (Dixon and Sims, 2000; 
Lenertz et al.; Panupinthu et al., 2008; Robling et al., 2006; Robling and Turner, 2009). 
Nucleotide release into the extracellular environment may occur through transporter and 
channel proteins, connexin or pannexin hemichannels, or vesicular exocytosis; although 
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the exact mechanisms have been debated (Bodin and Burnstock, 2001; Lazarowski et al., 
2011). In bone, ATP released by mechanical stress (Romanello et al., 2001) is thought to 
bind to P2 receptors on cells of the osteoblast and osteoclast lineages, resulting in 
remodelling (Buckley et al., 2003; Dixon, 1998; Lenertz et al.; Li J, 2005) (Figure 1.3).  
P2 receptors are known to play important roles in bone remodelling. For instance, 
in the P2Y family, P2Y1 has been proposed to increase osteoclast formation and bone 
resorption, while P2Y6 has been shown to enhance osteoclast survival (Korcok et al., 
2005), and P2Y2 has been shown to inhibit bone mineralization through obstruction of 
ALP activity (Orriss et al., 2010). Recent evidence suggests mice lacking functional 
P2Y12 receptors have decreased resorptive activity in osteoclasts, and exhibited 
protection from bone loss (Su, 2012). Additionally, P2ry13-deficient mice exhibit 
decreased osteoblast and osteoclast number, reduced bone turnover and increased marrow 
adipocytes (Biver et al., 2013). In the P2X family of subunits, P2X2 has been shown to 
increase bone resorption in osteoclasts, while P2X5 acts to increase osteoblast 
proliferation (Orriss et al., 2010). Thus, P2 receptors play an important role in bone 
remodelling. 
 
1.5.2  P2X7 Nucleotide Receptors 
Compared to the other P2X receptors, P2X7 has an extended intracellular C 
terminal tail that provides a docking site for intracellular signalling molecules and is 
essential for the receptor’s ability to elicit pore formation and membrane blebbing 
(Garcia-Marcos et al., 2006; Grol et al., 2009). Pore formation can lead to cell death by 
triggering apoptosis due to massive uptake of Cl- or excessive leakage of intracellular K+.  
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Figure 1.3 P2 receptors in bone. 
This general schematic indicates the potential roles for P2 nucleotide receptor 
signalling in bone. Nucleotides are released by inflammation as well as mechanical 
stimulation of bone. ATP released into the extracellular environment from osteoblasts can 
act in an autocrine and/or paracrine fashion to signal through multiple cell-surface P2 
receptors subtypes on osteoblasts and osteoclasts, regulating bone remodelling. Image 
courtesy of Dr. M.W. Grol. 
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Prolonged activation of P2X7 can provoke major cellular changes such as fragmentation 
of DNA or vesiculation and blebbing of the plasma membrane (Garcia-Marcos et al., 
2006). Previous research from our laboratory has shown that membrane blebbing occurs 
in osteoblasts isolated from mouse calvarial cells upon activation of P2X7 receptors with 
ATP or a more potent P2X7 agonist 2’,3’-O-(4-benzoylbenzoyl)-ATP (BzATP) 
(Panupinthu et al., 2007). In vivo, osteoblast blebbing has been seen in bone healing 
studies (Olmedo et al., 1999), although the function of blebbing remains unknown. In 
vitro pore formation in response to mechanical stimulation of osteoblasts seems to be 
mediated by P2 receptors, implicating a role for P2X7 receptor activation and pore 
formation in vivo (Grol et al., 2009; Li et al., 2005). 
 
1.5.3  Coupling P2X7 Activity in Bone Remodelling and Adiposity 
As reviewed above, recent research in bone and adipose tissues has revealed 
complex pathways linking bone remodelling to lipid metabolism (de Paula et al., 2010; 
Ferron et al., 2010). P2X7 is known to play a key role in bone remodelling (Grol et al., 
2009). Osteoblasts and osteoclasts have been shown to possess functional P2X7 receptors 
(Ke et al., 2003; Korcok et al., 2004; Naemsch et al., 2001; Panupinthu et al., 2008; 
Panupinthu et al., 2007). Mice deficient in P2X7 (P2rx7-/-) display diminished periosteal 
bone formation, excessive trabecular bone resorption (Ke et al., 2003), and an impaired 
response to mechanical loading (Li et al., 2005), implicating P2X7 signalling in 
mechanotransduction.  
Recent studies from our laboratory have illustrated that activation of P2X7 
receptors results in enhanced osteoblast differentiation and matrix mineralization 
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(Panupinthu et al., 2008). Interestingly, bone cells from P2rx7-/- mice displayed greater 
expression of adipogenic markers PPARγ and lipoprotein lipase in comparison to wild-
type (WT) cells. Moreover, there was suppressed osteoblast differentiation in cultures of 
bone cells from P2rx7-/- mice (Panupinthu et al., 2008). This finding is important to 
understanding the mechanisms regulating differentiation, as osteoblasts and adipocytes 
arise from the same multipotent mesenchymal precursor and become terminally 
differentiated to either lineage due to the influence of regulatory transcription factors 
such as Osx and PPARγ (Akune et al., 2004). Furthermore, P2X7-induced osteogenesis 
required both production of lysophosphatidic acid (LPA) and cyclooxygenase activity 
(Panupinthu et al., 2008). ATP release in response to mechanical stimulation has been 
shown by others to lead to prostaglandin E2 (PGE2) production by osteoblasts. PGE2 is a 
known anabolic factor in bone formation, the production of which is impaired in P2rx7-/- 
mice as well as the subsequent osteogenesis, even upon mechanical induction (Li et al., 
2005; Panupinthu et al., 2008). Therefore, it appears that the activation of P2X7 receptors 
directs the commitment of BMSCs towards the osteoblast lineage, and away from the 
adipocyte lineage (Figure 1.4). In this thesis, I extend these in vitro observations by 
examining the effect of P2X7 on adiposity in vivo.   
To date, there exists minimal literature on P2X7 in adipocytes. Given the 
association of P2X7 with lipid signalling pathways, this area of research is a fruitful 
avenue to pursue. Additionally, studies from our laboratory have found that P2X7 
activation in osteoblast-like cells triggers Ca²+-dependent stimulation of metabolic acid 
production that is dependent on glucose and phosphatidylinositol 3-kinase activity (Grol 
et al., 2012). Work from another lab has also shown that P2X7 is a key regulator of  
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Figure 1.4 The proposed role of P2X7 in osteogenesis and adipogenesis.  
Previous work has suggested that P2X7 plays a role in upregulating osteogenesis 
and suppressing adipogenesis. Bone cells isolated from mice lacking functional P2X7 
exhibit increased adipocyte markers and reduced osteogenic markers. Based on this work, 
P2X7 may play a role in the determination of lineage commitment from stromal cell 
populations.  
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aerobic glycolysis (Amoroso et al., 2012). Taken together, these studies reveal an 
emerging role for P2X7 in cellular metabolism. 
 
1.5.4  P2X7 Expression and Polymorphisms in Humans 
Human P2X7 receptor gene (P2RX7) polymorphisms represent a genetic risk 
factor for skeletal disease. Interestingly, P2RX7 is one of the most polymorphic P2 
receptors, with 40 characterized nonsynonymous single nucleotide polymorphism (SNPs) 
(Di Virgilio and Wiley, 2002). Studies have shown that two of the most common 
polymorphisms in this gene result in a complete loss of function (as homozygous or in 
combination with other loss-of function polymorphisms) (Fuller, 2009; Sluyter, 2011). 
The combination of these two variants is found in ~3% of human subjects, and has been 
found to be the most common cause of near-absence of P2RX7 function (Dao-Ung et al., 
2004). Furthermore, several recent studies have established the association of loss-of- 
function polymorphisms in the P2RX7 receptor with lower bone mineral density 
(Wesselius et al., 2013), accelerated bone loss (Gartland et al., 2012) and increased 
osteoporosis risk (Husted et al., 2013; Wesselius et al., 2013). Studies have also shown 
that loss-of-function P2RX7 polymorphisms are associated with increased fracture risk 
and rates of bone loss in post-menopausal women (Grol et al., 2009; Jorgensen et al., 
2012; Ohlendorff et al., 2007). Effects of these loss-of-function polymorphisms in 
humans are consistent with the skeletal phenotype of the P2rx7-/- mouse (Ke et al., 2003).  
As aforementioned, few studies have investigated the role of P2X7 in adipocytes. 
One study has shown that human adipocytes express functional P2RX7 (Madec et al., 
2011). In this same study, patients with metabolic syndrome showed enhanced expression 
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of P2RX7 in adipocytes, suggesting a link between P2X7 and metabolic syndrome. 
Additionally, elevated P2RX7 expression levels have been shown in obese patients and 
reduced levels have been shown in patients with type II diabetes mellitus (Glas et al., 
2009). When challenging mice lacking functional P2rx7 with a high-fat diet, these mice 
exhibited hyperglycemia and glucose intolerance (Glas et al., 2009), suggesting a role for 
P2X7 in metabolism. Moreover, increased rates of marrow adipogenesis in humans is 
associated with aging as well as chronic diseases such as diabetes mellitus and 
osteoporosis (Gourine et al., 2009). Currently, no studies exist that address the effects of 
P2X7 on the state of adiposity within the bone marrow. It will be important in future 
studies to investigate the role of P2X7 receptors in metabolic diseases affecting bone and 
adipose tissues.  
 
1.6  Effects of Mechanical Stimulation on Bone 
1.6.1  Mechanical Loading  
In 1892, Julius Wolff published his “Law of Transformation of Bone”, where he 
reported that bone alters its inner architecture due to loading and, as a secondary effect, 
alters its shape, processes that can be modeled using mathematical laws (Wolff, 1986).  
This adaptability in response to functional loading is a unique property of the skeleton 
(Prisby et al., 2008; Robling et al., 2006; Skerry, 2008). As bones provide the ability for 
locomotion, they are designed to endure cyclic loading forces from common activities 
such as walking, to running and vigorous weight-lifting (Robling et al., 2006; Skerry, 
2008). Load bearing bones of the axial and appendicular skeleton resist the deformations 
due to compressive, torsional or tensile forces (Duncan and Turner, 1995). Excessive 
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loading can result in failure, where bones fracture, most commonly due to torsional 
loading (Marieb et al., 2011).  
Skeletal mechanical loading is critical for the development, growth and 
maintenance of bones involved in weight-bearing (Turner et al., 2009). Moreover, 
mechanical loading is also necessary for the normal functioning of joints (Liu et al., 
2001). Mechanical loading has been shown to elicit anabolic responses in bone by 
altering the balance between resorption and formation (Ozcivici et al., 2010; Prisby et al., 
2008). The osteogenic effect of loading results from increased activity of osteoblasts and 
decreased activity of osteoclasts, leading to increased bone formation rates and net bone 
formation (Judex and Zernicke, 2000). The local anabolic response to bone loading is 
apparent from studies in athletes such as tennis players, where their playing arms develop 
larger, denser bones relative to their non-playing arms (Jones et al., 1977; Turner et al., 
2009). Thus, enhanced bone properties tend to be localized to the bones specifically 
involved in the loading events (Jones et al., 1977), as signal transmissibility becomes 
attenuated as it travels through the skeletal elements (Kiiski et al., 2008; Robling et al., 
2006).     
In the absence of mechanical loading, the skeleton experiences an absence of 
normal strain. This leads to accelerated bone turnover and loss of bone mass due to 
excessive resorption. This catabolic effect is evident in patients experiencing prolonged 
bed rest, those who are immobilized, and astronauts in microgravity (LeBlanc et al., 
2007; Robling et al., 2006). Overuse can also damage the bone tissue, eliciting bone 
remodelling to replace the damaged bone. However, if damage occurs faster than it can 
be remodelled, then microcracks accumulate and subsequently stress fractures can occur 
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(Robling et al., 2006).   
 
1.6.2  Mechanotransduction 
Mechanotransduction is the translation of mechanical stimulation into cellular 
responses (Grol et al., 2009; Robling and Turner, 2009). Various forms of mechanical 
stimulation include substrate stretching (tension), fluid shear stress, compressive loading 
and vibration. It has been suggested that bone cells have several mechanosensors at the 
cell surface that sense mechanical stimuli and initiate cellular responses through 
mechanotransduction (Turner et al., 2009). Putative mechanosensors, which may function 
individually or together, include: stretch-activated ion channels, focal adhesion kinases 
(FAK), proline-rich tyrosine kinase 2 (Pyk2), integrins, cell-cell adhesion elements 
(cadherins and gap junctions), primary cilia, and cytoskeletal elements (Papachroni et al., 
2009; Turner et al., 2009). When stimulated, mechanosensors initiate cell signalling in a 
cell-type, duration and force-dependent manner.  
Osteocytes have long been considered the key regulators of mechanotransduction 
in bone. This is due to their interconnectivity via processes and gap junctions, which are 
thought to allow them to regulate bone remodelling in response to mechanical loads 
(Bonewald and Johnson, 2008). The deformation of bones during loading can be sensed 
at the cellular level, whereby loading produces pressure gradients that drive extracellular 
fluid to flow through canaliculi (surrounding osteocyte processes) eliciting fluid shear 
stresses (Bonewald and Johnson, 2008). Shear stresses can elicit responses such as 
calcium influx via voltage- and mechanosensitive channels (Robling et al., 2006). 
Additionally, shear stress enhances ATP release into the extracellular environment, which 
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can then act on P2 receptors to initiate downstream signalling (Genetos et al., 2005; 
Robling et al., 2006) (Figure 1.2). SOST is also thought to play a role in 
mechanotransduction. SOST is constitutively expressed by osteocytes, and is an inhibitor 
of bone formation (Robling et al., 2008; Turner et al., 2009). SOST does this by binding 
low-density lipoprotein receptor-related protein 5 (LRP5) receptors, blocking Wnt 
binding and thus inhibiting Wnt signalling. Mechanical loading reduces SOST 
expression, thus increasing bone formation, whereas hind-limb unloading increases 
SOST expression and reduces bone formation (Robling et al., 2008; Turner et al., 2009). 
Mechanotransduction is thought to also play a role in the process of osteoblasts 
becoming mature osteocytes (Bonewald, 2006). The role of osteoblasts in 
mechanotransduction, and their ability to respond to vibration, is less well studied than 
the osteocyte (Bonewald and Johnson, 2008). Osteoblasts can act independently of the 
osteocyte to mediate mechanotransduction, as evident in cell cultures (Robling et al., 
2006). Mechanotransduction in osteoblasts is proposed to occur through mechanosensors 
such as stretch-activated ion channels, integrins and primary cilia. The 
mechanotransduction response is immediate, eliciting ATP and cytosolic calcium 
signalling, followed by production of other signalling molecules including nitric oxide 
(NO) and PGE2, which in contrast to NO is anabolic for osteoblast activity and bone 
formation. This is followed by activation of transcription factors leading to bone 
formation (Figure 1.5). 
BMSCs also have a role in mechanotransduction. The hydrostatic pressures 
within the marrow cavity produce fluid shear stresses on BMSCs, which can stimulate the 
release of NO, a strong inhibitor of bone resorption, likely via inhibition of RANKL 
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Figure 1.5 Mechanotransduction in bone.  
This schematic illustrates the proposed model for how mechanical stimulation 
initiates a signalling cascade beginning with mechanosensors on cells of the osteoblast 
lineage, releasing intracellular ATP stores to the extracellular environment. Extracellular 
nucleotides then act in an autocrine/paracrine fashion to activate P2X (green) and P2Y 
(red) cell surface receptors on surrounding cells. Specifically, activation of P2X7 results 
in calcium influxes that further initiate the release of secondary messengers acting on 
other receptors (blue), activating transcription factors and gene expression resulting in 
enhanced bone formation.  
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expression (Robling et al., 2006). Thus, osteoclasts are believed to have an indirect 
response in mechanotransduction. Taken together, it is evident that all bone cell lineages 
play a role in mechanotransduction through a variety of possible mechanisms. 
 
1.6.3  Low-Magnitude, High-Frequency Vibration 
Mechanical loading was first thought to produce an anabolic effects in bone at 
only high magnitudes, similar to what is experienced during vigorous physical activity 
(Rubin et al., 2001b). Conversely, studies over the last few decades have built a growing 
body of evidence demonstrating that low-magnitude stimuli can promote osteogenic 
effects in bone. With the immediate need for non-pharmacological interventions to 
mitigate bone loss, the advent of low-magnitude, high frequency whole-body vibration 
(WBV) has become a popular form of anabolic mechanical stimulation in bone (Rubin et 
al., 2001b). In the last decade alone, WBV has become wide-spread due to 
commercialization of these devices marketed towards athletic training, and as a potential 
prevention/treatment method for musculoskeletal diseases (Muir et al., 2013). 
WBV is accomplished by the subject (a human or animal) standing on a vibrating 
platform (Fritton et al., 1997). Vibration is a mechanical form of oscillatory motion that 
moves continuously back and forth about an equilibrium point (Halliday et al., 2008). In 
vivo vibration studies in animals and humans often report vibration with a sinusoidal 
function. The movement of vibration platforms can be controlled by altering frequency 
and/or amplitude (both of which affect acceleration). Frequency is measured by the 
number of oscillations per second, expressed in hertz (Hz) (Lorenzen et al., 2009). Peak-
to-peak amplitude is the maximum distance between the displacements on either side of 
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the equilibrium point. The maximum acceleration (rate of change in velocity over time) is 
dependent on frequency and amplitude. For a sinusoidal vibration, the maximum 
acceleration is given by the following equation: 
 
a max = A(2π f )
2
9.81  
where amax is maximum acceleration in g 
A is amplitude (0.5 of peak-to-peak displacement) in m 
f is the frequency in Hz 
 
Moreover, in the term ‘low magnitude, high-frequency vibration’, low-magnitude refers 
to acceleration (<1 g, where g = 9.98 m/s2) and high-frequency refers to frequencies in 
the range of 20 – 90 Hz (Lau et al., 2010). It is imperative that studies report these 
variables using consistent terminology for comparison among studies. 
It is important to note that, although use of WBV devices is commercialized and 
popular, the safety of these devices needs further study. Safety is a critical consideration, 
especially for those suffering with musculoskeletal diseases or injuries, and those who are 
infirm or elderly (Chan et al., 2013; Kiiski et al., 2008). Although vibration may be 
delivered with low acceleration, the signal can either become amplified (due to 
resonance) or attenuated (damped). Not surprisingly, transmissibility through skeletal 
tissues is dependent on the frequency, amplitude, maximal acceleration and location of 
measurement in the skeleton. To date, studies have shown that short daily exposures to 
vibration at low amplitudes are safe, but caution should be exercised with usage (Kiiski et 
al., 2008; Muir et al., 2013).  
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1.6.4  Effects of Whole-Body Vibration 
Low-magnitude, high-frequency WBV has been previously shown to increase 
bone formation (Garman et al., 2007; Hwang et al., 2009; Rubin et al., 2001a; Xie et al., 
2006; Xie et al., 2008), reduce fat formation (Luu et al., 2009; Rubin et al., 2007), 
increase lean muscle tissue (Verschueren et al., 2004; Xie et al., 2008) and improve 
balance (Gusi et al., 2006) (Figure 1.6). Low-magnitude, high-frequency vibration is 
estimated to produce microstrain that is several orders of magnitude below that which is 
experienced during vigorous physical activity in humans (Rubin et al., 2002). In vivo 
studies have demonstrated that brief vibration treatments with frequencies ranging from 
20-50 Hz over differing time courses (days, weeks, months) and can increase bone 
quantity and quality relative to controls (Judex et al., 2004, Rubin et al., 2002). 
Furthermore, hind-limb unloaded mice showed a significant reduction in the rate of bone 
formation (Rubin et al., 2001b). This effect in hind-limb unloaded mice was rescued by 
brief, intermittent vibration, which increased bone formation rates to control values. 
Vibration studies have tested a range of frequencies, amplitudes and accelerations for 
their impact on bone (Judex et al., 2005; Rubin et al., 2001b). However, despite the body 
of research showing a desirable effect of vibration on the skeleton, more recent studies 
have not supported this notion. Studies by other groups, using a variety of vibration dose 
parameters, do not show improved skeletal properties using WBV (Castillo et al., 2006; 
Cheung and Giangregorio, 2012; Lynch et al., 2011; Manske et al., 2012). Therefore, 
further studies are required to investigate the controversial results supporting the current 
paradigm. 
Additionally, a multitude of studies have reported the use of whole-body vibration  
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Figure 1.6 General overview of vibration-induced mechanotransduction. 
Osteoprogenitors, osteoblasts, osteoclasts and osteocytes are responsive to a 
variety of mechanical stimuli, including strain, fluid shear stress and vibration. The 
shaded triangle illustrates the strength of the vibration stimulus sensed at the animal, 
organ and cellular level. The mechanisms by which cells convert these stimuli into 
biological responses are referred to as mechanotransduction. Studies have shown that 
low-magnitude, high-frequency vibration can increase bone and muscle formation while 
reducing fat formation. However, the cellular mechanisms responsible for the changes 
seen with whole-body vibration are unknown. Given the clinical implications, 
understanding how whole-body vibration affects bone at the morphological and cellular 
level is of emerging interest. 
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as an anabolic factor in the musculoskeletal system, however, there remains to be a 
consensus on the ideal parameters to which tissues respond in an anabolic fashion. The 
proper anabolic dose of vibration frequency, amplitude, acceleration, and duration and 
repetitions of vibration exposure remains to be determined. Moreover, the cellular and  
molecular mechanisms underlying the response of bone to mechanical stimuli remain 
largely unknown. Taken together, this indicates the urgent need for further research on 
this form of mechanical stimulation as a training or treatment intervention. 
 
1.6.5 The Relationship between Mechanical Stimulation, Bone Formation and P2X7 
It is well established that mechanical loading is an strong anabolic stimulus for 
bone formation (Robling et al., 2006). As described above, mechanical stimulation leads 
to the release of nucleotides into the extracellular environment, which can then act as 
autocrine/paracrine regulators of osteoblast and osteoclast function through P2 receptor 
activation (Grol et al., 2009). Both bone cell types express multiple subtypes of P2X and 
P2Y receptors, and it has been hypothesized that P2 receptor signalling is important in 
mechanotransduction (Dixon and Sims, 2000) (Figure 1.3). A signalling cascade initiated 
by nucleotide release can elicit the formation of secondary signalling molecules such as 
NO, PGE2, and LPA from osteoblasts. Research from our laboratory has shown that 
osteoblasts produce LPA and PGE2 in response to P2X7 activation (Panupinthu et al., 
2008). Both NO and PGE2 are known as important biochemical mediators in mechanical 
loading (Robling et al., 2006). Secondary signalling along with P2 receptor activation can 
activate transcription factors (such as NFAT, CREB and β-catenin) leading to changes in 
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gene expression, resulting in enhanced osteoblast differentiation and bone formation 
(Figure 1.5).  
Studies have also shown that mechanical loading promotes osteoblast 
differentiation at the expense of adipogenesis (David et al., 2007). This is consistent with 
other work indicating that mechanical stimulation inhibits adipocyte differentiation from 
mesenchymal stem cells, favouring an osteogenic state even under the influence of an 
adipogenic environment (Sen et al., 2008). Furthermore, mouse calvarial cells exhibit 
pore formation in response to fluid shear stress (Li et al., 2005), suggesting involvement 
of P2X7. Additionally, the presence of P2X7 on osteoclasts can induce osteoclast 
apoptosis (Grol et al., 2009; Ke et al., 2003). Decreasing osteoclast function and 
increasing osteoblast function by mechanical stimulation and P2X7 activation may 
prevent or slow the detrimental effects of degenerative bone diseases. Whole-body 
vibration has been reported to enhance bone formation by reducing osteoclast function 
and increasing osteoblast function (Xie et al., 2006); it has also been shown to reduce 
adipogenesis (Luu et al., 2009; Rubin et al., 2007). Thus, whole-body vibration may 
cause release of ATP that subsequently activates P2X7, with consequent effects in bone 
and adipose tissues. P2X7 receptors themselves may be a target for future 
pharmacological and mechanical therapies.  
 
1.7  Rationale, Hypotheses and Objectives of the Research 
 
Given roles for P2X7 in the determination of cell fate and in 
mechanotransduction, we hypothesized that P2X7, mechanical vibration, and their 
possible interaction influence body composition in vivo. In this thesis, I developed a rapid 
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and reproducible method to characterize whole-body composition during growth and 
aging of mice, which has not been described previously. The goal was to use this and 
other methodologies to characterize a genetically modified mouse model with loss of 
P2rx7 function. I then investigated the response of mice to whole-body vibration and the 
possible role of P2X7 in this process. The three specific objectives were proposed, as 
described below. 
 
1.7.1  Quantitative Micro-Computed Tomography for Assessment of Age-Dependent 
 Changes in Murine Whole-Body Composition  
Rationale –Micro-computed tomography (micro-CT) is the gold-standard imaging 
modality used routinely to quantify radio-opaque tissue mass in small animal models, 
which also allows for accurate quantification of soft tissue volumes. Recent advances in 
micro-CT permit for in vivo imaging and quantification of whole-body composition 
(WBC), including total body, adipose, lean and skeletal tissue parameters that previously 
could only be evaluated post-mortem. In addition, there is a large demand for quantitative 
phenotyping of genetically modified mouse models. Consequently, there is a need to 
develop high-throughput methods for analysing WBC of mice. This is of particular 
importance for growth and aging studies, where mice must be scanned safely and 
repeatedly at several ages. However, a quantitative and effective method has yet to be 
validated for the repeated imaging of animals and quantification of WBC parameters. 
Specific Objective 1 – To characterize changes in whole-body composition of 
 mice during growth and aging using a novel, high-throughput method for analysis 
 of micro-CT images. 
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1.7.2 Loss of P2X7 Nucleotide Receptor Function Leads to Abnormal Fat 
 Distribution in Mice  
 Rationale – Expression of P2X7 receptors has been reported in adipocytes, yet 
little is known about their role in this tissue. Recent studies have also shown that the 
P2X7 receptor regulates metabolism and energy homeostasis in other cell types. Coupling 
this to previous research from our laboratory indicating that adipogenic markers are 
upregulated in cells lacking P2X7, a further investigation into the in vivo effects of P2rx7 
loss-of-function is necessary. As whole-body composition of skeletal, lean and adipose 
tissues change with age, we investigated an aging mouse model to potentially provide 
relevance to age-related diseases such as osteoporosis and obesity. 
Specific Objective 2 – To assess the role of P2X7 in adipocyte distribution and 
 lipid accumulation in vivo. 
 
1.7.3 Low-Magnitude, High-Frequency Vibration has No Effect on Murine Whole-
 Body Composition and Bone Microarchitecture 
Rationale – Recent evidence from our laboratory demonstrates that activation of 
P2X7 regulates both osteoblast differentiation and adipogenesis. Moreover, the signalling 
molecules regulating mesenchymal stem cell differentiation in response to 
mechanotransduction have yet to be elucidated. We propose that ATP is released upon 
mechanical stimulation, leads to the activation of P2X7 receptors, modulating 
osteogenesis and adipogenesis. Mechanical stimulation through WBV has been shown by 
some authors to have favourable effects on bone, adipose and muscle tissues. To 
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investigate vibration in a preclinical model, we studied its effects on WBC in wild-type 
and P2rx7 loss-of-function mice.  
Specific Objective 3 – To investigate the effects of whole-body vibration on body 
 composition and bone microarchitecture, and the possible role of P2X7 in these 
 processes.  
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CHAPTER TWO 
 
 
QUANTITATIVE MICRO-COMPUTED TOMOGRAPHY FOR 
ASSESSMENT OF AGE-DEPENDENT CHANGES  
IN MURINE WHOLE-BODY COMPOSITION1 
                                                
1 This Chapter has been reproduced from: 
K.L. Beaucage, S.I. Pollmann, S.M. Sims, S.J Dixon, D.W. Holdsworth. 2014. 
Quantitative micro-computed tomography for assessment of age-dependent changes in 
murine whole-body composition. [submitted], with some modifications. 
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2.1  Chapter Summary 
Micro-computed tomography (micro-CT) is used routinely to quantify radio-
opaque tissue mass in small animal models. Our goal was to evaluate repeated in vivo 
micro-CT imaging for monitoring whole-body composition in studies of growth and 
aging in mice. Male mice from 2-52 weeks of age were anesthetized and imaged using an 
eXplore Locus Ultra and/or eXplore speCZT scanner. Images were reconstructed into 3D 
volumes, signal-intensity thresholds were used to classify each voxel as adipose, lean or 
skeletal tissue, and tissue masses were calculated from assumed densities. Images 
revealed specific changes in tissue distribution with growth and aging. Quantification 
showed biphasic increases in total CT-derived body mass, lean and skeletal tissue masses, 
consisting of rapid increases to 8 weeks of age, followed by slow linear increases to 52 
weeks. In contrast, bone mineral density increased rapidly to a stable plateau at ~14 
weeks of age. On the other hand, adipose tissue mass increased continuously with age. A 
micro-CT-derived total mass was calculated for each mouse and compared with 
gravimetrically measured mass, which differed on average by less than 3%. Parameters 
were highly reproducible for mice of the same age, but variability increased slightly with 
age. There was also good agreement in parameters for the same group of mice scanned on 
the eXplore Locus Ultra and eXplore speCZT systems. This study provides reference 
values for normative comparisons; as well, it demonstrates the usefulness of in vivo 
single-energy micro-CT scans to quantify whole-body composition in high-throughput 
studies of growth and aging in mice. 
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2.2  Introduction 
Mouse models are increasingly important in biomedical research due to their ease of 
genetic manipulation, ability to mimic human diseases, small body size, and relatively 
affordable costs (Rosenthal and Brown, 2007). When using animal models, it is important 
to have reference values for normative comparisons. Mouse strains often used in research 
today include C57BL/6, BALB/c, 129 substrains, C3H and DBA/2 mice (Beck et al., 
2000; Buie et al., 2008; Crawley et al., 1997; Hankenson et al., 2008). Descriptions of the 
most commonly used C57BL/6 mouse include masses of wet and dry individually-
isolated bones, and bone mineral density (BMD) and bone mineral content (BMC) of 
specific bones (e.g. tibia and femur) obtained using destructive or imaging methods 
(Brochmann et al., 2003; Glatt et al., 2007; Sheng et al., 1999; Somerville et al., 2004). 
Although many parameters can be measured post-mortem, longitudinal in vivo studies of 
growing and aging mice were not possible until the advent of non-invasive imaging 
modalities. It is now important to establish safe, effective and reproducible approaches 
for assessing whole-body composition in vivo and to establish normal reference values 
for growing and aging mice.  
Several in vivo imaging modalities exist for determining skeletal phenotypes in 
animals, each with differing strengths and weaknesses. Dual-energy X-ray 
absorptiometry (DXA) is a simple approach to determine areal BMD (aBMD) and is used 
for clinical diagnosis and monitoring the progression of bone diseases such as 
osteoporosis (Pisani et al., 2013). Determination of fat content from the scans is also 
possible (Halldorsdottir et al., 2009; Pietrobelli et al., 1996; Senn et al., 2007; Sjogren et 
al., 2001). However, DXA does not distinguish between cortical and trabecular bone, and 
 57 
is known to overestimate or underestimate the density of large or small bones, 
respectively (Judex et al., 2003). When using small animal models such as mice, the 
accuracy of measurement is critical; therefore, CT methods are preferred. High-resolution 
peripheral quantitative computed tomography (HR-pQCT) is a method used clinically to 
determine BMD in peripheral long bones of human patients (Cheung et al., 2013) and has 
also been used to quantify BMD and bone microarchitecture in rodents (Bagi et al., 2006; 
Beamer et al., 1996; Richman et al., 2001). High-resolution magnetic resonance imaging 
(HR-MRI) can be used to quantify soft and hard tissues. Although radiation is not an 
issue in this method, high resolution images for bone morphometry require long scan 
times (Donnelly, 2011). Another CT method to determine BMD is synchrotron radiation 
micro-CT (SRmuCT). Although SRmuCT yields images with high spatial resolution and 
excellent signal-to-noise ratio, it has more commonly been used for ex vivo rather than in 
vivo studies (Donnelly, 2011; Ito, 2005; Ito et al., 2003; Martin-Badosa et al., 2003; 
Raum et al., 2007). Furthermore, a limitation of this modality is that few synchrotron 
facilities are available (Donnelly, 2011). Therefore, the widely available technology of 
micro-computed tomography (micro-CT) has become a popular choice for assessment of 
BMD and bone microarchitecture (Kazakia et al., 2008). 
Micro-CT is the gold standard for morphologic assessment and quantification of 
radio-opaque tissues in small samples (Donnelly, 2011; MacNeil and Boyd, 2007), 
including evaluation of skeletal anatomy, abnormalities and morphometry in rodent 
models (Ford-Hutchinson et al., 2003; Hankenson et al., 2008). Moreover, micro-CT has 
several advantages: it is designed specifically for imaging and analysis of small samples 
at high-resolution; some systems have the capacity to perform scans of whole animals 
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such as small rodents; in vivo scans can be obtained rapidly without sacrificing animals; 
and longitudinal studies with repeated scanning of animals are possible with low 
radiation exposure (Glatt et al., 2007; Granton et al., 2010; Judex et al., 2003). In 
addition, advanced micro-CT imaging allows for accurate quantification of soft-tissue 
volumes. This permits assessment of whole-body composition (WBC) in vivo, including 
total body, adipose, lean and skeletal tissue parameters (Granton et al., 2010), which 
previously could only be evaluated post-mortem using the other imaging modalities 
mentioned above. Thus, advanced in vivo micro-CT imaging is an emerging technique to 
monitor growth including normal and abnormal skeletogenesis in rodents (Guldberg et 
al., 2004). However, advanced image analysis can be quite time consuming and tedious, 
as large data sets can take hundreds of hours to quantify using conventional approaches. 
Therefore, as micro-CT has become a preferred imaging modality for quantification of 
WBC in small animals, the need for high-throughput methods of analysis becomes 
increasingly urgent.  
In the present study, we report the first use of micro-CT to monitor and repeatedly 
quantify WBC in groups of mice during growth and aging. WBC analysis was enabled by 
in-house-designed software, which quantifies whole-body parameters from scanned 
images, based on threshold density values of specific tissues and phantom calibrators. 
Although others have previously reported densities and characteristics of specific bones 
(Glatt et al., 2007; Miller et al., 2007; Somerville et al., 2004), there have been no 
previous studies using in vivo micro-CT to quantify changes in WBC of mice during 
growth and aging. In the present study, cohorts of mice were scanned at 3-week intervals 
from 2 to 8 weeks of age and from 8 to 26 weeks of age, with additional groups scanned 
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at 39 and 52 weeks of age. Outcome values included: total body mass (g); adipose, lean 
and skeletal tissue masses (g) and mass percents (%); bone mineral density (BMD, mg 
HA/cm3); and bone mineral composition (BMC, mg HA). Femur and tibia lengths were 
measured using anatomical markers, and maximum BMD of femoral mid-diaphyses was 
quantified. Variability and internal validity of the scanning protocol were assessed. Our 
findings establish that non-invasive single-energy micro-CT is an accurate and effective 
tool for characterizing the WBC of mice during growth and aging.   
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2.3  Materials and methods 
2.3.1  Animals 
Mice, maintained on a mixed genetic background of commonly used strains (C57BL/6 × 
129/Ola ×  DBA/2), were housed in standard cages and maintained on a 12-hour 
light/dark cycle, with water and standard mouse chow available ad libitum (2018 Teklad 
Global 18% protein rodent diet, Harlan Laboratories, Indianapolis, IN, USA). This study 
was conducted in accordance with the policies and guidelines of the Canadian Council on 
Animal Care and was approved by the Animal Use Subcommittee of The University of 
Western Ontario, London, Canada. Four cohorts of mice were studied. For cohort 1, the 
same mice were scanned at 2, 5 and 8 weeks of age. The mice in cohort 2 were scanned 
at three-week intervals from 8 to 26 weeks of age, inclusive. Cohort 3 mice were studied 
at 39 weeks of age. Finally, the mice in cohort 4 were scanned at 52 weeks of age (Table 
2.1). 
 
2.3.2  Micro-computed tomography (micro-CT) image acquisition 
Whole-body composition of mice between 2 and 52 weeks of age was assessed using 
micro-CT. Mice were anesthetized with isoflurane (Forane, catalog # CA2L9100, Baxter 
Corporation, Mississauga, ON, Canada) and imaged using an eXplore Locus Ultra micro-
CT scanner and/or an eXplore speCZT scanner (GE Healthcare Biosciences, London, 
ON, Canada). A calibrating phantom composed of air, water and cortical bone-mimicking 
epoxy having a bone mineral equivalent of 1100 mg/cm3 (SB3; Gammex, Middleton, WI, 
USA) (White, 1978) was scanned together with the animals. On the eXplore Locus Ultra 
scanner, 1000 projection images were obtained over a single 16- 
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Table 2.1 Mouse cohorts. 
 
Whole-body scans using micro-computed tomography were performed on four cohorts of 
male mice. In cohort 1, the same mice were scanned at three-week intervals (2, 5 and 8 
weeks of age). Cohort 2 mice were scanned at three week-intervals (from 8-26 weeks of 
age). Cohort 3 was scanned only at 39 weeks and cohort 4 only at 52 weeks of age. All 
cohorts were scanned using the eXplore Locus Ultra system, and cohort 1 was also 
scanned using the eXplore speCZT system. 
 
  
Cohort 1 2 3 4 Total 
Age (weeks) 2-8 8-26 39 52 2-52 
Number of mice (n) 8 8 8 7 31 
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second rotation (80 kVp, 55 mA tube current, 16 ms exposure). On the eXplore speCZT 
scanner, 900 projection images were obtained over a single 5-minute rotation (90 kVp, 40 
mA tube current, 16 ms exposure). While still anesthetized immediately after scanning, 
mice were gravimetrically weighed using a portable electronic precision scale (Acculab 
VICON VIC-511; Sartorius Group, Germany). 
 Data sets were reconstructed into 3D volumes from the X-ray projection data with 
nominal isotropic voxel spacing of 154 µm (eXplore Locus Ultra) and 50 µm (eXplore 
speCZT) using a cone-beam filtered backprojection algorithm. The 50 µm volumes from 
the eXplore speCZT were then spatially-averaged to 100 µm (to improve the signal-to-
noise characteristics of the volume) and 150 µm (to compare with data from the eXplore 
Locus Ultra). The reconstructed data were linearly rescaled into Hounsfield units (HU), 
with the voxel gray-level of air being -1000 HU and water 0 HU.  
 
2.3.3  Analysis of whole-body composition  
Using MicroView software (GE Healthcare Biosciences), three signal-intensity 
thresholds (-200, -30 and 190 HU) were used to classify each voxel as adipose (-200 to -
31 HU), lean (-30 to 189 HU), or skeletal tissue (≥190 HU), respectively for the 154 and 
150 µm scans. A different set of global thresholds was determined using MicroView for 
classification of adipose, lean and skeletal tissue for the 100 µm scans (-275, -40 and 250 
HU, respectively). The signal-intensity thresholds were determined visually by applying 
thresholds to CT-derived data from several mice at each age to properly classify tissues 
based on observed anatomy. In-house-designed software was used to calculate tissue 
masses from assumed tissue densities of 0.95 (adipose), 1.05 (lean) and 1.92 (skeletal) 
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g/cm3, as listed by the International Commission on Radiation Units and Measurements 
(ICRU, 1989). The software computed the tissue masses first by calculating the volume 
of voxels (in cm3) for each of adipose, lean, and bone tissue using the signal-intensity 
thresholds described above (Beaucage et al., 2014; Granton et al., 2010). Once the 
volume of each tissue was calculated, its contributing mass was computed as the product 
of the tissue volume and the corresponding tissue density. The sum of all tissue masses 
yielded a CT-derived estimate of whole-body mass. In addition, the software was used to 
calculate BMD and BMC. Briefly, BMD was computed as the ratio of the average HU 
value of the skeletal region of interest (ROI) to the measured HU value of the SB3 
calibrator, multiplied by the known hydroxyapatite (HA)-equivalent density of the SB3 
(1100 mg/cm3). Thereafter, the program automatically computed BMC as the product of 
the BMD (mg HA/cm3) and the total volume of the skeletal ROI used in the BMD 
calculation. 
 
2.3.4  Hind-limb long-bone length  
Bone lengths were determined using the line measurement tool in MicroView. Femurs 
were measured from the base of the lateral femoral condyle to the tip of the greater 
trochanter. Tibial lengths were measured from the base of the medial malleolus to the tip 
of the intercondylar eminence.  
 
2.3.5  Determination of maximum bone mineral density 
The maximum value of BMD was determined for an ROI that encompassed the mid-
diaphysis of the left femur. The ROI was 33% of the total femur length along the long 
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axis and spatially encompassed the entire mid-diaphysis in the other axes. In-house-
designed software was used to determine the maximum BMD value for each femur. For 
consistency, when assessing these BMD values in Cohort 1 mice using 100 µm eXplore 
speCZT scans, we used the same threshold value as above for skeletal tissue (250 HU). 
Similarly, when assessing the BMD in skeletally mature mice (Cohorts 2-4) using 154 
µm eXplore Locus Ultra scans, we used the same threshold value as above for skeletal 
tissue (190 HU). For each ROI, a histogram of BMD values was generated, plotting the 
gray level frequency versus the gray level from the indicated skeletal thresholds to the 
maximum value. The maximum BMD was reported as the 95th percentile of this 
histogram. 
 
2.2.6  Statistical analyses  
Data are presented as means ± standard deviation (S.D.). Differences between two groups 
were assessed using the Student’s t-test. Differences among three or more groups were 
evaluated by two-way analysis of variance followed by a Bonferroni multiple 
comparisons test. Curves were fit to growth data (total body mass, lean and skeletal tissue 
mass, BMD and BMC) by non-linear least squares regression using two-phase 
association in GraphPad Prism software version 5 (GraphPad Software Inc., La Jolla, CA, 
USA). Curves were fit to growth data for adipose tissue mass by non-linear least squares 
regression using an exponential growth equation in GraphPad Prism. Differences were 
accepted as statistically significant at p < 0.05. All n values represent the number of mice 
used in each group.  
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2.4  Results 
2.4.1  Imaging whole-body composition of mice during growth and aging 
A total of 31 male mice, divided into four cohorts, were assessed using in vivo 
quantitative micro-CT at specific ages (Table 2.1). Scans obtained using the eXplore 
Locus Ultra micro-CT were reconstructed with nominal isotropic voxel spacing of 154 
µm and rescaled into Hounsfield units. An in-house-designed program was used to assign 
each voxel as adipose, lean or skeletal tissue, based on threshold values. Representative 
mid-coronal images demonstrate the pattern of changes in whole-body composition 
during growth and aging (Figure 2.1). At 2 weeks of age, the mice had a large amount of 
adipose tissue (blue) relative to their body size, which appeared to be primarily 
subcutaneous fat. At this age, the skeleton was still developing, as evident by the larger 
relative size of the appendicular skeletal elements and skull relative to overall body size, 
as well as incomplete mineralization of caudal vertebrae. By 5 weeks of age, we saw a 
marked reduction in subcutaneous adipose tissue accompanied by a corresponding 
increase in the proportion of lean tissue. At 52 weeks of age, mice exhibited a marked 
increase in visceral adiposity at the expense of lean tissue. These examples illustrate that 
3D micro-CT images with appropriate thresholding can reveal the localization of tissue 
types within the body and changes in their distribution with growth and aging.   
 
2.4.2  Quantification of whole-body composition during growth and aging 
Adipose, lean and skeletal tissue volumes were converted into tissue masses by 
multiplying each volume by the respective tissue densities of 0.95, 1.05, and 1.92 g/cm3 
(ICRU, 1989). Time course studies revealed dramatic changes in body composition
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Figure 2.1 Representative micro-CT images of whole-body composition showing 
total, adipose, lean, and skeletal tissues.  
Cohorts of male mice at several ages were anesthetized for whole-body scans 
using the eXplore Locus Ultra micro-CT. Scans were reconstructed with nominal 
isotropic voxel spacing of 154 µm and rescaled into Hounsfield units using the same 
protocol for all ages. An in-house-designed program was used to assign each voxel as 
adipose, lean or skeletal tissue, based on threshold values. Each row shows the same mid-
coronal slice from a single representative mouse at each age, indicated on the left. Images 
were overlaid with the identified skeletal tissue (shown in white as surface-rendered 
images of the highest quality with no decimation). Second and third columns show 
adipose tissue (blue) and lean tissue (red), respectively. High-density particles in the 
abdomen of mice from 5-52 weeks of age arose from material in the animal chow. Scale 
bar represents 1 cm at each age point. Images are representative of at least 7 mice at each 
age point.   
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during growth, and more modest changes during aging (Figure 2.2). Total CT-derived 
body mass showed an initial rapid increase from 2 to 8 weeks of age, followed by a slow 
linear increase to 52 weeks of age (Figure 2.2 A). Lean and skeletal tissue masses and 
BMC displayed a pattern similar to that of total body mass (Figure 2.2 C, 2 E, 2 F). In 
contrast, BMD rose rapidly until 11-14 weeks and then plateaued (Figure 2.2 B). Unlike 
other parameters, adipose tissue mass increased continuously, with the rate of increase 
escalating with age (Figure 2.2 D). The percent change in whole-body composition 
parameters was calculated between 2 and 52 weeks of age (Table 2.2). We found that 
lean and skeletal masses increased 300-350%, whereas adipose tissue mass showed a 
larger relative increase of over 460%. BMD doubled and BMC increased 7-fold, 
reflecting both the increase in BMD and growth in skeletal mass over time.  
We next assessed the variability in whole-body composition parameters among 
mice at each age. Figure 2.3 illustrates the range of values observed for each individual 
mouse. Variability was also quantified as the coefficient of variation (Table 2.3). 
Variability in CT-derived total body mass was relatively constant at each age (Figure 2.3 
A), with coefficients of variation ranging from 7 to 9%.  On the other hand, coefficients 
of variation for BMD and BMC were larger at 2 weeks of age decreasing to 1-2% and 4-
5% in older age groups, respectively (Figure 2.3 B and C). Adipose tissue mass showed 
greatest variability (Figure 2.3 D), with coefficients ranging from 16% at 2 weeks of age 
to 26-33% in older mice. Variability of lean tissue mass was relatively constant (Figure 
2.3 E), with coefficients ranging between 4 and 6%; whereas variability in skeletal tissue 
mass decreased with aging (Figure 2.3 F), with the coefficient of variation declining from 
10% at 2 weeks to 3% at 52 weeks.   
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Figure 2.2 Quantification of changes in whole-body composition with mouse age. 
Cohorts of male mice were imaged as described in the legend to Figure 2.1. In-
house-designed software was used to calculate tissue masses from assumed tissue 
densities of 0.95 (adipose), 1.05 (lean), and 1.92 (skeletal) g/cm3, respectively.  Total 
body mass (A) exhibited an initial rapid increase from 2 to 8 weeks of age, followed by a 
slow linear increase to 52 weeks. Bone mineral density (BMD, B) also showed a rapid 
increase until 11-14 weeks of age, but in this case was followed by a plateau. Bone 
mineral content (BMC, C) and lean and skeletal tissue masses (E, F) showed patterns 
similar to A. In contrast, adipose tissue mass (D) displayed a distinct pattern, increasing 
continuously with the rate of increase rising with age. Data points for 8-week-old mice in 
cohorts 1 and 2 are plotted overlaid in each graph. Data are means ± S.D., n ≥ 7 mice per 
age group. Curves were fit by non-linear least squares regression.  
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Table 2.2 Percent change of whole-body composition parameters with 
growth and aging. 
 
 
Data represent means ± S.D. of the indicated parameters obtained from scans on the 
eXplore Locus Ultra of mice at 2 weeks of age and 52 weeks of age (n = 8 and 7 mice, 
respectively). All parameters were significantly greater at 52 weeks of age compared to 
their values at 2 weeks of age (p < 0.05 determined using unpaired two-tailed Student’s t-
test).  
  
 2 weeks of age Mean 
± S.D. 
52 weeks of age 
Mean ± S.D. 
Percent increase 
CT-derived total  
body mass (g) 7.8 ± 0.2 36.3 ± 1.2 364 
Adipose tissue mass (g) 1.8 ± 0.3 10.1 ± 2.6 463 
Lean tissue mass (g) 4.8 ± 0.2 21.3 ± 1.2 341 
Skeletal tissue mass (g) 1.2 ± 0.1 4.8 ± 0.1 306 
BMD (mg HA/cm3) 171.2 ± 6.8 339.6 ± 6.3 98 
BMC (mg HA) 105.8 ± 14.5 850.9 ± 37.0 704 
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Figure 2.3 Variability of whole-body composition values. 
Images of male mice were obtained and analyzed as described in the legends to 
Figures 1 and 2. Data points (black circles) represent values of the indicated parameter 
for each individual mouse. Data show the vertical scatter for the age indicated 
numerically on the x-axis (horizontal scatter was introduced for clarity only). Eight mice 
were imaged at each age except 52 weeks, where n = 7 mice. Bars indicate mean ± S.D. 
for each age. Data for 8-week-old mice are presented for both cohorts 1 and 2. A-F 
illustrate parameters of whole-body composition in absolute values. G-I illustrate 
adipose, lean and skeletal tissue masses as a percentage of the total CT-derived body 
mass.   
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Table 2.3 Coefficients of variation in whole-body composition values at selected 
ages. 
  
Male mice were scanned and images were analyzed as described in the legends to Figures 
1 and 2. Coefficients of variation were calculated as the ratio of the S.D. to the mean, 
expressed as a percentage. Eight mice were imaged at each age except 52 weeks, where n 
= 7 mice.  
 
  
 Coefficient of Variation (%) 
2 weeks of age 26 weeks of age 52 weeks of age 
CT-derived total 
body mass 
7.6 8.5 9.0 
BMD 4.0 1.3 1.8 
BMC 13.7 4.2 4.4 
Adipose tissue mass 15.8 32.6 25.8 
Lean tissue mass 4.3 5.2 5.8 
Skeletal tissue mass 10.0 4.1 2.9 
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When tissue masses were expressed as a percentage of total body mass, a large 
decrease in adipose tissue mass was apparent from 2 to 5 weeks of age, with a 
corresponding increase in lean tissue mass (Figure 2.3 G, H).  In contrast, the percentage 
of skeletal tissue remained relatively constant with growth and aging (Figure 2.3 I).  
 
2.4.3  Length of long bones during growth and aging  
When characterizing skeletal phenotypes of mice, the assessment of bone length has been 
a measurement frequently reported in the literature (Beamer et al., 1996; Brodt et al., 
1999; Glatt et al., 2007; Somerville et al., 2004). Therefore, to establish external validity, 
we determined the lengths of hind-limb long bones using our micro-CT data sets. Using 
the line measurement tool in MicroView software, the right and left tibiae and femurs 
were measured in the scanned volume of each mouse. Tibial lengths were determined 
from the base of the medial malleolus to the tip of the intercondylar eminence (Figure 2.4 
A, B). Femoral length was measured from the base of the lateral femoral condyle to the 
tip of the greater trochanter (Figure 2.4 D, E). Both bones showed rapid growth – over 2 
to 8 weeks of age, tibial length increased from 10.5 to 16.3 mm and femoral length 
increased from 8.7 to 15.3 mm. Thereafter, there was only a slight increase in length to 
17.3 mm for the tibia and 16.7 mm for the femur at 52 weeks of age. There were no 
significance differences between left and right bones at any age point (Figure 2.4 C, F).  
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Figure 2.4 Lengths of tibiae and femurs in growing and aging mice.  
Right and left tibiae and femurs were measured using the line measurement tool 
in MicroView from base of the medial malleolus to tip of the intercondylar eminence (for 
tibiae) and base of the lateral femoral condyle to tip of the greater trochanter (for femurs). 
Right and left bone lengths were overlaid (C, F), revealing no significant differences 
between right and left limb lengths (p > 0.05, determined by two-way repeated measures 
ANOVA). Data are means ± S.D. Eight mice were imaged at each age except 52 weeks, 
where n = 7 mice. 
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2.4.4  Maximum bone mineral density  
As regional variations in BMD occur within skeletal tissue, the maximum BMD value 
within a defined ROI better reflects the extent of compact bone mineralization. Therefore, 
we assessed maximum BMD of an ROI comprised of the mid-diaphyseal region of the 
femur. Maximum BMD values were reported as the 95th percentiles of the densities. 
These values displayed a rapid increase from 2 to 11 weeks of age, followed by a slow 
linear increase to 52 weeks of age (Figure 2.5). Values for the 99th percentile showed a 
similar pattern as the 95th percentile, reaching 1102 ± 38 mg HA/cm3 at 39 weeks of age, 
comparable to previously reported values for cortical bone BMD in mice of 1100 to 1200 
mg HA/cm3 (Entezari et al., 2012; Windahl et al., 1999). These findings reveal that 
maximum BMD increases during growth in mice.   
 
2.4.5 Internal validity, precision and reproducibility of scanning protocols 
To assess reproducibility of the scanning protocol, we examined two separate cohorts of 
mice at 8 weeks of age (C1 and C2). Both cohorts were scanned using the eXplore Locus 
Ultra micro-CT. Images were reconstructed with isotropic voxel spacing of 154 µm, 
rescaled into Hounsfield units and subjected to whole-body composition analysis. Similar 
values were obtained for the two cohorts of mice (Figure 2.6). For example, the 
differences in gravimetric and CT-derived total body masses were only 2.9% and 2.5%, 
respectively. This similarity provided justification for combining data from the two 
cohorts of mice to obtain the time courses illustrated in Figure 2.2. Moreover, there was 
no significant difference between total body masses measured gravimetrically and using 
micro-CT.   
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Figure 2.5 Maximum bone mineral density.  
Mice from 2 to 8 weeks of age were scanned on the eXplore speCZT system at 50 
µm and re-binned to 100 µm for these analyses. Mice from 11 to 52 weeks of age were 
scanned on the eXplore Locus Ultra system at 154 µm nominal voxel spacing, as 
described in the legends of Figures 1 and 2. Left femurs were cropped from the whole-
body images and axes were reoriented. A region of interest (ROI) that encompassed the 
mid-diaphysis in all three spatial directions was cropped from each of the volumes. The 
ROI, which included only cortical bone, was then used to determine the maximum value 
of BMD. Data are means ± S.D., n = 7 mice per age group. The curve was fit by non-
linear least squares regression.  
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Figure 2.6 Reproducibility of whole-body composition determinations. 
Two separate cohorts of 8-week-old male mice were imaged as described in the 
legend to Figure 1 and then weighed to determine gravimetric total body mass. Data were 
subsequently analyzed to determine CT-derived total body mass and adipose, lean and 
skeletal tissue masses as described in the legend to Figure 2.  Symbols represent values of 
the indicated parameter for each individual mouse (filled black circles represent animals 
in cohort 1, and open circles represent cohort 2). Bars are means ± S.D. Eight mice were 
imaged in each cohort. There were no significant differences between values of 
gravimetric and CT-derived total body masses, providing validation of the micro-CT-
derived tissue mass measurements. In addition, there were no significant differences in 
masses of adipose, lean or skeletal tissue between cohorts 1 and 2 (p > 0.05, determined 
by two-way ANOVA).  
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 Next, the relationship between gravimetric and CT-derived total body mass was 
examined in greater detail.  We compared the gravimetric to the CT-derived mass at all 
ages (Table 2.4). The computed total mass corresponded well with the weight of each 
mouse. The CT-derived masses were consistently less than the gravimetrically measured 
masses, differing by < 3%. Although small, this difference was significant in mice ≥ 17 
weeks of age. These data provide internal validation of the accuracy of our micro-CT-
derived tissue mass measurements.  
 As described above, whole-body composition was assessed using the eXplore 
Locus Ultra micro-CT scanner at 154 µm resolution. However, the growing mice in 
cohort 1 (age 2-8 weeks) had smaller, less mineralized bones. Therefore, to confirm the 
accuracy of measurements made using the eXplore Locus Ultra scanner, cohort 1 was 
also scanned at higher resolution using the eXplore speCZT scanner. Images produced 
using the eXplore speCZT scanner at 50 µm isotropic voxel spacing were spatially-
averaged to 100 and 150 µm. There were small, but in some cases, statistically significant 
differences in the CT-derived measures of total mass, BMD, BMC, and adipose, lean and 
skeletal tissue mass obtained using each scanner (Figure 2.7). CT-derived total body 
mass, BMC and lean tissue mass showed the least differences among scan conditions 
(Figure 2.7 A, C and E). Scans obtained using the eXplore Locus Ultra appeared to 
underestimate adipose tissue mass relative to those obtained using the eXplore speCZT 
scanner (Figure 2.7 D and G), while slightly overestimating lean tissue mass (Figure 2.7 
E and H).  Interestingly, images obtained using the eXplore speCZT scanner with 100 µm 
voxel spacing, appeared to underestimate BMD relative to the other conditions (Figure 
2.7 B), while overestimating skeletal tissue mass (Figure 2.7 F and I).  
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Table 2.4 Gravimetric and CT-derived total body masses of mice at each age. 
 
Male mice were imaged as described in the legend to Figure 1 and then weighed to 
determine gravimetric total body mass. Data were subsequently analyzed to determine 
CT-derived total body mass. For 8-week-old mice, data are shown for cohorts 1 and 2, 
individually and combined. Data are means ± S.D. n equals the number of mice scanned. 
The percent differences between means are shown in the right column. * indicates 
significance difference between gravimetrically and micro-CT-derived total body masses 
(p < 0.05, assessed by two-way repeated measures ANOVA with Bonferroni’s post hoc 
test).  
 
Age    
(weeks) Cohort 
Gravimetric Mass (g) 
Mean ± S.D. 
CT-derived Mass (g) 
Mean ± S.D. n 
%   
Difference 
 2 1 8.0 ± 0.2 7.8 ± 0.2 8 1.9 
 5 1 19.5 ± 0.5 19.1 ± 0.6 8 1.7 
 8 1 24.3 ± 0.5 23.9 ± 0.5 8 1.6 
 8 2 23.6 ± 0.6 23.3 ± 0.6 8 1.6 
 8 1 + 2 24.0 ± 0.4 23.6 ± 0.4 16 1.6 
11 2 22.7 ± 0.5 22.2* ± 0.5 8 2.2 
14 2 23.1 ± 0.5 22.8 ± 0.5 8 1.5 
17 2 24.0 ± 0.4 23.4* ± 0.4 8 2.3 
20 2 24.8 ± 0.8 24.2* ± 0.7 8 2.4 
23 2 25.8 ± 0.7 25.1* ± 0.7 8 2.8 
26 2 26.2 ± 0.8 25.5* ± 0.8 8 2.9 
39 3 33.2 ± 0.9 32.6* ± 0.9 8 2.1 
52 4 37.2 ± 1.3 36.3* ± 1.2 7 2.5 
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Figure 2.7 Comparison of whole-body composition values determined using 
different scanners and voxel spacing.  
Cohort 1 mice were scanned at 2, 5 and 8 weeks of age on both the eXplore Locus 
Ultra and eXplore speCZT micro-CT scanners. Images were reconstructed to 154 µm for 
the eXplore Locus Ultra (green), and 150 µm and 100 µm for the eXplore speCZT (red 
and blue, respectively), and rescaled into Hounsfield units. Each voxel was then assigned 
as adipose, lean or skeletal tissue, and tissue masses were calculated. A-F illustrate 
parameters of whole-body composition in absolute values. G-I illustrate adipose, lean and 
skeletal tissue masses as a percentage of the CT-derived total body mass. Data are means 
± S.D., n = 8 mice in each cohort. a indicates significant difference between the Ultra and 
speCZT 150 µm scans, b indicates significant difference between the Ultra and speCZT 
100 µm scans, and c indicates significant difference between the speCZT 150 µm and 
speCZT 100 µm scans (p < 0.05, determined by two-way repeated measures ANOVA 
with Bonferroni’s post hoc test). 
 
 
 
 
 
 
 81 
 
 
 
 
 
 82 
 Taken together, these data establish that non-invasive single-energy micro-CT is a 
valid, precise and reproducible tool for characterizing WBC of mice during growth and 
aging. 
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2.5  Discussion 
BMD and composition are commonly reported measures of bone quantity and quality; 
these can be used to infer skeletal strength, fracture risk and disease state (Donnelly, 
2011; Dougherty, 1996; Kazakia et al., 2008). Invasive methods have traditionally been 
used to determine BMD and composition, requiring post-mortem studies of whole bones 
in small animals. Destructive testing can be used to assess microarchitecture, mechanical 
tests to determine strength and elastic modulus, and ash measurements to reveal chemical 
composition (Donnelly, 2011; Kazakia et al., 2008). These methods are time consuming, 
destructive and require sacrificing the animal. Therefore, rapid, quantitative and non-
invasive alternatives are desirable. Imaging modalities such as micro-CT have become a 
preferred avenue for measuring BMD and microarchitecture of isolated bones, in addition 
to assessing skeletal growth in vivo (Bouxsein et al., 2010; Guldberg et al., 2004).  
 In the present study, we investigated changes in whole-body composition with 
growth and aging in mice. Using non-invasive micro-CT, we were able to repeatedly scan 
cohorts of mice over several ages. Our results provide valuable reference data for 
researchers using mouse models of development, aging and disease. The whole-body 
masses measured using gravimetric and CT methods align well with previous reports of 
age-related changes in gravimetric whole-body mass of mice. Our mice more than 
doubled their body mass between 2 and 5 weeks of age, and exhibited ~50% increase 
between 4 and 8 weeks.  Previous studies of growing male C57BL/6 mice reported a 
more modest ~30% increase between 1 to 2 months (Glatt et al., 2007), and a comparable 
~47% increase in body mass (Somerville et al., 2004). Moreover, between 4 and 52 
weeks of age, we observed an ~2.3-fold increase in body mass similar to previous reports 
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of ~2.0 to 2.2-fold increase in body mass over the same period (Glatt et al., 2007; 
Halloran et al., 2002; Somerville et al., 2004).  
 To the best of our knowledge, the present study is the first to report CT-derived 
whole skeleton data for mice. Previous studies have reported CT-derived BMD for 
individual bones (vertebra, femur, tibia) (Amblard et al., 2003; Beamer et al., 1996; Buie 
et al., 2008; Martin-Badosa et al., 2003; Richman et al., 2001). We found that whole-
body BMD values increase until 11 to 14 weeks of age, then plateau. Glatt and colleagues 
showed using DXA that whole-body aBMD increased rapidly up to 4 months of age in 
C57BL/6 mice, followed by a slower increase up to 12 months of age (Glatt et al., 2007). 
Bonkowski et al. measured aBMD and BMC in young (6-7 weeks), adult (7-10 months) 
and aged (28-32 months) mice. In keeping with our findings, they reported a large 
increase associated with growth (young-adult) and only small changes associated with 
aging (adult-aged) (Bonkowski et al., 2006).  
 Our micro-CT methodology offers the ability to quantify adipose and lean tissue 
components of the mouse in addition to measuring the skeletal tissues. It is known that 
the C57BL/6 mouse has a propensity to gain weight with age compared to other mouse 
models (Brochmann et al., 2003). Our data confirm other work using DXA showing a 
gradual increase in adipose tissue mass percent between 1 and 5 months of age, sharply 
increasing thereafter up to 12 months of age (Glatt et al., 2007). Interestingly, our work 
shows the proportion of adipose tissue at 2 weeks of age is high relative to body mass, 
whereas lean tissue is quite low. These values change drastically at 5 weeks of age, at 
which time adipose tissue mass has dropped and lean tissue mass has increased. 
Adiposity is important for early survival through thermal regulation by brown adipose 
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tissue up to ~10 days of age (Xue et al., 2007). Thereafter, mice begin to develop 
insulation in the form of white adipose tissue until weaning at 21 days; white adipose 
tissue then quickly diminishes by 2 months of age (Kozak et al., 2010; Xue et al., 2007). 
In keeping with these previous studies, our data showed pronounced subcutaneous 
adiposity at 2 weeks of age followed by a drastic reduction at 5 weeks, possibly reflecting 
changes in the requirement for thermal insulation. Furthermore, the replacement of 
adipose by lean tissue may reflect increased energy demands due to ambulation and 
dietary changes post-weaning at 3 weeks of age. 
 We also found that the maximum value of BMD increases rapidly until 11 weeks 
of age, and is then followed by a slow linear increase. Maximum BMD values represent 
the degree of mineralization of compact cortical bone. These values were found to 
increase with age and, in older mice, were comparable to values previously reported for 
cortical bone BMD in mice (Entezari et al., 2012; Windahl et al., 1999). As we are 
reporting maximum BMD values, it is important to note that these are often higher than 
values reported in other studies quantifying mean BMD in ROIs that include both 
compact bone and marrow spaces.  
 In the present study, we provide several measures to evaluate the internal and 
external validity of our protocol. First, we measured the lengths of the tibia and femur to 
compare them with published values. Although seemingly straightforward, considerably 
different measurement methods have been previously reported. Many early studies 
measured mouse bone lengths using calipers or micrometer screw gauges (Somerville et 
al., 2004); others have used conventional radiographs, pQCT (Beamer et al.), micro-CT 
(Amblard et al., 2003) or a combination of manual and imaging techniques (Bagi et al., 
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2006). However, precisely defined anatomical beginning and end points for 
measurements are not always described. We selected identifiable anatomical landmarks 
to consistently measure the long bones. Our findings correlate well with data from 
previous reports. Somerville et al. showed similar changes in tibial length with age in 
male C57BL/6 mice (Somerville et al., 2004). Somerville’s study showed an ~20% 
increase in tibia length between 1 and 3 months of age, followed by a ~2.8% increase 
between 3 and 12 months of age (Somerville et al., 2004). Our data revealed a ~24% 
increase in tibia length between 1 and 3 months of age and an ~3.4% increase between 3 
and 12 months of age. Femur lengths of our male mice showed similar patterns to that of 
other work in male C57BL/6 mice, with only small increases in bone length after 2 
months of age (Glatt et al., 2007). Specifically, Glatt and coworkers showed an ~33% 
increase in femur length between 1 and 3 months of age, followed by a ~3.9% increase 
between 3 and 12 months (Glatt et al., 2007). Our data revealed ~30% increase in femur 
length between 1 and 3 months of age, followed by a ~6.5% increase between 3 and 12 
months. These findings help validate our methodology and establish its reproducibility.  
 As a measure of internal validity, we compared CT-derived total body masses to 
gravimetrically measured masses at each age.  These values were in good agreement, 
with the CT protocol underestimating total body weight by less than 3%. This finding 
helps establish the accuracy of our imaging and analysis methods for determining tissue 
masses.  
 To assess reproducibility, we scanned two separate cohorts of mice, both at 8 
weeks of age, at different times using the same scanner and scanning protocol. These data 
revealed that the two cohorts of mice had nearly identical distributions of tissue and total 
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body weights. Stability and reproducibility of the eXplore Locus Ultra micro-CT system 
itself has been previously shown (Du et al., 2007), further solidifying this assessment. In 
addition, we scanned one cohort of mice at 2, 5 and 8 weeks of age using two micro-CT 
systems. We found that there was good agreement between WBC outputs from scanning 
on both systems, although it is evident that machine-specific performance parameters 
(e.g., resolution and noise) can influence measurements. Taken together, our findings 
establish the validity and reproducibility of this approach for quantifying whole-body 
composition in studies of growth and aging in mice.  
 Our protocol offers a number of advantages. First, mice are anesthetized by 
isoflurane inhalation, which is less invasive with reduced adverse effects compared to 
anesthetic agents that are injected intraperitoneally. Mice recover quickly and repeated 
use of isoflurane is possible without harm. Scout scans can be used to determine precise 
positioning of animals prior to full scanning. Scans are non-invasive, rapid (as short as 16 
seconds) and have low-radiation exposures. To establish the radiation safety of micro-CT 
scanning, a recent study demonstrated no significant effect on cardiac and pulmonary 
tissues in mice that were purposely delivered multiple exposures at triple the typical dose 
of radiation over a 6-week period (Detombe et al., 2013). Thus, repeated scans can be 
used to monitor changes over time in longitudinal studies without concern for adverse 
dose-related effects. Moreover, analysis using this whole-body composition method is 
high-throughput. In addition, our study shows that repeated long term imaging of mice 
(such as those in cohort 2, which were scanned every three weeks for a total of four 
months) is safe. 
 There are also some limitations of our protocol that should be noted. To allow for 
 88 
accurate measurement of WBC and maintain an acceptably low radiation dose, the 
volumes required spatial averaging to lower resolutions (100 and 150 µm) to diminish 
noise levels in the images. Thus, in younger mice with smaller skeletons, skeletal mass 
and BMD may be underestimated due to under-mineralization and partial volume effects 
arising from increased isotropic voxel spacing. In addition, to quantify microarchitecture 
within the trabecular network of mouse bones, higher scan resolutions are required, as 
trabeculae are approximately 30-50 µm in width (Bouxsein et al., 2010). Thus, our in 
vivo scans at 50 µm are not capable of imaging small trabecular struts in mouse bones. 
Therefore, assessments of mouse bone microarchitecture must be performed at a scan 
resolution of ≤ 20 µm as post-mortem specimen scans.  
 Another limitation is that the earliest age that can be assessed is 2 weeks. It is not 
possible to obtain in vivo data from animals younger than this, as their bones are not 
sufficiently mineralized to perform quantifiable analyses at these resolutions. In contrast, 
micro-CT measurements of ex vivo murine fetal skeletons correlate well with standard 
histological techniques in mice as young as gestational day 17-19 (Oest et al., 2008). 
Furthermore, assessments of whole-mouse skeletons as young as 2 days of age are 
feasible when scanning post-mortem and with higher scan resolutions (Guldberg et al., 
2004). To the best of our knowledge, in vivo micro-CT scanning prior to 2 weeks of age 
in mice has yet to be reported. 
 The present study is the first characterization of changes in WBC during growth 
and aging of mice using micro-CT. Our findings provide critical reference data for other 
investigators using mice as disease models. Additionally, we show marked differences in 
WBC values during a period of rapid growth between 2 and 5 weeks of age, highlighting 
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the importance of collecting data at precise ages when comparing groups within this 
range. Moreover, our study presents an in-depth analysis of WBC using an in-house-
designed micro-CT protocol. This innovative methodology facilitates precise, long-term, 
repeated assessment of adipose, lean and skeletal tissues in vivo in growing and aging 
mice. Furthermore, our non-invasive method minimizes the use of research animals, as 
the mice can be scanned repeatedly. In addition, the 3D volumes enabled us to precisely 
measure growing long bones using consistent anatomical markers. Our findings establish 
that non-invasive single-energy micro-CT is an accurate and effective tool for high-
throughput high-content characterization of WBC in mouse models.    
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CHAPTER THREE 
 
 
LOSS OF P2X7 NUCLEOTIDE RECEPTOR FUNCTION LEADS TO 
ABNORMAL FAT DISTRIBUTION IN MICE1 
                                                
1 This Chapter has been reproduced with permission from: 
K.L. Beaucage, A. Xiao, S.I. Pollmann, M.W. Grol, R.J. Beach, D.W. Holdsworth, S.M. 
Sims, M.R. Darling, S.J. Dixon. 2014. Loss of P2X7 nucleotide receptor function leads to 
abnormal fat distribution in mice. Purinergic Signal. 10(2):291-304, with some 
modifications. 
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3.1  Chapter Summary 
The P2X7 receptor is an ATP-gated cation channel expressed by a number of cell 
types. We have shown previously that disruption of P2X7 receptor function results in 
downregulation of osteogenic markers and upregulation of adipogenic markers in 
calvarial cell cultures. In the present study, we assessed whether loss of P2X7 receptor 
function results in changes to adipocyte distribution and lipid accumulation in vivo. Male 
P2X7 loss-of-function (KO) mice exhibited significantly greater body weight and 
epididymal fat pad mass than wild-type (WT) mice at 9 months of age. Fat pad 
adipocytes did not differ in size, consistent with adipocyte hyperplasia rather than 
hypertrophy. Histological examination revealed ectopic lipid accumulation in the form of 
adipocytes and/or lipid droplets in several non-adipose tissues of older male KO mice (9-
12 months of age). Ectopic lipid was observed in kidney, extraorbital lacrimal gland and 
pancreas, but not in liver, heart or skeletal muscle. Notably, lacrimal gland and pancreas 
from 12-month-old male KO mice had greater numbers of adipocytes in perivascular, 
periductal and acinar regions. As well, lipid droplets accumulated in the renal tubular 
epithelium and lacrimal acinar cells. Blood plasma analyses revealed diminished total 
cholesterol levels in 9- and 12-month-old male KO mice compared to WT controls. 
Interestingly, no differences were observed in female mice. Moreover, there were no 
significant differences in food consumption between male KO and WT mice. Taken 
together, these data establish novel in vivo roles for the P2X7 receptor in regulating 
adipogenesis and lipid metabolism in an age- and sex-dependent manner.   
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3.2  Introduction 
Global epidemics of metabolic syndrome diseases represent major health and economic 
burdens, with incidences on the rise (Dixon, 2010; Hassan et al., 2012). Obesity (central 
adiposity), dyslipidemia, hypertension, type 2 diabetes mellitus and cardiovascular 
diseases are hallmarks of metabolic syndrome (Dulloo and Montani, 2012). Recent 
studies have shown that, in addition to lipid storage, adipose tissue regulates other tissues 
and systems throughout the body. In particular, adipose is an active endocrine organ 
(Hassan et al., 2012; Shuldiner et al., 2001) that is involved in cross-talk with other tissue 
types such as bone (Ducy et al., 2000; Ferron et al., 2010). Moreover, it plays important 
roles in local and systemic inflammation (Jacobi et al., 2012; Suganami et al., 2012) and 
energy metabolism (Kopecky et al., 2004; Lee et al., 2007; Medina-Gomez, 2012).  
Extracellular nucleotides, such as ATP, signal through purinergic (P2) receptors 
on the membrane of most cell types. Two subfamilies of P2 receptors exist: P2X (ATP-
gated nonselective cation channels) and P2Y (G protein-coupled receptors) (Burnstock, 
2007). There are seven known subtypes of P2X receptors, P2X1-7. P2X7 is of emerging 
interest as a potential therapeutic target in a number of diseases. This receptor is unique 
in that it is activated by relatively high concentrations of ATP. Moreover, P2X7 signaling 
can cause the formation of large nonselective membrane pores and induce dynamic 
membrane blebbing (Burnstock, 2007; Panupinthu et al., 2008). This receptor plays 
important roles in chronic pain (Hughes et al., 2007; Sorge et al., 2012), apoptosis 
(Coutinho-Silva et al., 1999; Gu et al., 2011; Surprenant et al., 1996), bone remodeling 
(Grol, 2009; Ke et al., 2003; Li J, 2005), immune responses (Dubyak, 2012; Miller et al., 
2011; Sakowicz-Burkiewicz et al., 2013; Solle et al., 2001) and the function of exocrine 
 98 
and endocrine organs (Burnstock and Novak, 2013; Novak, 2008). 
Genetically modified mice that lack functional P2X7 receptors (KO) present with 
an osteopenic phenotype owing to diminished periosteal bone formation and excessive 
trabecular bone resorption (Ke et al., 2003). Moreover, these mice exhibit an impaired 
skeletal response to mechanical loading (Li J, 2005). In vitro evidence has since 
demonstrated that activation of P2X7 receptors in bone-forming osteoblasts results in 
cell-autonomous enhancement of differentiation and matrix mineralization (Panupinthu et 
al., 2008). Moreover, cultures of bone cells from P2X7 KO mice, which include 
mesenchymal progenitors, display greater expression of adipogenic markers compared to 
cultures from wild-type (WT) mice. This upregulation of adipogenic markers was 
accompanied by downregulation of osteogenic markers and suppression of osteoblastic 
differentiation (Panupinthu et al., 2008). Osteoblasts and adipocytes both arise from 
mesenchymal stem cells and become terminally differentiated through expression of 
master transcription factors such as osterix and peroxisome proliferator-activated receptor 
γ (PPARγ) (Ducy et al., 1997; Muruganandan et al., 2009; Rosen et al., 2000). Therefore, 
evidence points to P2X7 playing a critical role in directing differentiation towards the 
osteoblast lineage and away from the adipocyte lineage.  
The P2X7 receptor has also been shown to regulate cellular metabolism. 
Activation of P2X7 on osteoblast-like cells dramatically increases the production of 
metabolic acid (Grol et al., 2012). This P2X7-induced increase in proton efflux is 
dependent on the activity of phosphatidylinositol 3-kinase and the presence of glucose. It 
has also been shown that heterologous expression of P2X7 in HEK293 cells promotes 
aerobic glycolysis, and increases levels of glycolytic enzymes and glycogen stores 
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(Amoroso et al., 2012). Therefore, P2X7 activation enhances cellular energy metabolism, 
suggesting a role for this receptor in energy homeostasis. 
Expression of functional P2X7 receptors has been reported in adipocytes purified 
from murine white adipose tissue (Sun et al., 2012), as well as cultured adipocytes from 
human visceral and subcutaneous adipose tissues (Madec et al., 2011). However, little is 
known about the role of P2X7 receptors in adipose tissue. Recent studies have reported 
that ablation of P2rx7, the gene encoding P2X7, does not affect body and gonadal fat pad 
weights in mice up to 4 months of age (Sun et al., 2012). In the present study, we report 
that loss of P2X7 function leads to increased adiposity and lipid accumulation in older 
male mice. P2X7 KO mice were found to have increased body and epididymal fat pad 
weights, and reduced total plasma cholesterol levels compared to WT mice at 9 months 
of age. Ectopic lipid deposits were observed in the kidneys, pancreas and extraorbital 
lacrimal glands. There were no significant differences in food consumption by KO and 
WT mice at any age. These results point to heretofore unrecognized roles for the P2X7 
receptor in adipogenesis and lipid metabolism.   
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3.3  Materials and methods 
3.3.1  Animals 
The P2X7 KO mouse was obtained from Pfizer (Solle et al., 2001). Although a splice 
variant (with C-terminal truncation) is detectable in some tissues of the Pfizer KO mouse, 
it is inefficiently trafficked to the cell surface and displays greatly diminished receptor 
function (Masin et al., 2012). Mice were maintained on a mixed genetic background 
(129/Ola × C57BL/6 × DBA/2) by crossbreeding of heterozygous mice. Genotypes were 
identified by PCR. Mice were housed in standard cages and maintained on a 12-hour 
light/dark cycle, with water and standard mouse chow (2018 Teklad Global 18% protein 
rodent diet, Harlan Laboratories, USA) available ad libitum. All aspects of this study 
were conducted in accordance with the policies and guidelines of the Canadian Council 
on Animal Care and were approved by the Animal Use Subcommittee of the University 
of Western Ontario, London, ON, Canada. 
 Food intake and body composition of 2, 6, 9 and 12-month-old WT and KO mice 
were assessed. For these studies, mice were housed individually. Mice and food were 
weighed using a portable electronic scale (Acculab VICON VIC-511; Sartorius Group, 
Germany). Food intake was determined by subtracting the weight of food remaining after 
each week from the initial amount of food provided. 
 
3.3.2  Micro-computed tomography (micro-CT)  
Mice were anesthetized with isoflurane (Forane, catalog # CA2L9100, Baxter 
Corporation, Mississauga, Canada) and imaged using an eXplore Locus Ultra micro-CT 
scanner or an eXplore speCZT scanner (GE Healthcare Biosciences, London, ON, 
 101 
Canada). Scans were analysed as described previously (Granton et al., 2010). Briefly, a 
calibrating phantom composed of air, water and cortical bone-mimicking epoxy with a 
mineral value of 1.1 g/cm3 (SB3; Gammex RMI) (Gulam et al., 2000) was scanned 
together with the animals. On the eXplore Locus Ultra, 1000 projection images were 
obtained over a single 16-second rotation (80 kVp, 55 mA tube current, 16 ms exposure). 
On the speCZT scanner, 900 projection images were obtained over a single 5-minute 
rotation (90 kVp, 40 mA tube current, 16 ms exposure). Each of the eXplore Locus Ultra 
and speCZT data sets were reconstructed into 3D volumes with an isotropic voxel 
spacing of 154 µm and 150 µm, respectively, and scaled into Hounsfield units (HU). 
Using MicroView software (GE Healthcare Biosciences), three signal-intensity 
thresholds (-200, -30 and 190 HU) were used to classify each voxel as adipose, lean or 
skeletal tissue, respectively. Custom software was used to calculate tissue masses from 
assumed tissue densities of 0.95 (adipose), 1.05 (lean), and 1.92 (skeletal) g/cm3. The 
computed total mass corresponded well with the measured weight of each mouse (within 
± 2%). In addition, the software was used to calculate bone mineral density (BMD) and 
bone mineral content (BMC).  Briefly, BMD was obtained as the ratio of the average HU 
value of the skeletal region of interest to the measured HU value of the SB3 calibrator, 
multiplied by the known density of the SB3 (1.1 g/cm3).  Thereafter, the program 
automatically computed BMC as the product of the BMD and the total volume of the 
skeletal region of interest used in the BMD calculation. 
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3.3.3  Histology and histomorphometry 
Mice were fasted 6 hours prior to euthanasia by CO2 (100%) asphyxiation. Mice were 
weighed and organs harvested, weighed and prepared for histological analyses using 
standard protocols. The following organs/tissues were examined: 
epididymal/retroperitoneal fat pads, heart, liver, spleen, pancreas, kidneys, salivary 
glands (submandibular and sublingual), extraorbital lacrimal glands, Harderian glands 
and skeletal muscle (quadriceps). All tissues were fixed in 10% neutral buffered formalin 
(pH 7.0). Some samples were then processed, paraffin-embedded and blocks were 
sectioned at 5 µm thickness using a Leica RM2255 microtome (Leica Microsystems, 
Wetzlar, Germany). Sections were mounted on positively charged glass slides (Superfrost 
plus microslides; VWR International, Mississauga, ON, Canada) and stained with 
hematoxylin and eosin (H&E, Harris hematoxylin and eosin; Surgipath, Leica 
Microsystems).  
 Adipocyte number and diameter in fat pads were determined using Image Master 
software (Photon Technology International Inc., London, ON, Canada). Adipocyte 
density was calculated as the number of adipocytes within the field of view (FOV) 
divided by the area of the FOV (1.30 mm2). Adipocyte diameter was obtained by 
measuring the maximum diameter of each adipocyte within the same FOV. 
 After harvest, other samples were manually cut into small (2 × 2 × 2 mm) 
portions in preparation for staining with osmium tetroxide (modified from (Carson, 
1996)) to reveal lipid deposits. Briefly, tissue samples were fixed in 10% neutral buffered 
formalin (pH 7.0) overnight, washed and stained with osmium tetroxide (VWR 
International, Mississauga, ON, Canada) 1% in water for 2 h with intermittent agitation. 
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Samples were then washed with water for 15 min × 2, differentiated with 5% periodic 
acid solution in water (Alfa Aesar, Ward Hill, MA, USA) for 30 min, agitating 
periodically and washed twice more with running water for 30 min each. Samples were 
then processed, paraffin-embedded, sectioned and stained with H&E.  
 Osmium tetroxide staining was quantified using a Leica DM1000 microscope 
coupled to a DFC295 digital camera and Leica Application Suite software (version 
3.8.0). Brightness and contrast were adjusted by the same amounts for all images of each 
tissue type (both WT and KO). A blinded observer then quantified the area of tissue 
stained with osmium tetroxide using Image Master software. For all images of each 
tissue, brightness and threshold values for the RGB channels were adjusted to select for 
osmium tetroxide staining (black), but not hematoxylin or eosin staining. To quantify 
total tissue area, brightness and RGB thresholds were adjusted to select for the total area 
of stained tissue (including osmium tetroxide, hematoxylin and eosin). The area of 
osmium-positive staining was reported as a percentage of total tissue area. 
 
3.3.4  Blood plasma chemistry and tissue lipid analyses 
Mice were fasted for 6 h prior to euthanasia by CO2 asphyxiation. Cardiac puncture was 
performed immediately post-mortem to obtain plasma samples for analysis of glucose, 
triglyceride (TG) and total cholesterol (TC) levels.  Blood, treated with EDTA 
anticoagulant, was sedimented for 10 min at 10,000 rpm. Plasma was frozen at -20ºC, 
and contents were analyzed using a Cobas Mira S autoanalyser (Metabolic Phenotyping 
Laboratory, Robarts Research Institute, London, ON, Canada). In addition, immediately 
following cardiac puncture, some tissues were harvested, snap frozen in liquid nitrogen, 
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and stored at -20ºC. Tissues were homogenized and lipids extracted using the Folch 
technique (Folch et al., 1957). Total cholesterol and triglycerides were then quantified 
using enzymatic, colorimetric assays described previously (Burnett et al., 1997).  
 
3.3.5  Statistical Analyses 
Data are presented as means ± SEM or as medians and ranges. Differences between two 
groups were assessed using t tests. Differences among three or more groups were 
evaluated by two-way analysis of variance followed by a Bonferroni multiple 
comparisons test. For variables with non-normal distribution, comparisons were 
performed using a nonparametric Mann-Whitney U-test. Differences were accepted as 
statistically significant at p < 0.05. All n values represent the number of mice used in 
each group. For histological studies, at least 2 sections were examined of each tissue from 
each mouse.   
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3.4  Results 
3.4.1  Age- and sex-dependent effects of loss of P2X7 receptor function on body 
mass and composition 
At 9 months of age, male P2X7 KO mice appeared larger than male WT mice (Figure 3.1 
a). WT and KO mice were sacrificed and weighed at 2, 6, 9 and 12 months of age. 
Interestingly, the total body weight of male KO mice was significantly greater than WT 
at 9 months of age (Figure 3.1 b, Table 3.1). In contrast, there were no significant 
differences in the total body weight of female mice in any age group (Table 3.2). The 
significant difference in body weight of male mice at 9 months of age was confirmed 
independently in a second cohort of mice (11 WT and 12 KO mice). When both cohorts 
were combined, the body weights of WT and KO mice were 39.5 ± 1.7 g and 48.9 ± 1.3 
g, respectively (means ± SEM, n = 21 and 22 mice, respectively, p < 0.05, t test).  
 To determine tissue changes underlying the greater body weight of KO mice, 
whole-body composition was analysed using micro-CT. Live mice were anaesthetized 
and scanned. Images were reconstructed at an isotropic voxel size of 150 or 154 µm and 
masses of adipose, lean and skeletal tissues determined using MicroView software and an 
in-house designed analysis program (Figure 3.2 a). Micro-CT confirmed greater total 
body mass in a third cohort of KO mice at 9 months of age, and revealed significantly 
greater adipose tissue mass in these mice compared to WT controls (Figure 3.2 b,c). 
Using this approach, no significant differences in lean tissue mass, skeletal tissue mass, 
bone mineral content or bone mineral density were detected at any age (Figure 3.2 d-g).  
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Figure 3.1 Body weight of male wild-type (WT) and P2X7 knockout (KO) mice.   
a Image depicting the greater body size of a P2X7 KO male mouse in comparison 
to a WT male mouse at 9 months of age. b Two, 6, 9 and 12-month-old WT and KO mice 
were sacrificed and weighed to compare total body mass. Greater body weight was seen 
only at 9 months of age in KO mice compared to WT controls. Data are means ± SEM, n 
= 10 mice of each genotype and age. *Indicates significant difference between KO and 
WT (p < 0.05), determined by two-way analysis of variance and Bonferroni post hoc test.  
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Figure 3.2 Micro-CT analysis of whole-body composition of male WT and P2X7 KO 
mice.  
a Top left panel (Total) is a reconstructed micro-CT mid-coronal image of a live 
male 6-month-old WT mouse. Image was overlaid with the identified skeletal tissue 
(shown in white as a surface-rendered image in the top right panel).  Lower panels are 
images of the same slice showing lean tissue in red and adipose tissue in blue. b-g Data 
are means ± SEM of the indicated parameters. Nine-month-old KO mice exhibit 
significantly greater total body mass and adipose tissue mass than WT controls. In 
contrast, lean tissue mass, skeletal mass, bone mineral content and bone mineral density 
were not significantly different at any age. *Indicates significant difference between KO 
and WT (p < 0.05) at the same age, determined by two-way analysis of variance and 
Bonferroni post hoc test (n = 6-8 mice of each genotype at each age). 
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3.4.2 Morphometric analysis of adipocytes from fat pads of WT and P2X7 KO mice 
Since P2X7 is expressed in adipocytes (Madec et al., 2011) and the difference in total 
body mass was associated with a significant increase in adipose tissue, we examined the 
fat pads in WT and KO mice. Epididymal fat pads of WT and KO male mice (9 and 12 
months of age) were isolated and weighed post-mortem. Fat pad mass was significantly 
greater in KO than in WT male mice at 9 months of age (Figure 3.3 a,b), with no 
significant difference observed at 12 months of age (Table 3.1). In addition, no 
significant differences were observed in the mass of female parametrial fat pads 
(analogous to the epididymal fat pads in male mice) at either 9 or 12 months of age 
(Table 3.2). Thus, these data show the same age- and sex-dependence as the differences 
in body weight and composition described above.  
 Histological assessments of epididymal fat pads in 9- and 12-month-old male 
mice revealed similar adipocyte morphology in WT and KO mice (Figure 3.3 c). 
Adipocyte size and density were determined by quantifying the largest diameter and 
counting the number of adipocytes per field of view (five fields of view analysed for 2 
sections from each mouse fat pad). These parameters did not differ significantly in WT 
and KO mice of either age group (Figure 3.3 d,e). The similar size and density of 
adipocytes in WT and KO mice, together with the greater fat pad mass in 9-month-old 
male KO indicate that the difference in fat pad mass is due to adipocyte hyperplasia, 
rather than hypertrophy. 
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Figure 3.3 Morphometric analysis of adipocytes in fat pads of male WT and P2X7 
KO mice.  
Epididymal fat pads were isolated post-mortem. a Image depicting epididymal fat 
pads from a 9-month-old WT and KO mouse. Scale bar represents 1 cm. b Mass of 
epididymal fat pads was significantly greater in P2X7 KO than in WT male mice at 9 
months of age. Data are means ± SEM, n = 10 mice of each genotype. Combined mass of 
right and left fat pads is reported. *Indicates significant difference between KO and WT 
(p < 0.05), determined by t test. c Representative histological sections of epididymal fat 
pads from 9-month-old male WT and P2X7 KO mice stained with H&E, with no marked 
differences in appearance. d,e Sections of fat pads from 9- and 12-month-old mice were 
analyzed for adipocyte density and size. The number of adipocytes and largest diameter 
of each adipocyte in each field of view were measured. Data for 9-month-old mice are 
shown. For both 9- and 12-month-old mice, there was no significant difference between 
WT and KO in adipocyte density or size (p > 0.05, t test). Data are means ± SEM, n = 5 
mice of each genotype and age with 2 sections and 5 fields of view per section analysed 
for each mouse.  
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3.4.3  Histological differences in the kidneys of WT and KO mice 
In addition to fat pads, several tissues from 2-, 9- and 12-month-old male and female 
mice were isolated post-mortem, weighed and assessed histologically. Histological 
differences were noted in specific tissues of older male mice using H&E staining. No 
differences were apparent in 2-month-old male mice or female mice at any age.   
 P2X7 is expressed in the collecting ducts of adult mouse kidney (Hillman et al., 
2005). We found that, at both 9 and 12 months of age, kidney tissue exhibited spherical 
vacuole-like spaces (~3-12 µm in diameter; yellow arrowheads), which did not stain with 
H&E (Figure 3.4 a). There were markedly greater numbers of these spaces in male KO 
than in WT mice. We next examined tissues stained with osmium tetroxide, which 
specifically labels lipids and lipid-rich structures for optical microscopy (Belazi et al., 
2009). A population of spherical structures stained positively with osmium tetroxide in 
kidney tissues only from KO mice (Figure 3.4 b, black stain), consistent with the 
presence of lipid droplets in some renal tubular epithelial cells. Image analysis revealed 
that osmium tetroxide staining was significantly greater in kidneys from KO than from 
WT mice (Figure 3.4 c). Based on size and shape, these osmium-stained structures appear 
to correspond to a subset of the spherical vacuole-like spaces identified in sections 
stained with H&E. Despite these histological alterations, there was no significant 
difference in the mass of the kidneys at any age in both males and females (Tables 3.1 
and 3.2).  
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Figure 3.4 Histology of kidneys in male WT and P2X7 KO mice.  
a Representative histological sections of cortico-medullary region of the kidney 
from 12-month-old male WT and P2X7 KO mice stained with H&E. At both 9 and 12 
months of age, KO kidney exhibited multiple spherical structures (~3-12 µm in diameter, 
yellow arrowheads), which failed to stain with H&E. b Staining with osmium tetroxide 
revealed that these spherical structures were filled with lipid (black). Images shown are 
from 12-month-old male mice; similar results were found in 9-month-old male mice (not 
shown). Scale bar represents 50 µm for all images. Images are representative of 8-11 
male mice of each genotype and age (9 and 12 months). c For 12-month-old mice, the 
area that stained positively with osmium tetroxide was determined using image analysis 
and expressed as a percentage of the total tissue area. Data are medians and interquartile 
ranges (IQR, boxes) with whiskers representing the 10th and 90th percentiles; n = 5 mice 
of each genotype with 2 sections per mouse. At least 2 fields of view per section were 
analysed. *Indicates a significant difference between KO and WT (p < 0.05), determined 
by one-tailed Mann-Whitney U-test.  
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3.4.4  Histological differences in the pancreases of WT and KO mice  
In exocrine pancreas, P2X7 is expressed in ducts and may regulate secretion (Novak, 
2008). Pancreases were isolated from 2-, 9- and 12-month-old WT and KO mice. Striking 
histological differences were observed in male mice at 12 months of age; no differences 
were observed in younger mice or in female mice. Pancreatic tissues from 12-month-old 
male KO mice exhibited multiple large, membrane-bound structures (~10-30 µm in 
diameter), resembling adipocytes (Figure 3.5 a,b). The intracellular vacuole in these cells 
failed to stain with H&E. Staining with osmium tetroxide confirmed the presence of 
lipids (arrowheads) (Figure 3.5 c,d). These adipocytes were located in the exocrine 
pancreas predominantly among ducts and vasculature, as well as in boundaries between 
pancreatic lobes and sporadically among acini. No adipocytes were observed associated 
with pancreatic islets. By comparison, few adipocytes were seen in pancreatic tissues 
from age- and sex-matched WT mice. Quantification confirmed that osmium tetroxide 
staining was significantly greater in the pancreatic tissues of KO compared to WT mice 
(Figure 3.5 e). No differences were noted in the appearance of acini in WT and KO 
pancreases. There were also no significant differences between WT and KO in the mass 
of the pancreas at any age in male and female mice (Tables 3.1 and 3.2).    
 
3.4.5 Histological differences in the extraorbital lacrimal glands of WT and KO mice 
Exocrine pancreas and extraorbital lacrimal glands are serous glands that exhibit similar 
histological appearances.  P2X7 has been reported in both the acinar and ductal cells of 
rat lacrimal gland (Hodges et al., 2009). As observed for pancreas, we found a greater 
number of adipocytes in the extraorbital lacrimal glands of male mice at 12 months of 
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Figure 3.5 Histology of pancreas in male WT and P2X7 KO mice.  
Images are representative histological sections at low magnification (a and c), 
with higher magnification images from the same fields shown in b and d.  a,b 
Representative histological sections of pancreas from 12-month-old male WT and P2X7 
KO mice stained with H&E. KO pancreas exhibited multiple large membrane-bound 
spherical structures (~10-30 µm in diameter, yellow arrowheads), which failed to stain 
with H&E, resembling adipocytes. These structures were located predominantly among 
ducts and vasculature, as well as in boundaries between pancreatic lobes.  c,d Staining 
with osmium tetroxide confirmed the identity of these cells as adipocytes (yellow 
arrowheads). Images are representative of 10 male mice of each genotype.  e The area 
that stained positively with osmium tetroxide was determined using image analysis and 
expressed as a percentage of the total tissue area. Data are medians and IQR (boxes) with 
whiskers representing the 10th and 90th percentiles; n = 5 mice of each genotype with 2 
sections per mouse. At least 2 fields of view per section were analysed. *Indicates a 
significant difference between KO and WT (p < 0.05), determined by one-tailed Mann-
Whitney U-test. 
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age (Figure 3.6), with no differences in younger or in female mice. These adipocytes 
were observed among the ducts and vasculature, as well as at the boundaries between 
lobes. In addition, small lipid droplets (~1 µm in diameter) accumulated in the basal 
aspect of lacrimal acinar cells to a much greater extent in KO than in WT mice (Figure 
3.6 d,e). As in kidney and pancreas, osmium tetroxide staining was significantly greater 
in the extraorbital lacrimal glands of KO compared to WT mice (Figure 3.6 f). In males, 
the mass of the extraorbital lacrimal glands was significantly greater in KO than in WT 
mice at 2 months of age (Table 3.1). However, there were no significant differences in 
older males or in females (Table 3.2).   
 
3.4.6  Histological differences in the salivary glands of WT and KO mice 
P2X7 expression has been reported previously in both ducts and acinar cells of mouse 
submandibular gland (Nakamoto et al., 2009; Pochet et al., 2007). Interestingly, in our 
study the submandibular salivary gland displayed multiple spherical structures that did 
not stain with H&E (Figure 3.7 a). Like the kidney tissues, a greater number of these 
structures were observed in glandular tissue from older male KO mice than from WT 
mice. However, in contrast to the tissues described above, these spherical structures in the 
submandibular gland did not stain with osmium tetroxide (Figure 3.7 b), revealing the 
absence of lipid. In addition, these structures appeared to be located centrally within acini 
of the submandibular gland, but were absent in the adjacent sublingual gland. Moreover, 
there were no significant differences in the mass of the salivary glands at any age in both 
males and females (Tables 3.1 and 3.2).  
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Figure 3.6 Histology of extraorbital lacrimal glands in male WT and P2X7 KO mice.  
Images are representative histological sections at low magnification (a and c), 
with higher magnification images from the same fields shown in b, d and e. a,b 
Representative histological sections of extraorbital lacrimal glands from 12-month-old 
male WT and P2X7 KO mice stained with H&E. Similar to pancreas, adipocyte-like cells 
(yellow arrowheads) were observed among ducts and vasculature, as well as in 
boundaries between lobes in glands from KO mice. c,d Osmium tetroxide staining 
confirmed the presence of adipocytes in the KO tissues. e Higher magnification images of 
regions outlined by yellow rectangles in d (inset). These images reveal markedly greater 
accumulation of small lipid droplets in the basal cytoplasm of acinar cells in the KO 
mice. Images are representative of 10 male mice of each genotype. f The area that stained 
positively with osmium tetroxide was determined using image analysis and expressed as 
a percentage of the total tissue area. Data are medians and IQR (boxes) with whiskers 
representing the 10th and 90th percentiles; n = 5 mice of each genotype with 2 sections per 
mouse. At least 2 fields of view per section were analysed. *Indicates a significant 
difference between KO and WT (p < 0.05), determined by one-tailed Mann-Whitney U-
test. 
  
 121 
  
 122 
 
 
 
Figure 3.7 Histology of salivary glands in the male WT and P2X7 KO mice. 
 a Representative histological sections of salivary glands from 12-month old male 
WT and P2X& KO mice stained with H&E (SM: submandibular gland, SL: sublingual 
gland). At both 9 and 12 months of age, multiple spherical structures, which failed to 
stain with H&E (yellow arrowheads), were observed in the submandibular but not 
sublingual gland. b Staining with osmium tetroxide revealed that these spherical 
structures did not contain lipid (images shown are from 12-month-old male mice). Scale 
bar represents 50 um for all images. Images are representative of 8-11 male mice of each 
genotype and age (9-12 months).  
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3.4.7  Histology of spleen and other tissues of interest in WT and KO mice 
P2X7 is highly expressed in cells of the immune system and therefore in organs such as 
the spleen (Sun et al., 2012). Spleens were isolated post-mortem, weighed and assessed 
histologically at 9 and 12 months of age. H&E revealed greater basophilic staining 
coupled with megakaryocyte hyperplasia in male KO compared to WT mice at 12 months 
of age (Figure 3.8 a). These histological differences were accompanied by significantly 
greater mass of the spleen (Figure 3.8 b). Osmium tetroxide did not reveal lipid staining 
in the spleen (not shown).  
 Several other tissues were isolated post-mortem and assessed by histology. Livers 
and hearts from male KO mice had significantly larger masses than WT at 9 months of 
age; a difference not seen at 12 months of age. No histological differences between WT 
and KO were apparent in these tissues or in skeletal muscle at either age. No other 
histological or weight differences were seen in males (Table 3.1). In females, no 
significant differences were seen in the mass of any of the tissues examined (Table 3.2). 
Furthermore, no histological differences were seen in any female tissues at any age (data 
not shown). 
 
3.4.8  Food consumption, blood plasma chemistry and tissue lipid analyses 
To assess whether the phenotype seen in older male mice was the result of differences in 
diet, food consumption was measured by weighing food once weekly. No significant 
differences in average daily food consumption were seen between male WT and KO mice 
at any age (Figure 3.9), suggesting that the phenotype may be due to metabolic 
differences.  
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Figure 3.8 Histology of spleen in male WT and P2X7 KO mice.  
a Representative histological sections of spleen from 12-month-old male WT and 
P2X7 KO mice stained with H&E. Images revealed greater basophilic staining coupled 
with megakaryocyte hyperplasia in the KO compared to the WT spleen. No differences 
between WT and KO were observed in spleen sections stained with osmium tetroxide 
(not shown). b The mass of the spleen of was significantly greater in KO than in WT at 
12 months of age only. Data are means ± SEM, n = 10 mice of each genotype (*p < 0.05, 
t test). 
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Figure 3.9 Food consumption by male WT and P2X7 KO mice.  
Food consumption was measured by weighing food once weekly. No significant 
differences were seen at any age between the WT and KO mice. Data are the mean 
consumption per day and are expressed as means ± SEM, p > 0.05, determined by two-
way analysis of variance and Bonferroni post hoc test, n ≥ 6 mice of each genotype and 
age.  
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 To investigate the metabolic phenotype, blood plasma samples were obtained by 
cardiac puncture and assayed for glucose, triglyceride and total cholesterol. In 
comparison to WT, male KO mice had significantly reduced plasma cholesterol levels at 
both 9 and 12 months of age. No significant differences in plasma triglyceride or glucose 
levels were seen at either age for WT and KO mice (Table 3.3). Furthermore, no 
significant differences in any plasma parameters were seen in female WT and KO mice at 
9 and 12 months of age (Table 3.4). Selected tissues were isolated post- mortem to 
determine whether histological changes were accompanied by changes in tissue levels of 
triglycerides or total cholesterol. KO mouse heart tissue had significantly reduced tissue 
cholesterol levels in comparison to WT controls at 9 months of age; whereas, there were 
no significant differences in triglyceride or cholesterol levels in other tissues (Table 3.5). 
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Table 3.3 Blood plasma cholesterol, triglyceride and glucose levels (in mmol/L) 
in male wild-type (WT) and P2X7 knockout (KO) mice 
 
 
Glucose, triglyceride, and total cholesterol (mmol/L) were measured in blood plasma 
samples obtained by cardiac puncture. In comparison to WT, KO mice had significantly 
reduced plasma cholesterol levels both at 9 and 12 months of age. No significant 
differences in plasma triglyceride or glucose levels were seen between WT and KO mice 
at either age. Data are means ± SEM, *p < 0.05 compared to corresponding WT based on 
unpaired two-tailed t test, n = 9 mice of each genotype and age.  
 
 
 
 
 
 
 
 
  
Parameter 
9 months 12 months 
WT KO WT KO 
Cholesterol 3.83 ± 0.27 2.91 ± 0.10* 3.34 ± 0.10 2.77 ± 0.21* 
Triglycerides 0.72  ± 0.05 1.03 ± 0.15 0.89 ± 0.12 0.70 ± 0.07 
Glucose 11.42 ± 0.77 10.69 ± 0.82 11.36 ± 0.73 12.31 ± 0.56 
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Table 3.4 Blood plasma cholesterol, triglyceride and glucose levels (in mmol/L)  
in female wild-type (WT) and P2X7 knockout (KO) mice 
 
 
 
Glucose, triglyceride, and total cholesterol (mmol/L) were measured in blood plasma 
samples obtained by cardiac puncture. No significant differences were observed between 
KO and WT. Data are means ± SEM, n ≥ 7 mice per group. 
 
 
Parameter 
9 months 12 months 
WT KO WT KO 
Cholesterol 2.32 ± 0.17 2.33 ± 0.09 2.23 ± 0.21 2.12 ± 0.11 
Triglycerides 0.81 ± 0.06 0.74 ± 0.16 0.60 ± 0.09 0.57 ± 0.06 
Glucose 10.33 ± 0.62 10.57 ± 0.35 12.56 ± 0.48 12.91 ± 1.17 
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Table 3.5 Tissue cholesterol and triglyceride levels for male wild-type (WT) and 
P2X7 knockout (KO) mice at 9 months of age 
 
 
Data are means ± SEM in mg per gram of tissue.  
Data are based on 6 animals per group.  
*indicates significant difference from WT (p < 0.05), based on unpaired two-tailed t test. 
 
  
 
Tissue 
Cholesterol Triglycerides 
WT KO WT KO 
Liver 3.93 ± 0.47 3.74 ± 0.16 47.1 ± 7.4 45.3 ± 12.0 
Pancreas 3.36 ± 0.05 3.46 ± 0.16 72.2 ± 9.8 62.6 ± 15.2 
Spleen 3.70 ± 0.13 4.26 ± 0.34 30.7 ± 6.3 16.1 ± 5.2 
Heart 1.73 ± 0.03 1.64 ± 0.02* 7.2 ± 0.8 6.1 ± 1.4 
Kidney 6.43 ± 0.17 6.25 ± 0.20 39.2 ± 9.1 26.7 ± 5.7 
Salivary 
Glands 4.71 ± 0.22 4.35 ± 0.15 85.8 ± 17.0 59.1 ± 12.0 
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3.5  Discussion 
The P2X7 receptor serves a number of important functions in multiple tissues throughout 
the body. Previous in vitro studies have shown that P2X7 suppresses expression of 
adipocyte differentiation markers (Panupinthu et al., 2008) and acts through 
phospholipases and sphingomyelinases to generate bioactive lipid signalling molecules 
(Costa-Junior et al., 2011). Here, we report abnormal adipocyte and lipid accumulation in 
mice lacking functional P2X7, pointing to a generalized role for P2X7 in regulating lipid 
storage and metabolism in vivo. 
 
3.5.1  Loss of P2X7 receptor function in mice imparts changes in whole-body 
composition due to adipocyte hyperplasia 
We used the Pfizer KO mouse in which there is global disruption of P2X7 function 
(Masin et al., 2012; Solle et al., 2001). This mouse model has been studied extensively; 
however, most studies have focused on the phenotype of younger animals. It has 
previously been reported that the Pfizer KO mouse displays no gross phenotypic 
differences at early ages (Ke et al., 2003; Sun et al., 2012; Taylor et al., 2009). In the 
present study, we allowed these mice to age, which revealed an unexpected increase in 
body mass due to greater lipid accumulation in older KO mice. Previous characterization 
of the femurs and tibias of older Pfizer KO mice revealed diminished periosteal bone 
formation and excessive trabecular bone resorption (Ke et al., 2003). In the present study, 
we did not detect any difference in skeletal mass at the whole-body level, perhaps 
indicating regional effects of P2X7 disruption.  
 We observed that fat pad mass was greater in KO than in WT mice at 9 months of 
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age. An increase in adipose tissue mass can result from greater adipocyte size 
(hypertrophy), greater adipocyte cell number (hyperplasia), or both (Bjorntorp, 1991). 
Previous studies have shown that both visceral and subcutaneous adipocytes express 
P2X7 receptors (Madec et al., 2011; Volonte et al., 2006). Adipocyte size and density 
were similar in WT and KO, indicating that the increase in mass was due to adipocyte 
hyperplasia. Adipocyte number is determined both by the recruitment and differentiation 
of stem cells into mature adipocytes and by adipocyte apoptosis (Drolet et al., 2008). 
Therefore, our results suggest that loss of P2X7 may decrease apoptosis of mature 
adipocytes or increase adipogenesis from mesenchymal stem cells.  
 Mesenchymal stem cells are widely distributed in connective tissues such as bone 
marrow, as well as in the perivascular niche (Bouacida et al., 2012). These cells are 
capable of differentiating into multiple lineages including fibroblasts, chondrocytes, 
osteoblasts and adipocytes. Moreover, human mesenchymal stem cells have been shown 
to express several P2 receptors including P2X7 by both RT-PCR and immunoblotting 
(Zippel et al., 2012). In addition, we have shown previously that cultures of bone cells 
from Pfizer P2X7 KO mice display greater expression of adipogenic markers compared 
to wild-type cells (Panupinthu et al., 2008). Thus, P2X7 may suppress adipocyte 
differentiation from mesenchymal stem cells. In this regard, when mesenchymal stem 
cells are induced to differentiate into adipocytes, exogenous ATP reduces the formation 
of lipid droplets and suppresses adipogenic differentiation (Zippel et al., 2012). Taken 
together, these in vitro results support our in vivo findings of greater numbers of 
adipocytes in P2X7 KO mice.  
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3.5.2  Mice with loss of P2X7 receptor function exhibit ectopic deposition of 
adipocytes and lipid droplets 
In the present study, the observed distribution of adipocytes in adipose tissues and 
ectopically in perivascular regions of the KO mice corresponds to locations where 
mesenchymal stem cells are known to reside. Previous studies have shown that 
mesenchymal stem cells exist in both lacrimal glands (You et al., 2011) and pancreas, 
specifically in ductal regions (Rovira et al., 2010). Thus, it is possible that loss of P2X7 
enhances the differentiation of mesenchymal progenitor cells towards the adipocyte 
lineage, resulting in increased adipocyte numbers in periductal regions of the pancreas 
and lacrimal glands. In future studies, lineage tracing could be used to determine the 
commitment of mesenchymal progenitors to adipocytes, shedding light on the role of 
P2X7 in adipogenesis.  
 Recent work has shown that P2X7 regulates cellular metabolism. Grol and 
coworkers showed that activation of P2X7 leads to a dramatic, glucose-dependent 
increase in metabolic acid production by osteoblasts (Grol et al., 2012). In addition, work 
from another lab has shown that heterologous expression of P2X7 in vitro leads to 
upregulation of glycolytic enzymes and an increase in lactate production (Amoroso et al., 
2012). Thus, overall energy expenditure may be less in mice lacking functional P2X7 
receptors, resulting in increased accumulation of fat as the animals age. It is also possible 
that P2X7 receptors have direct effects on lipid metabolism. In this regard, several studies 
have shown that P2X7 couples to activation of phospholipases in various cell types 
(Costa-Junior et al., 2011; Le Stunff et al., 2004; Panupinthu et al., 2008; Panupinthu et 
al., 2007). Thus, loss of P2X7 function in cells that normally express this receptor may 
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disrupt lipid metabolism leading to the eventual accumulation of lipid droplets in the 
cytosol.  
Novak and coworkers have shown previously that Pfizer KO mice display 
abnormal exocrine secretion from the pancreas and lacrimal glands (Novak et al., 2010). 
Pancreatic secretion was significantly reduced in KO mice, whereas tear production was 
increased. Interestingly, the secretory phenotype was affected by the sex of the animal, 
with males more dependent on P2X7 expression, as observed for ectopic lipid deposition 
in the present study and skeletal remodeling in a previous study (Ke et al., 2003). This 
sexual dimorphism may reflect interactions between estrogen and P2X7 signaling. In this 
regard, it has been shown previously that 17β-estradiol inhibits P2X7-mediated currents 
through a non-genomic mechanism (Cario-Toumaniantz et al., 1998).  
In the present study, accumulation of lipid droplets was also observed in the renal 
tubular epithelium. Previous reports have shown that, in healthy mice, P2X7 is expressed 
in the renal collecting duct, but not in the glomeruli or other tubules (Hillman et al., 
2002). The function of P2X7 in collecting duct remains poorly understood. A previous 
study reported no abnormalities in renal morphology or histology in a different P2X7 KO 
mouse model (6- to 8-week-old female mice) (Taylor et al., 2009). In the present study, 
lipid droplets were observed only in older male mice, perhaps explaining the lack of 
phenotype in the earlier study.  
In our study, no histological differences were observed in liver, heart, skeletal 
muscle or Harderian glands. Although it has been reported that P2X7 is expressed in 
hepatocytes, and cardiac and skeletal myocytes (Emmett et al., 2008; Volonte et al., 
2006; Young et al., 2012), there was no apparent accumulation of lipid in these cells. 
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Therefore, absence of P2X7 alone is not sufficient to trigger lipid abnormalities in all 
tissues.   
 
3.5.3  Metabolic dysregulation in P2X7 KO mice — a potential role for P2X7 in 
metabolic syndrome 
Analysis of blood plasma revealed significantly reduced levels of total cholesterol in the 
male KO mice in older age groups. In contrast to humans, mice carry cholesterol mainly 
in the form of high-density lipoprotein (HDL) (Daugherty, 2002; Getz and Reardon, 
2012; Zadelaar et al., 2007). On the other hand, fasting blood glucose concentrations 
were not significantly different between WT and KO mice of all age groups and sexes 
(although glucose levels were noted to be relatively high in both WT and KO mice). 
Therefore, it was unlikely that the heavier KO males were diabetic. Furthermore, 
assessment of food intake in our study revealed no significant differences between WT 
and KO mice at any age. Additionally, others have reported no differences in 
spontaneous locomotor activity of P2X7 WT and KO mice (Basso, 2009). Therefore, the 
changes in adiposity in older males are likely due to metabolic dysregulation. The present 
study reveals that P2X7 KO mice exhibit some of the characteristics of metabolic 
syndrome, including increased central adiposity, reduced levels of HDL and the 
deposition of ectopic lipids in lean tissues.   
We found that loss of P2X7 had noticeable effects on body weight and adiposity 
only in older animals. These findings are consistent with other studies showing no 
differences in body weight between P2X7 KO and WT mice at younger ages, even when 
fed a high-fat diet (Glas et al., 2009; Sun et al., 2012). Aging itself is known to be 
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associated with metabolic dysfunction including alterations in glucose and fatty acid 
metabolism, and redox homeostasis (Houtkooper et al., 2011). Thus, it is possible that the 
additional metabolic impairment arising from loss of P2X7 results in a phenotype only 
when combined with age-related changes in metabolism.  Alternatively, it is conceivable 
that loss of P2X7 affects younger mice, but results in such gradual lipid accumulation 
that it manifests only in older animals. Interestingly, total mass and fat pad mass were 
significantly greater in KO than in WT mice at 9 months of age, but there were no 
significant differences in 12-month-old animals. Thus, it is possible that loss of P2X7 
function accelerates age-related changes in body composition.   
 In summary, we have shown that male mice lacking functional P2X7 receptors 
develop ectopic lipid accumulations as they age. Our study reveals that P2X7 receptors 
play a generalized role in regulating lipid storage and metabolism in vivo. Further 
research is required to elucidate the role of P2X7 in regulating the differentiation of 
adipocytes from mesenchymal stem cells. As well, our findings provide additional 
impetus to probe the emerging roles of P2X7 in the control of energy and lipid 
metabolism.   
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CHAPTER FOUR 
 
 
LOW-MAGNITUDE, HIGH-FREQUENCY VIBRATION 
HAS NO EFFECT ON MURINE WHOLE-BODY 
COMPOSITION AND BONE MICROARCHITECTURE 
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4.1  Chapter Summary 
Whole-body vibration (WBV) has been shown by some investigators to both 
promote bone formation and suppress adipogenesis, leading to changes in whole-body 
composition. The P2X7 receptor is a nonselective cation channel activated by the binding 
of extracellular ATP. P2X7 receptors are expressed by both osteoblasts and osteoclasts, 
and have been suggested to play a role in skeletal mechanotransduction. Our objective 
was to study the effects of WBV on whole-body composition and bone microarchitecture, 
and to assess whether these effects were mediated by the P2X7 receptor.  Male 8-week-
old wild-type (WT) and P2X7 loss-of-function (KO) mice were placed on a vibration or 
control (non-vibrated) platform for 15 min/day, 5 days/week for 18 weeks. The 
experimental group was subjected to low-magnitude, high-frequency WBV (45 Hz, 0.3 g 
maximum acceleration). Mice were scanned by micro-CT to assess whole-body 
composition prior to and during the experimental period. In contrast to some previous 
studies, we did not observe significant effects of vibration on whole-body mass, adipose, 
lean or skeletal tissue masses, bone mineral density, or bone mineral content in WT or 
KO mice. Ex vivo high-resolution scans of hind limbs revealed small but significant 
differences between genotypes in femoral mid-diaphyseal cortical area, and tibial distal-
diaphyseal cortical area and thickness. In contrast, there were no significant effects of 
vibration on skeletal microarchitecture. Moreover, femoral and tibial lengths were 
unaffected by genotype or vibration. We conclude that, under the conditions studied, 
WBV does not induce changes in murine whole-body composition or bone 
microarchitecture either in the presence or absence of functional P2X7 receptors.   
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4.2  Introduction 
Obesity and musculoskeletal diseases such as osteoporosis are some of the most prevalent 
diseases in our society. Though pharmacological agents are available to treat these 
conditions, they are expensive and vary in their efficacy and side effects. As such, 
development of cost-effective non-pharmacological approaches that are non-invasive is 
highly desirable. Whole-body vibration (WBV) platforms, a popular commercially 
available product, aim to meet this need. These devices are described as a non-invasive 
mechanical loading technology and a safer alternative than drug therapies, which some 
propose build bone (Chan et al., 2013; Rubin et al., 2001), increase muscle mass and 
strength (Milanese et al., 2013; Osawa et al., 2013), and reduce adiposity (Cristi-Montero 
et al., 2013; Vissers et al., 2010). However, while some studies support WBV as a 
potential therapeutic treatment, other studies do not replicate the benefits (Roelants et al., 
2004; Tapp and Signorile, 2014; von Stengel et al., 2011). Therefore, whether whole-
body vibration has beneficial effects on body composition is still controversial, providing 
the rationale for systematic investigation. 
It is well established that mechanical loading is an anabolic stimulus in bone 
(Frost, 2001; Prisby et al., 2008; Robling et al., 2006). In 1892, Julius Wolff published 
his “Law of Transformation of Bone”, reporting that bone alters its inner architecture due 
to loading and, as a secondary effect, alters its shape (Wolff, 1986). Mechanically-
induced osteogenesis results in improved bone strength, particularly in areas of bone 
subjected to increased loading (Frost, 2001). Mechanical stimuli are also necessary for 
the normal functioning of joints (Liu et al., 2001). The adaptive response of the skeleton 
is made possible by the ability of cells to sense and translate a mechanical stimulus into a 
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biochemical signal, a process known as mechanotransduction (Grol et al., 2009; Robling 
and Turner, 2009).  
Low-magnitude, high-frequency vibration has previously been shown to increase 
bone formation (Rubin et al., 2001; Xie et al., 2008), reduce fat formation (Luu et al., 
2009; Rubin et al., 2007), increase lean muscle tissue and strength (McKeehen et al., 
2013; Mettlach et al., 2014; Xie et al., 2008) and promote anabolic response in 
intervertebral discs (Gusi et al., 2006; McCann et al., 2013). However, the cellular and 
molecular mechanisms underlying the response of tissues to mechanical stimuli remain 
largely unknown. Moreover, the actions of vibration are inconsistent, with some 
investigators reporting that vibration has minimal effects on musculoskeletal tissues 
(Christiansen et al., 2009; Lynch et al., 2010; Lynch et al., 2011; Manske et al., 2012).   
Potential pathways mediating cellular responses to mechanical loading have been 
investigated. Perhaps the most widely endorsed view is that nucleotides are released from 
cells in response to mechanical stimulation (Bodin and Burnstock, 2001; Burnstock, 
2007), and serve as mediators of the response of skeletal cells to mechanical loading 
(Dixon and Sims, 2000; Lenertz et al., 2011; Panupinthu et al., 2008; Robling et al., 
2006; Robling and Turner, 2009). ATP is released by mechanical stress (Romanello et 
al., 2001) and binds to P2 receptors, resulting in bone remodelling (Buckley et al., 2003; 
Lenertz et al., 2011; Li, 2005).  
P2 receptors are subdivided into two classes: P2X (ATP-gated nonselective cation 
channels) and P2Y (G protein-coupled receptors) (Burnstock, 2007). Osteoblasts and 
osteoclasts express multiple P2 receptor subtypes (Lenertz et al., 2011; Orriss et al., 
2010). Seven subtypes of P2X receptors, P2X1-7, are known to exist. Of these, P2X7 is 
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emerging as a key player in a number of physiological and pathological processes. An 
extended C-terminal tail confers unique properties to this receptor, such as the ability to 
form pores and induce plasma membrane blebbing (Burnstock, 2007; Garcia-Marcos et 
al., 2006; Grol et al., 2009; Panupinthu et al., 2008). Moreover, P2X7 receptors are 
implicated in bone remodeling (Gartland et al., 2012; Grol et al., 2013; Husted et al., 
2013; Ke et al., 2003; Li, 2005; Wesselius et al., 2013), cellular metabolism and energy 
homeostasis (Amoroso et al., 2012; Grol et al., 2012), as well as adiposity and lipid 
accumulation (Chapter 3).  
Mice that have been genetically modified to lack functional P2X7 receptors (KO) 
exhibit diminished periosteal bone formation and excessive trabecular bone resorption 
(Ke et al., 2003). Interestingly, these mice show an impaired skeletal response to axial 
loading of the ulna (Li, 2005). In comparison to cultures from wild-type (WT) mice, bone 
cells from P2X7 KO mice (which include mesenchymal progenitor cells) exhibit greater 
expression of adipogenic markers accompanied by suppression of osteogenic markers 
(Panupinthu et al., 2008). Therefore, P2X7 may be activated during 
mechanotransduction, directing differentiation towards the osteoblast lineage and away 
from the adipocyte lineage. 
The objective of the present study was to explore the effects of WBV on murine 
body composition and bone microarchitecture, and the possible role of P2X7 in these 
processes. We used a custom-built platform for in vivo low-magnitude, high-frequency 
WBV of mice, as described previously (McCann et al., 2013). The vibration parameters 
used in the present study were similar to those used by other investigators who 
demonstrated anabolic effects on bone in mice (Xie et al., 2006; Xie et al., 2008). 
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Quantitative micro-CT imaging was used to assess murine whole-body composition and 
bone microarchitecture. We found no significant effects of vibration on whole-body 
composition parameters, including total body mass, and adipose, lean and skeletal tissue 
masses. Although genotype was found to influence skeletal microarchitecture, there were 
no significant effects of vibration. Together with the results of other recent studies, our 
findings highlight the need to re-evaluate current thinking on the effects of low-
magnitude, high-frequency WBV on body composition.    
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4.3  Materials and Methods 
4.3.1  Animals 
The P2X7 KO mouse was obtained from Pfizer (Solle et al., 2001). A splice variant (with 
C-terminal truncation) is detectable in some tissues of the Pfizer KO mouse; however, it 
is inefficiently trafficked to the cell surface and displays greatly diminished receptor 
function (Masin et al., 2012) thereby justifying the use of this mouse as a loss-of-function 
model. Mice were maintained on a mixed genetic background (129/Ola × C57BL/6 × 
DBA/2) by crossbreeding of heterozygous mice. Genotypes were identified by PCR. 
Mice were individually housed in standard cages and maintained on a 12-hour light/dark 
cycle, with water and standard mouse chow (2018 Teklad Global 18% protein rodent 
diet, Harlan Laboratories, USA) available ad libitum. Mice were weighed immediately 
after scanning, and food was weighed weekly using a portable electronic scale (Acculab 
VICON VIC-511; Sartorius Group, Germany). Food intake was assessed throughout the 
study by subtracting the weight of food remaining after each week from the known 
amount of food provided. One outlier mouse was excluded from the food intake data due 
to abnormal grinding of food without ingestion. All aspects of this study were conducted 
in accordance with the policies and guidelines of the Canadian Council on Animal Care 
and were approved by the Animal Use Subcommittee of the University of Western 
Ontario, London, ON, Canada. Data for the WT NV group in the present study also 
appear in Chapter 2 for Cohort 2 mice (ages 8 to 26 weeks) and in the whole-body 
composition and food consumption data in Chapter 3 for 8-week-old (2 month) and 26-
week-old (6 month) WT mice.  
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4.3.2  Vibration platform and procedure 
We developed a low-magnitude, high-frequency vibration platform designed specifically 
for small animal studies, as described previously (McCann et al., 2013). Briefly, 
vibrations were produced by an electromagnetic shaker regulated by an open-loop 
controller. To effectively reduce resonance frequencies, the platform itself was 
constructed using 12-mm thick aerospace-grade aluminum-core honeycomb, and was 
then mounted atop the electromagnetic shaker. This system allowed us to apply vertical 
sinusoidal vibrations with up to 1 g maximum acceleration, 10 to 90 Hz frequency range, 
and 0.01 to 0.33 mm peak-to-peak displacement. Acceleration was monitored using a 
precision accelerometer, and validated by high-speed imaging. The acceleration accuracy 
was confirmed to be within 4% and precision at 45 Hz was better than 0.70%. 
 Eight-week-old male WT and P2X7 KO mice were separated into either a sham 
(non-vibrated, NV) or experimental (vibrated, VIB) groups. Mice in the experimental 
groups were placed in cages affixed to the vibration platform and subjected to whole-
body vibration at 45 Hz, 74 µm peak-to-peak amplitude, and 0.3 g maximum acceleration 
for 15 min/day, 5 days/week over an 18-week period. These vibration parameters were 
selected as they have been reported in some studies to induce anabolic skeletal effects in 
mice (Prisby et al., 2008; Xie et al., 2006; Xie et al., 2008). Mice in the sham groups 
were placed in cages on a control platform for the same duration of time, in close 
proximity to the actual vibration platform while it was in operation for the corresponding 
experimental group. All mice were housed individually in custom plastic cages during 
experimentation. The plastic cages were affixed to the vibration platform to reduce 
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resonance frequencies. Cages did not contain bedding so as to avoid dampening the 
vibration. 
 
4.3.3  Whole-body in vivo micro-CT image acquisition 
Longitudinal in vivo micro-CT imaging was used to quantify whole-body composition 
(including skeletal, adipose and lean tissue masses) prior to (at week 0), during (at 3, 6, 9, 
12 and 15 weeks) and immediately following the experimental period (at 18 weeks). The 
duration of the study was determined based on the results of previous studies, which 
showed skeletal effects of WBV within 3 weeks and effects on adipose tissue distribution 
within 15 weeks (Rubin et al., 2007; Xie et al., 2006; Xie et al., 2008). Mice were 
anesthetized with isoflurane (Forane, catalog # CA2L9100, Baxter Corporation, 
Mississauga, Canada) and imaged using an eXplore Locus Ultra micro-CT scanner (GE 
Healthcare Biosciences, London, ON, Canada). Scans were analysed as described 
previously (Chapter 2). Briefly, a calibrating phantom composed of air, water and cortical 
bone-mimicking epoxy with a mineral value of 1100 mg/cm3 (SB3; Gammex, Middleton, 
WI, USA) (White, 1978) was scanned together with the animals. One thousand projection 
images were obtained over a single 16-second rotation (80 kVp, 55 mA tube current, 16 
ms exposure). While still anesthetized, immediately after scanning, mice were weighed 
gravimetrically using a portable electronic precision scale (Acculab VICON VIC-511; 
Sartorius Group, Germany). 
 Data sets were reconstructed into 3D volumes from the X-ray projection data with 
nominal isotropic voxel spacing of 154 µm using a cone-beam filtered backprojection 
algorithm. The reconstructed data were linearly rescaled into Hounsfield units (HU), with 
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the voxel gray-level of air being -1000 HU and water 0 HU.  
 
4.3.4  Whole-body composition analysis 
Using MicroView software (GE Healthcare Biosciences), three signal-intensity 
thresholds (-200, -30 and 190 HU) were used to classify each voxel as adipose (-200 to  
-31 HU), lean (-30 to 189 HU), or skeletal tissue (≥190 HU). In-house-designed software 
was used to calculate tissue masses from assumed tissue densities of 0.95 (adipose), 1.05 
(lean), and 1.92 (skeletal) g/cm3 as listed by the International Commission on Radiation 
Units and Measurements (ICRU, 1989). The sum of all tissue masses yielded a CT-
derived estimate of whole-body mass, which corresponded well to the gravimetric mass 
of each mouse (within 3%). In addition, the software was used to calculate bone mineral 
density (BMD; mg HA/cm3) and bone mineral content (BMC; mg HA).  Briefly, BMD 
was computed as the ratio of the average HU value of the skeletal region of interest (ROI) 
to the measured HU value of the SB3 calibrator, multiplied by the known hydroxyapatite 
(HA)-equivalent density of the SB3 (1100 mg/cm3).  Thereafter, the program 
automatically computed BMC as the product of the BMD and the total volume of the 
skeletal ROI used in the BMD calculation. 
 
4.3.5  High-resolution micro-CT image acquisition 
Mouse hind limbs were isolated post-mortem, fixed in 10% neutral buffered formalin, 
and imaged using an eXplore Locus RS micro-CT scanner (GE Healthcare Biosciences, 
London, ON, Canada) to characterize trabecular and cortical bone properties. The 
calibrating phantom was scanned together with specimens. The scanning protocol was as 
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follows: 900 X-ray projection images were acquired at an angular increment of 0.4 
degrees over a single 2.75-hour gantry rotation (80 kVp, 450 mA tube current, 4.5 s 
exposure, 2 frames per view angle averaged). Using a filtered backprojection algorithm, 
the data sets were reconstructed into 3D volumes with an isotropic voxel spacing of 20 
µm, and then linearly rescaled into HU using the internal air and water calibration 
standards.  
 
4.3.6  High-resolution micro-CT analysis 
Reconstructed images were cropped and analysed using MicroView software. Briefly, 
femur and tibia were spline cropped and reoriented to the axes. Selected ROIs were then 
assessed using the Bone Analysis Tool in MicroView. Consistently sized box ROIs were 
placed in the mid-diaphysis of the femur and tibia, and distal tibia for cortical analyses, 
avoiding the presence of trabeculae. BMD and cortical analyses (including slice data and 
radial thickness) were selected and reported using user-defined threshold values. 
Trabecular analyses were performed on cylindrical ROIs from the distal femur and 
proximal tibia, landmarked by the distal-most aspect of the epiphyseal line, and contained 
within the marrow space ensuring that no cortical bone was included. BMD, structure 
model index (SMI), direct measures, anisotropy and stereology analyses were selected, 
using the same threshold values as above. Images of isosurfaced bones were obtained 
using the snapshot option within MicroView with the highest surface quality and no 
decimation. 
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4.3.7  Hind limb long-bone analyses 
Bone lengths were measured using the line measurement tool in MicroView. Femurs 
were measured from the base of the lateral femoral condyle to the tip of the greater 
trochanter. Tibial lengths were measured from the base of the medial malleolus to the tip 
of the intercondylar eminence. 
 
4.3.8  Statistical analyses 
Data are presented as means ± standard error of the mean (SEM). Differences among 
three or more groups were evaluated by two-way analysis of variance (ANOVA) 
followed by a Bonferroni multiple comparisons test. Differences were accepted as 
statistically significant at p < 0.05. All n values represent the number of mice used in 
each group.  
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4.4  Results 
4.4.1  Evaluation of the effect of vibration on murine whole-body composition 
We first investigated the effects of low-magnitude, high-frequency vibration on murine 
body composition and the possible role of P2X7.  Eight-week-old male WT and P2X7 
KO littermate mice were separated into age-matched control (non-vibrated, NV) and 
experimental (vibrated, Vib) groups. Experimental groups were subjected to WBV at 45 
Hz and 74 µm peak-to-peak amplitude (giving maximum acceleration of 0.3 g) for 15 
min/day, 5 days/week over a period of 18 weeks. To assess the systemic effects of WBV, 
in vivo micro-CT was used to quantitatively monitor whole-body composition 
longitudinally at 3-week intervals. Each voxel was assigned as adipose, lean or skeletal 
tissue based on threshold values using an in-house-designed program. The sum of all 
tissue masses yielded a CT-derived estimate of whole-body mass (Figure 4.1 A). When 
the change in total body mass (in g) was evaluated over the 18-week period, we did not 
observe any significant differences between NV and Vib or between WT and KO mice. 
We then calculated changes in total body mass as percentages of baseline values at week 
0 (Figure 4.2 A). Again, no significant effects of vibration or genotype were observed. 
 WBV of mice has been shown by some authors to enhance trabecular bone 
volume fraction, inhibit trabecular bone resorption, increase the rate of bone formation on 
the endocortical surface, and increase cortical and bone marrow areas in the proximal 
tibia (Xie et al., 2006; Xie et al., 2008). However, over the 18-week period of our study, 
we found no significant effect of vibration or genotype on whole-body BMD, BMC or 
skeletal tissue mass, both when data were analysed as absolute values (Figure 4.1 B-D) or  
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Figure 4.1 Vibration does not significantly alter whole-body composition of WT or 
P2X7 KO mice.  
WT and P2X7 KO mice were subjected to vibration (Vib) or sham control (non-
vibrated, NV). Mice were anesthetized and scanned by micro-CT at baseline (week 0, 8 
weeks of age) and at 3-week intervals for 18 weeks (26 weeks of age). An in-house-
designed program was used to assign each voxel as adipose, lean or skeletal tissue, based 
on threshold values. Tissue masses were then calculated from assumed tissue densities of 
0.95 (adipose), 1.05 (lean), and 1.92 (skeletal) g/cm3. Data are changes in indicated 
whole-body composition parameters from baseline (week 0) to week 18, expressed in 
absolute units. There were no significant effects of vibration on whole-body composition 
parameters. Additionally, there were no significant effects of genotype on whole-body 
composition. Data are means ± SEM (n = 6-8 mice per group), where p > 0.05 by two-
way ANOVA.  
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Figure 4.2 Effects of vibration on whole-body composition of WT or P2X7 KO mice 
expressed as relative changes.  
WT and P2X7 KO mice were subjected to vibration (Vib) or sham control (non-
vibrated, NV). Mice were anesthetized and scanned by micro-CT at baseline (week 0, 8 
weeks of age) and at 3-week intervals for 18 weeks (26 weeks of age). Images of mice 
were obtained and analysed as described in Figure 4.1. Data are changes in indicated 
whole-body composition parameters from baseline (week 0) to week 18, expressed as a 
percentage of the baseline values. There were no significant effects of vibration on 
whole-body composition parameters. Additionally, there were no significant effects of 
genotype on whole-body composition. Data are means ± SEM (n = 6-8 mice per group), 
where p > 0.05 by two-way ANOVA. 
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as percent changes from baseline values (Figure 4.2 B-D). Previous studies have also 
shown that P2X7 KO mice display differences compared to WT in histomorphometric 
parameters of individual bones (Ke et al., 2003). However, differences were not apparent 
in the present study at the whole-body level, consistent with regional effects of P2X7 
disruption.  
Some investigators have reported that WBV reduces adipose tissue volume 
(Rubin et al., 2007) and enhances muscle accretion (Xie et al., 2008). However, we did 
not find any significant effect of vibration or genotype (Figure 4.1 E, F, 4.2 E, F). The 
absence of effect of genotype on adiposity in the 6-month-old mice used for this study is 
consistent with our findings in Chapter 3, which demonstrate an effect of P2X7 only at 9 
months of age. 
Some previous studies have suggested that vibration can induce skeletal changes 
in as little as 3 weeks (Xie et al., 2006) and adipose tissue changes in 12-15 weeks (Rubin 
et al., 2007). Though gravimetric body mass (Figure 4.3 A) corresponded well to the CT-
derived total body mass (within 3%), no effects of vibration or genotype were found on 
body mass or skeletal tissue mass (Figure 4.3 B). Similarly, there were no significant 
effects of vibration or genotype on adipose or lean tissue masses at any time point (Figure 
4.3 C, D)1. Taken together, these data reveal that, under the conditions studied, WBV 
does not induce changes in murine whole-body composition. 
 As an additional measure, we assessed whether offsetting effects of vibration on  
                                                
1 In contrast to the results of the Bonferroni test, two-way ANOVA indicated an overall 
significant effect of vibration on adipose and lean tissues mass in WT mice. However, the 
cohort of WT mice that were vibrated began at time 0 with a greater percentage of 
adipose tissue mass (and less lean tissue mass) than the non-vibrated cohort, accounting 
for this apparent effect of vibration. 
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Figure 4.3 Time course of changes in whole-body composition of WT and P2X7 KO 
mice.  
WT and P2X7 KO mice were subjected to vibration (Vib) or sham control (non-
vibrated, NV), scanned, and analysed as described in the legend to Figure 1. A Data 
indicate the gravimetric mass of mice over the 18-week experimental period. B-D 
Skeletal, adipose and lean tissue mass are expressed as a percentage of CT-derived total 
body mass at each time. No significant differences were seen among WT NV, WT Vib, 
KO NV and KO Vib at any time point throughout the course of the experimental 
regimen. Data are means ± SEM (n = 6-8 mice per group). 
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food intake might have masked possible effects of vibration on whole-body composition. 
Food consumption was measured by weighing food once weekly, then calculating mean 
food consumption per day over the experimental period for each group (Figure 4.4). No 
significant effects of vibration or genotype were observed in eating behaviour. Thus, diet 
did not appear to have any confounding effect on our assessment of whole-body 
composition. 
 
4.4.2  Evaluation of the effect of vibration on bone microarchitecture 
Other studies have shown that the effects of mechanical loading are localized to loaded 
bones (Robling et al., 2006; Sugiyama et al., 2010; Turner, 1999) and, within those 
bones, site-specific effects are observed (Fritton et al., 2005). Therefore, we assessed the 
local effects of vibration on microarchitectural parameters in the femur and tibia. High-
resolution (20 µm) ex vivo micro-CT scans of hind-limbs were performed at the end of 
the experimental period. Visual assessment of representative images at the gross level did 
not reveal any marked differences in shape or architecture (Figure 4.5). Moreover, no 
significant effects of vibration or genotype were observed on long bone lengths (Figure 
4.6). 
We then evaluated specific regions of interest in the femur and tibia. Others have 
reported an effect of vibration on cortical bone parameters in the femoral diaphysis 
(Vanleene and Shefelbine, 2013). In the present study, an ROI containing only cortical 
bone of the mid-diaphysis was isolated, and we used the Bone Analysis Tool in 
MicroView to assess cortical parameters. Our data did not reveal significant effects of 
vibration on BMD, BMC, BV/TV, Ct.Th, Ma.Ar or Ct.Ar (Figure 4.7). However, we did 
observe a small but significant effect of genotype on Ct.Ar (Figure 4.7 F).  
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Figure 4.4 Food consumption by mice.  
Food consumption was measured by weighing food once weekly over the course 
of the experimental period. No significant differences were observed among groups. Data 
are the mean consumption per day over the 18-week experimental period and are 
expressed as means ± SEM (n ≥ 6 mice per group), p > 0.05, determined by two-way 
ANOVA. 
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Figure 4.5 Representative high-resolution micro-CT images of femur and tibia. 
 Immediately following the 18-week experimental period, mice were sacrificed 
and left hind-limbs were isolated from mice for ex vivo scanning. Using the eXplore 
Locus RS micro-CT scanner, images were reconstructed with nominal isotropic voxel 
spacing of 20 µm and rescaled into Hounsfield units. MicroView software was used to 
crop femur and tibia from the whole hind-limb volume. Each column shows images from 
a single representative mouse in each of the study groups. The first row shows coronal 
sections of the femur that are 3D surface-rendered to illustrate trabeculae and cortical 
bone. The second row shows surface-rendered femurs from the posterior perspective. The 
third row shows surface-rendered tibias from the medial perspective. The fourth row 
shows a sagittal view of the cropped proximal tibia to illustrate trabeculae. Images are 
representative of left femur and tibia from 6 mice in each group.   
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Figure 4.6 Lengths of femurs and tibiae at the completion of the 18-week 
experimental period.   
Left tibiae and femurs were measured using the line measurement tool in 
MicroView from base of the lateral femoral condyle to tip of the greater trochanter (for 
femurs, A) and base of the medial malleolus to tip of the intercondylar eminence (for 
tibiae, B). There were no significant differences between genotypes or vibrated (Vib) and 
non-vibrated (NV) groups. Data are means ± SEM (n = 6 mice per group), p > 0.05 
determined by two-way ANOVA.  
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Figure 4.7 Analysis of mid-diaphyseal cortical region of the femur.   
 Using MicroView software, left femurs were cropped from the hind-limb images 
and axes were reoriented. A region of interest (ROI) that encompassed the mid-diaphysis 
in all three spatial directions was cropped from each of the volumes. The ROI included 
only cortical bone. The cropped ROI was then used to determine the bone mineral density 
(BMD, mg HA/cm3), bone mineral content (BMC, mg HA), bone volume fraction 
(BV/TV), cortical mean thickness (Ct.Th, mm), cortical marrow area (Ma.Ar, mm2) and 
cortical area (Ct.Ar, mm2) with the Bone Analysis Tool in MicroView. There were no 
significant differences between vibrated (Vib) and non-vibrated (NV) groups. There was 
a significant effect of genotype on Ct.Ar. Data are means ± SEM (n = 6 mice per group), 
* indicates p < 0.05 by two-way ANOVA with a Bonferroni post hoc test.  
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Thereafter, we assessed the effects of vibration on the distal femoral trabeculae 
(Figure 4.8), as some other investigators have shown responses to WBV in this region 
(Judex et al., 2002; Tezval et al., 2011). A cylindrical ROI was placed in the marrow 
cavity of the distal femur that encompassed only trabecular bone immediately above the 
growth plate. BMD, BMC, BV/TV, Tb.N, Tb.Th and Tb.Sp were assessed. No significant 
effects of vibration or genotype were observed.  
 We also evaluated cortical and trabecular regions of the tibia. Others have 
reported an effect of WBV on cortical bone parameters in tibia (Vanleene and Shefelbine, 
2013; Xie et al., 2006). We first examined cortical bone of the mid-diaphysis (Figure 
4.9).  
Again, no significant effects of vibration or genotype were observed. Next, we 
assessed the distal-diaphyseal cortical region of the tibia (Figure 4.10). Our data did not 
reveal significant effects of vibration; however, we did observe a significant effect of 
genotype on Ct.Th (Figure 4.10 D). As well, two-way ANOVA revealed an overall 
significant effect of genotype on Ct.Ar (Figure 4.10 F), with significantly smaller cortical 
area in P2X7 KO compared to WT mice.  Finally, we assessed trabecular bone in the 
proximal tibia (Figure 4.11). No significant effects of vibration or genotype were 
observed in this region.  
 Taken together, these data indicate that, under the conditions studied, WBV does 
not induce changes in the microarchitecture of the murine femur and tibia.  
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Figure 4.8 Analysis of distal femoral trabeculae.  
A cylindrical region of interest (ROI) that encompassed the perimeter of the 
marrow cavity in all three spatial directions was cropped from each of the volumes. The 
ROI began at the proximal end of the growth plate in the distal metaphysis and extended 
proximally while excluding the surrounding cortical bone. The cropped ROI was then 
used to determine the BMD (mg HA/cm3), BMC (mg HA), BV/TV, trabecular number 
(Tb.N), trabecular thickness (Tb.Th, mm) and trabecular spacing (Tb.Sp, mm) with the 
Bone Analysis Tool in MicroView. A - F) There were no significant differences between 
genotypes or between vibrated (Vib) and non-vibrated (NV) groups. Data are means ± 
SEM (n = 6 mice per group), where p > 0.05 determined by two-way ANOVA. 
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Figure 4.9 Analysis of mid-diaphyseal cortical region of the tibia.  
A region of interest (ROI) that encompassed the mid-diaphysis in all three spatial 
directions was cropped from each of the volumes. The ROI included only cortical bone. 
The cropped ROI was then used to determine the BMD (mg HA/cm3), BMC (mg HA), 
BV/TV, Ct.Th (mm), Ma.Ar (mm2) and Ct.Ar (mm2) with the Bone Analysis Tool in 
MicroView. There were no significant differences between genotypes or between 
vibrated (Vib) and non-vibrated (NV) groups. Data are means ± SEM (n = 6 mice per 
group), where p > 0.05 determined by two-way ANOVA. 
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Figure 4.10 Analysis of distal-diaphyseal cortical region of the tibia.  
A region of interest (ROI) that encompassed the distal-diaphysis in all three 
spatial directions was cropped from each of the volumes. The ROI included only cortical 
bone. The cropped ROI was then used to determine the BMD (mg HA/cm3), BMC (mg 
HA), BV/TV, Ct.Th (mm), Ma.Ar (mm2) and Ct.Ar (mm2) with the Bone Analysis Tool 
in MicroView. There were no significant differences between vibrated (Vib) and non-
vibrated (NV) groups. There was a significant effect of genotype on Ct.Th and Ct.Ar. 
Data are means ± SEM (n = 6 mice per group), * indicates p < 0.05 by two-way ANOVA 
with a Bonferroni post hoc test. The effect of genotype on Ct.Ar was significant based on 
the results of two-way ANOVA (p < 0.05).  
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Figure 4.11 Analysis of proximal tibial trabeculae.  
A cylindrical region of interest (ROI) that encompassed the perimeter of the 
marrow cavity in all three spatial directions was cropped from each of the volumes. The 
ROI was selected starting at the end of the growth plate in the proximal metaphysis and 
extended distally while excluding the surrounding cortical bone. A-F) The cropped ROI 
was then used to determine the BMD (mg HA/cm3), BMC (mg HA), BV/TV, Tb.N, 
Tb.Th (mm) and Tb.Sp (mm) with the Bone Analysis Tool in MicroView. There were no 
significant differences between genotypes or between vibrated (Vib) and non-vibrated 
(NV) groups. Data are means ± SEM (n = 6 mice per group), where p > 0.05 determined 
by two-way ANOVA. 
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4.5  Discussion 
Whole-body vibration has recently gained popularity due to studies indicating that it may 
be a non-pharmacological approach to building bone (Gilsanz et al., 2006; Xie et al., 
2008), increasing muscle strength (Tapp and Signorile, 2014; Verschueren et al., 2004; 
Xie et al., 2008) and reducing fat tissue mass (Milanese et al., 2013; Rubin et al., 2007; 
Vissers et al., 2010; Xie et al., 2008). WBV is appealing due to its ease of use, minimal 
time requirements, and accessibility for those who are unable to do high-impact exercises 
(such as infirmed, injured, elderly or obese individuals) (Chan et al., 2013; Tapp and 
Signorile, 2014). However, the effects of WBV are controversial and poorly understood. 
The aim of the present study was to assess the effects of WBV on murine body 
composition and bone microarchitecture, and the possible role of P2X7 in these 
processes. We analysed whole-body composition using in vivo quantitative micro-CT. 
Unexpectedly, our analysis did not reveal significant changes in body composition in 
response to vibration.  
Some previous studies showed anabolic skeletal responses to WBV using the 
same vibration parameters (Xie et al., 2006; Xie et al., 2008). However, consistent with 
our findings, recent studies from a number of other groups have not demonstrated 
anabolic effects of vibration on skeletal tissues (Lynch et al., 2011; Manske et al., 2012; 
van der Jagt et al., 2012; Wenger et al., 2010). In addition, we did not see a significant 
effect of vibration on adiposity. Our findings, though in contrast to those of Rubin and 
coworkers, who observed a ~28% decrease in adipose tissue volume in the torso after 12 
weeks measured using CT (Rubin et al., 2007), are consistent with a more recent report 
showing fat pad masses are unaffected by WBV (Lynch et al., 2010). It should be noted 
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that the study by Rubin and colleagues used a vibration protocol of 90 Hz with a 
displacement of ~12 µm (0.2 g maximum acceleration) for 15 min/day, 5 days/week over 
the course of 15 weeks (Rubin et al., 2007). In contrast, our study used 45 Hz and ~74 
µm peak-to-peak amplitude (0.3 g maximum acceleration) for 15 min/day, 5 days/week 
over the course of 18 weeks. It is possible that these small differences in vibration 
protocols may have impacted the effects of vibration on adipose tissues. Unfortunately, 
some investigators do not include specific information on vibration parameters or how 
parameters were validated (Lorenzen et al., 2009). This may be one reason for 
inconsistencies in the literature.  
It is also possible that responses to vibrational stimuli are dependent on genetic 
differences among strains of mice (Judex et al., 2002; Prisby et al., 2008). For example, 
the study by Rubin et al. showed effects of WBV on mice of male C57BL/6 strain (Rubin 
et al., 2007), while other studies from this group showed enhanced cortical bone 
properties in female mice on a BALB/cByJ background (Xie et al., 2008). Reports from 
another author do not show anabolic skeletal effects of WBV in male BALB/c mice 
(Lynch et al., 2011), and another group shows no response in several skeletal sites and 
some response in other sites of male C57BL/6 mice (Wenger et al., 2010). Additionally, 
we noted large ranges in sample sizes of animal populations used in vibration studies, 
from as little as 3 to as many as 20 animals per treatment group (Mettlach et al., 2014; 
Rubin et al., 2007). In our study, a sample size calculation was performed with a two-
sided alpha of 0.05 and power of 80%. We used the variability of gravimetric mass (SD = 
1.3 g), BMD (SD = 8.67 mg HA/cm3), BMC (SD = 41.1 mg HA), lean tissue (SD = 1.0 
g), and skeletal tissue (SD = 0.17 g) in WT non-vibrated mice.  We determined that 
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sample sizes of n = 5, 3, 6, 6 and 3 mice, respectively, were required to detect a 
difference of ≥ 10% between treatment groups. Our study used a minimum of 6 animals 
per group; thus ensuring that sample sizes were sufficient to detect effect sizes of 10% or 
less. Taken together, the differing strains, sexes and sample sizes used in other studies 
likely contribute to the inconsistent body of literature on the effects of WBV treatment. 
Because we failed to detect changes in whole-body composition induced by 
vibration, we proceeded to use high-resolution micro-CT to determine whether vibration 
leads to localized skeletal changes in hind-limb long bones. This decision was based on 
observations in the literature that suggest that the effects of mechanical stimuli are 
exhibited solely in loaded bones (Robling et al., 2006; Sugiyama et al., 2010; Turner, 
1999). In this regard, some studies show favourable effects of vibration of BV/TV in 
trabeculae, as well as greater cortical bone area and marrow area in the proximal tibia 
(Xie et al., 2008). However, we saw no differences in tibial trabecular or cortical bone 
structure; consistent with that reported by Lynch and colleagues (Lynch et al., 2010). On 
the other hand, that bone lengths did not change significantly with vibration in this study 
is consistent with the findings of most other groups (Xie et al., 2006; Xie et al., 2008). 
Bone lengths also did not differ significantly with genotype; a finding consistent with 
previously reported phenotype for P2X7 KO mice (Ke et al., 2003). Additionally, it is 
possible that the scan resolution could have affected the outcomes in this study. Although 
we scanned with 20 µm voxel size; however, the width of mouse trabeculae fall within 30 
– 50 µm (Bouxsein et al., 2010). Thus, it is possible that even higher scan resolutions (< 
20 µm) could have produced different results, albeit at the expense of markedly increased 
scan times and impaired signal-to-noise ratios.  
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With regards to the P2X7 KO mouse model, the current study also did not 
observe any effects of genotype at the whole body level for mice between 2 and 6 months 
of age. This is in keeping with our findings in Chapter 3 that show only at older ages (9 
months) do KO mice exhibit greater adiposity than WT mice. Additionally, Ke and 
coworkers showed reduced total bone content and smaller bone diameters in femurs of 
KO mice compared to WT mice, differences which were subtle at 2 months of age and 
more pronounced at 9 months (Ke et al., 2003; Li, 2005). Thus, the P2X7 KO phenotype 
manifests with age and as only young animals were included in the present study, only 
subtle effects of genotype were observed.  
The possible mechanism through which vibration affects skeletal tissues is 
unclear, as is the reason for conflicting reports as to the in vivo effects of WBV. In vitro 
studies reveal that mechanical stimulation increases mesenchymal stem cell (MSC) 
proliferation and differentiation (Luu et al., 2009). Moreover, vibration is reported to 
maintain the osteogenic potential of bone marrow (Ozcivici et al., 2010). Others have 
shown that mechanical strain enhances osteogenesis while suppressing adipogenesis in 
MSC cultures, even under conditions favoring adipogenesis (Sen et al., 2008). However 
these findings are controversial, as other studies have shown that vibration reduces the 
osteogenic potential of MSCs, diminishing osterix expression and inhibiting matrix 
mineralization (Lau et al., 2011). Therefore, further investigation of mechanotransduction 
in response to vibrational stimuli is required using both in vitro and in vivo models.  
Skeletal aging may affect how bone senses WBV, as the sensitivity of bone to 
mechanical signals appears to decrease with age (Prisby et al., 2008; Robling et al., 2006; 
Rubin et al., 1992). Using a tibial compression loading model, Willie and coworkers 
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showed anabolic responses in young mice at 10 weeks of age, but not in older mice at 26 
weeks of age (Willie et al., 2013). Some have observed anabolic effects of WBV on bone 
in mice at 7, but not 22 months of age (Lynch et al., 2010), whereas others show effects 
of vibration on mice at 18 months of age (Wenger et al., 2010). Our animals ranged from 
8 to 26 weeks of age, which may have affected our outcomes. Given that some studies 
have observed anabolic responses in older mice, future studies examining WBV in this 
KO mouse model may yield different results at an older age when the phenotype is more 
pronounced. Additionally, future work could also assess the acute, rather than chronic, 
effects of vibration in both younger and older mice. 
 Some research has shown that extending the duration of skeletal loading does not 
result in proportional increases in bone mass, since the response fades as bone cells 
become desensitized to mechanical loading over time (Robling et al., 2006). Whether the 
existence of such a period of desensitization applies to WBV is still controversial, as 
some investigators have shown that a rest period during vibration fails to its potentiate 
cellular effects (Xie et al., 2006), whereas others have shown that it can inhibit 
adipogenesis (Sen et al., 2011) while enhancing osteogenic responses (Gross et al., 2004; 
LaMothe and Zernicke, 2004). Our experimental procedure entailed one bout of WBV 
per day for 5 days/week over the course of 18 weeks. It is possible that multiple bouts of 
vibration over a shorter time period might be more effective.  
In summary, our data are consistent with a number of other studies reporting 
little-to-no improvement of skeletal parameters in response to WBV (Castillo et al., 2006; 
Lynch et al., 2010; Lynch et al., 2011; Manske et al., 2012). Together with the results of 
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these studies, our findings highlight the need to re-evaluate current thinking on the effects 
of low-magnitude, high-frequency WBV on body composition in vivo.    
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CHAPTER FIVE 
 
 
GENERAL DISCUSSION 
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5.1 Summary and Conclusions 
This thesis characterized a non-invasive method to monitor body composition 
during growth and aging in mice, and also evaluated the effects of P2X7 and mechanical 
vibration on body composition. We demonstrated that whole-body composition analysis 
using micro-CT could be performed rapidly and accurately in mice. We then applied this 
methodology to study the effects of P2X7 and whole-body vibration. Using wild-type 
(WT) and P2X7 knockout (KO; P2rx7-/-) mice, we found that P2X7 plays a previously 
unknown role in the regulation of adiposity and metabolism. Next, we evaluated the 
effects of whole-body vibration on WT and KO mice. We found that, under the 
conditions used, low-magnitude, high-frequency vibration does not induce changes in 
body composition or bone microarchitecture either in the presence or absence of P2X7 
receptors. The specific objectives, results and conclusions of each data chapter are 
summarized in greater detail below.  
 
5.1.1 Quantitative Micro-Computed Tomography for Assessment of Age-
 Dependent Changes in Murine Whole-Body Composition: Objective, 
 Summary and Conclusions 
Chapter 2 – Specific Objective – To characterize changes in whole-body composition of 
 mice during growth and aging using a novel, high-throughput method for analysis 
 of micro-CT images. 
Chapter 2 – Summary and Conclusions 
1. Cohorts of mice at several ages were scanned using micro-CT to assess 
whole-body composition, which included assessment of total, adipose, lean 
and skeletal tissues. The resulting images provided a useful means for 
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visually determining changes in the distribution of tissues during growth and 
aging in mice. 
2. Quantification of the micro-CT data using whole-body composition analysis 
revealed distinct age-related changes in tissue masses. Specifically, total body 
mass, bone mineral content (BMC), lean and skeletal tissue masses exhibited 
biphasic changes consisting of rapid increases up to 11 weeks of age, 
followed by a slow increase up to 52 weeks of age. Bone mineral density 
(BMD) rapidly increased up to 11 weeks of age then plateaued, while adipose 
tissue exhibited a continuous increase with age. 
3. Variability within our cohorts of mice at each age was assessed. Individual 
mouse whole-body composition data and coefficients of variation were 
computed. The coefficients of variation were within 10% of the mean, with 
the exception of adipose tissue, which ranged between 16-33% and became 
more variable with age. 
4. We describe a method to reproducibly measure tibia and femur lengths using 
anatomical landmarks and a line measurement tool in MicroView software. 
Tibia and femur both rapidly increased in length prior to 11 weeks of age, 
then exhibited a slow, continuous increase up to 52 weeks of age. 
5. Using regions of interest in the femoral mid-diaphysis, we quantified 
maximum BMD values. The maximum BMD values show a biphasic curve, 
rapidly increasing to 11 weeks of age then exhibiting much slower increases 
with age. 
6. To assess reproducibility, we examined two separate cohorts of mice at 8 
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weeks of age at different times, using the same scanner and protocol. Similar 
values were obtained for the two cohorts of mice. 
7. We compared values for total body mass, obtained gravimetrically and CT-
derived, at each age. There was excellent agreement, with CT-derived masses 
slightly (< 3%) less than gravimetrically determined masses. 
8. A higher-resolution scanner (speCZT) was used to image younger mice, and 
data were compared to those obtained from our lower-resolution micro-CT 
scanner (Ultra). There were slight but statistically significant differences in 
the volumetric measures of total mass, BMD, BMC, and adipose, lean and 
skeletal tissue mass.   
9. The present study is the first to report CT-derived, whole-skeleton data for 
growing and aging mice. Our micro-CT methodology offers the ability to 
accurately and precisely quantify adipose and lean tissue volumes of the 
mouse in addition to measuring skeletal tissue volume, providing normative 
comparisons for researchers using mouse models.  
 
5.1.2 Loss of P2X7 Nucleotide Receptor Function Leads to Abnormal Fat 
 Distribution in Mice: Objective, Summary and Conclusions 
Chapter 3 – Specific Objective – To assess the role of P2X7 in adipocyte distribution and 
 lipid accumulation in vivo. 
Chapter 3 – Summary and Conclusions 
1. We studied mice at 2, 6, 9 and 12 months of age. By allowing mice to age, we 
revealed an unexpected increase in body mass due to lipid accumulation in 
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male KO mice at 9 months of age compared to WT controls. This effect was 
sex-dependent, as no differences were noted for female mice at any age. 
2. Quantitative micro-CT whole-body composition analysis confirmed greater 
total body mass in KO mice at 9 months of age, and revealed significantly 
greater adipose tissue mass in these mice compared to WT controls. 
3. We observed significantly greater epididymal fat pad mass was in KO than in 
WT male mice at 9 months of age, with no significant difference observed at 
12 months of age. 
4. Histological assessments of epididymal fat pads in 9- and 12-month-old male 
mice revealed similar adipocyte morphology, adipocyte size and adipocyte 
density in WT and KO mice. Thus, the greater fat pad mass was attributed to 
adipocyte hyperplasia, rather than hypertrophy. 
5. Lipid staining revealed significantly greater lipid accumulation in the 
following male KO tissues compared to WT controls: lipid droplets in kidney 
at 9 and 12 months of age, adipocytes in the pancreas at 12 months of age, 
and both lipid droplets and adipocytes in the extraorbital lacrimal glands at 12 
months of age. 
6. Lipid accumulations were not observed in the following tissues in KO 
compared to WT: the submandibular salivary glands, heart, spleen, liver, 
Harderian glands and skeletal muscle. However, at 12 months of age the 
spleen had significantly greater mass in male KO mice compared to WT 
controls. H&E of spleen revealed greater basophilic staining coupled with 
megakaryocyte hyperplasia. 
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7. No significant differences in average daily food consumption were seen 
between male WT and KO mice at any age, suggesting that the phenotype 
may be due to metabolic differences, which we assessed with blood plasma 
analysis. Male KO mice had significantly reduced plasma cholesterol levels 
at both 9 and 12 months of age. No significant differences in plasma 
triglyceride or glucose levels were seen at either age for WT and KO mice. 
8. We report abnormal adipocyte and lipid accumulation in mice lacking 
functional P2X7 receptors, revealing a novel role for P2X7 in regulating lipid 
storage, deposition and metabolism in vivo. 
 
5.1.3 Low-Magnitude, High-Frequency Vibration has No Effect on Murine Whole-
 Body Composition and Bone Microarchitecture: Objective, Summary and 
 Conclusions 
Chapter 4 – Specific Objective – To investigate the effects of whole-body vibration on 
 body composition and bone microarchitecture, and the possible role of P2X7 in 
 these processes.  
Chapter 4 – Summary and Conclusions 
1. We assessed the systemic effects of WBV in vivo using micro-CT to quantify 
whole-body composition of WT and KO mice, which were separated into 
either non-vibrated or vibrated groups throughout the experimental period. 
2. No effects of vibration or genotype were found in body mass, BMD, BMC, 
skeletal tissue mass, adipose or lean tissue masses at any time point. In 
contrast to the findings of some other investigators, our data reveal that under 
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the conditions studied, WBV does not induce changes in murine whole-body 
composition. 
3. No significant effects of vibration or genotype were observed on food intake. 
Thus, diet did not appear to have any confounding effect on our assessment of 
whole-body composition. 
4. High-resolution (20 µm) ex vivo micro-CT scans of hind-limbs were 
performed at the end of the experimental period. Visual assessment of 
representative images did not reveal any marked differences in shape or 
architecture. No significant effects of vibration or genotype were observed on 
long bone lengths. 
5. WBV does not induce changes in cortical properties of the mid-diaphyseal 
femur, the mid-diaphyseal or distal diaphyseal tibiae. However, there was a 
small but significant effect of genotype in Ct.Ar of mid-diaphyseal cortical 
femur, as well as Ct.Ar and Ct.Th distal-diaphyseal cortical tibiae. 
6. WBV does not induce changes in trabecular properties of the distal femur and 
proximal tibia.  
7. Overall, we did not observe an effect of vibration using our study parameters; 
therefore, we are unable to draw conclusions about the role of P2X7 in 
mediating the biological effects of WBV. 
8. Together with the results of other recent studies, our findings highlight the 
need to re-evaluate current thinking on the effects of low-magnitude, high-
frequency WBV on whole-body composition in vivo and bone 
microarchitecture.   
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5.2 Limitations of the Research and Future Research Directions 
Genetically modified mouse models — All studies in this thesis relied on mouse models, 
and as such inherent issues arise. The wild-type mice from the study in Chapter 2 were 
used in the whole-body composition assessments to validate the methodology and 
provide normative values for other researchers. The mice used for studies in this thesis 
established a role for P2X7 in lipid distribution and metabolism; whereas, we were 
unable to establish whether or not P2X7 might play a role in mediating the effects of 
whole body vibration reported by others. The P2X7 KO mouse was obtained from Pfizer 
(Solle et al., 2001). Although initial studies showed an absence of P2X7 protein in these 
mice, recent studies have shown a splice variant (with C-terminal truncation) is 
detectable in some tissues of the Pfizer KO mouse (Masin et al., 2012). This group 
demonstrated that this splice variant, which is present in the salivary glands and spleen, is 
inefficiently trafficked to the cell surface, resulting in greatly diminished receptor 
function (Masin et al., 2012). Thus, while not a complete KO, there is global loss of 
P2X7 function in the Pfizer KO mouse model. 
Our mice were maintained on a mixed genetic background (129/Ola × C57BL/6 × 
DBA/2) by crossbreeding of heterozygous mice. The maintenance of the mixed 
background, rather than backcrossing onto a pure C57BL/6 strain, enabled comparisons 
between our data and the results of other studies that characterized the KO mouse (Ke et 
al., 2003; Labasi et al., 2002; Li, 2005; Panupinthu et al., 2008; Panupinthu et al., 2007; 
Solle et al., 2001). It should also be noted that a naturally occurring polymorphism 
(P451L) with some loss-of-function occurs in the C-terminus of P2X7, and is found in 
several commonly used mouse strains, including C57BL/6 and DBA/2 (Adriouch et al., 
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2002). Given that the mixed genetic background our mice contains both of these strains, 
it is possible that the differences observed between WT and KO mice could be 
underestimated. Future studies should consider backcrossing the KO mouse onto a pure 
C57BL/6 strain and re-characterizing the skeletal phenotype, which may differ from the 
current KO mouse phenotype due to reduced genetic variability. Additionally, it may be 
of interest to cross this mouse onto a different background with higher BMD values, such 
as BALB/c or C3H strains (Judex et al., 2002), to determine if P2X7 loss-of-function 
produces greater severity of osteopenia in these animals. On the other hand, these strains 
with higher BMD values have been shown to be less responsive to the osteogenic effects 
of mechanical loading, when compared to strains with intrinsically lower BMD such as 
C57BL/6 (Judex et al., 2002). Thus, crossing onto a strain with higher BMD would 
perhaps make these animals more suitable for studies not involving mechanotransduction. 
Moreover, the generation of tissue-specific P2X7 knockouts would help clarify the 
specific role of P2X7 in, for example, adipocytes and osteoblasts.  
 
Micro-CT-derived data — In this thesis, whole-body composition data are an integral 
part of each study. As such, it was imperative that we confirmed the validity and 
reliability of our technique, as reported in Chapter 2. Although we conducted a rigorous 
study to validate our protocol, some limitations exist. Though micro-CT is the gold 
standard technique for measuring radio-opaque tissues, repeated acquisition of in vivo 
data from living mice is a recently developed method. Studies that have used this 
technology have not performed repeated measurements in vivo in a longitudinal manner. 
As such, we had little literature to compare with as most studies use pQCT and DXA for 
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live or post-mortem quantification of whole-body composition. Moreover, whole-body 
composition data acquired from micro-CT scans as described in Chapter 2 is a novel 
technique. Thus, the numerical values attained using pQCT, DXA and micro-CT imaging 
modalities are not comparable. As in vivo micro-CT continues to gain popularity, future 
studies should consider using our threshold-based whole-body composition methodology 
for rapid image analysis in longitudinal studies of mice. 
It also should be noted that micro-CT resolutions for in vivo and ex vivo scanning 
differ markedly, and as such the data attained differ as well. In vivo micro-CT is 
appropriate for whole-body composition analyses, but when assessing microarchitectural 
properties of bone, the resolution is simply not sufficient due to the small size of mouse 
bones. We chose to use an ex vivo high-resolution scanning protocol at 20 µm voxel 
spacing to assess femoral and tibial microarchitecture, as trabeculae are approximately 
30-50 µm in width (Bouxsein et al., 2010). Therefore, assessments of mouse bone 
microarchitecture must be performed at a scan resolution of ≤ 20 µm as post-mortem 
specimen scans. We used 2.75-hour, 20 µm resolution scans. Although higher resolutions 
are possible with our micro-CT scanners (~6 µm), the cost is greater and, as spatial 
resolution is increased, scan time and image noise increase significantly. Though 20 µm 
voxel spacing appeared to be sufficient for our purposes, the possibility remains that 
additional information would have been obtained with higher-resolution scanning. Future 
work should attempt to optimize higher-resolution scanning protocols. 
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Whole-body vibration — Little is known about the WBV parameters required to elicit 
changes in whole-body composition. Some previous studies have shown that low-
magnitude, high-frequency vibration is anabolic to bone using a protocol of 45 Hz, 0.3 g 
acceleration for 3-6 weeks (Xie et al., 2006; Xie et al., 2008), while studies using 90 Hz, 
0.2 g acceleration had extended experimental periods of up to 15 weeks observed reduced 
adiposity (Rubin et al., 2007). We chose our WBV parameters based on studies showing 
the anabolic effect on bone (45 Hz, 0.3 g), and extended the time course of the 
experimental period (up to 18 weeks) to assess effects on adiposity. As we did not 
observe these effects in our mouse model, the possibility arises that differing WBV 
protocols have distinct consequences. Thus, it is plausible that altering the treatment 
regimen (time-course or vibration frequency and/or acceleration) could produce tissue-
specific effects. This possibility should be explored in future work. Moreover, the effects 
of acute vibration on gene expression levels should be assessed using real-time PCR. 
Only recently have studies begun to incorporate this approach, and these studies will be 
critical for defining tissue-specific protocols for in vivo vibration.  
Quantification in Chapter 4 was heavily reliant on micro-CT data. Future work 
should include histomorphometric assessments in calcified and decalcified long bones 
from this study, to determine the effects of vibration at the cellular level. This includes 
assessment of bone lining cells, osteoclasts, quantification of marrow adiposity, and 
evaluation of the knee joint to determine if WBV affects these tissues. Our preliminary 
data from collaborative studies indicate that WBV may have a detrimental effect on 
articular cartilage of the knee, inducing osteoarthritis-like changes in some mice within 2 
weeks of vibration treatment (unpublished). Thus, histological assessment of these tissues 
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may add valuable insights into tissue-specific effects of WBV. 
The use of other mouse models with skeletal defects that include compromised 
bone quality, as well as mouse models of metabolic dysfunction and excess adipose 
deposition, should be considered for future work. These studies would provide insight as 
to whether mechanical stimulation has any therapeutic effects in a range of skeletal and 
metabolic disease models. Additionally, unknown signalling pathways that play a role in 
transducing WBV may be identified. 
It remains a possibility that the mixed genetic background of our animal model 
could have influenced the response to vibration treatment, as different mouse strains 
(with dissimilar bone mineral densities) respond differentially to vibration treatment 
(Judex et al., 2002). Moreover, humans have a great deal of genetic variability, which 
affects bone mineral density and may also result in differential responses to vibration 
treatment. Therefore, studying WBV in genetically-modified mice may be useful for 
determining signalling pathways involved in mediating skeletal mechanotransduction, but 
may not be directly applicable to clinical WBV due to the inherent genetic variability in 
humans. 
We studied a chronic model of WBV, anticipating greater bone accrual and 
reduced fat tissue with a prolonged exposure to vibration. However, the longevity of this 
treatment may be limitation. While some studies have shown anabolic responses in bone 
with prolonged exposure to WBV (Xie et al., 2008), others have noted that bone can 
become desensitized to repeated exposures of mechanical loading over time (Robling, 
2006; Willie et al., 2013). Similar observations have been made in humans during 
exercise activities such as walking or running, where remodelling slows as the bone 
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adapts to repeated mechanical stimulation of similar intensities. Interestingly, it is 
believed that this adaptation occurs during a defined refractory period, after which bone 
is capable of anabolic responses to mechanical stimuli once more. The presence of such a 
refractory period suggests that multiple bouts of vibration separated by a time interval 
may be necessary to induce effects on whole-body composition (Robling, 2006; Sen et 
al., 2011).  
Another future goal would be to identify potential signalling pathways mediating 
mechanotransduction in vivo. To do so, the use of in vitro approaches will be critical in 
determining the underlying signalling mechanisms. Only recently have studies begun to 
reveal that mechanical stimulation can influence mesenchymal stem cell (MSC) 
proliferation and differentiation (Luu et al., 2009). Furthermore, vibration has been 
shown to maintain the osteogenic potential of bone marrow stromal cells (Ozcivici et al., 
2010), while discouraging commitment to the adipocyte lineage (Sen et al., 2011). At the 
same time, others have shown that osteoblast commitment is reduced and matrix 
mineralization inhibited with vibration in vitro (Lau et al., 2011). Given the controversial 
nature of these findings, future studies should further investigate these effects. 
Additionally, the specific signalling pathways that regulate the commitment of 
mesenchymal stem cells to either the osteoblast or adipocyte lineage in response to 
vibration should be explored. 
We have specifically designed, built and tested two vibration platforms to explore 
the effects of vibration in vitro. The first of these platforms is designed to image cell 
cultures using microscopy during treatment in individual cell culture dishes (Holdsworth 
et al., 2012), while the other is a modification of the in vivo whole-body vibration 
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platform with custom 6-well cell culture plate inserts. These systems may allow us in 
future studies to rigorously determine the key players in mechanotransduction at the 
cellular level, and unveil the signalling pathways mediating the effects of vibration.  
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5.3 Contributions of the Research to the Current State of Knowledge 
 
Novel imaging approaches — Medical imaging is a large and diverse field that 
incorporates several different imaging modalities, providing insights into disease by 
revealing internal structures in a non-invasive manner. The imaging modality used in 
each this thesis was micro-CT, the gold standard for quantification of radio-opaque 
tissues (Donnelly, 2011; MacNeil and Boyd, 2007). New micro-CT machines have the 
capacity for short scan times and low radiation dosages, which has opened up the 
possibility of repeated in vivo scanning of mice in longitudinal studies (Glatt et al., 2007; 
Granton et al., 2010; Judex et al., 2003).  
Prior to this thesis, there had been no reports of repeated in vivo scanning of mice 
over a long time course. Our study reported in Chapter 2 is the first characterization of 
changes in whole-body composition during growth and aging of mice using micro-CT 
and whole skeleton data. This method offers the ability to quantify adipose and lean 
tissue components of the mouse in addition to measuring the skeletal tissues. The 
methodology described in Chapter 2 facilitates analysis of large data sets. Moreover, our 
study was the first to scan mice as young as 2 weeks of age in vivo; other studies have 
only used post-mortem scans for young age groups (Guldberg et al., 2004; Oest et al., 
2008). Furthermore, our study provided many novel methods, including a precise method 
to measure the length of long bones using anatomical markers. We also described a 
method for determining maximum bone mineral density, which reflects mineralization 
better than mean BMD. Our data showed marked differences in whole-body composition 
values during the period of rapid growth between 2 and 5 weeks of age, highlighting the 
importance of collecting data at precise ages when comparing groups within this range. 
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Moreover, our findings provide critical reference data for other investigators using mice 
as disease models. Therefore, Chapter 2 makes significant contributions to the field of 
micro-CT imaging of mouse models, as others can use this methodology for 
characterizing their mouse models in an efficient, non-invasive, and high-throughput 
manner.  
 
Implications for metabolic disease — The P2X7 receptor has been linked to a role in 
directing osteoblast and adipocyte commitment from mesenchymal progenitors, as 
cultured cells from KO mice show greater adipogenic markers accompanied by reduced 
osteogenic markers (Panupinthu et al., 2008). Additionally, P2X7 activation has been 
shown to enhance cellular energy metabolism, suggesting a role for this receptor in 
regulating energy homeostasis (Amoroso et al., 2012; Grol et al., 2012). P2X7 receptors 
are present in mouse adipocytes (Sun et al., 2012) and human adipocytes (Madec et al., 
2011), but little is known about their role in these tissues. In Chapter 3, we reported that 
loss of P2X7 function leads to increased adiposity and lipid accumulation in older male 
mice. P2X7 KO mice were found to have increased body and epididymal fat pad weights, 
coupled with reduced total plasma cholesterol levels compared to WT mice at 9 months 
of age. Additionally, we showed that male mice lacking functional P2X7 receptors 
develop ectopic lipid accumulations as they age. Our study revealed previously 
unrecognized roles for the P2X7 receptor in adipogenesis, lipid storage and metabolism 
in vivo. This provides the impetus to further elucidate the roles of P2X7 in the control of 
energy and lipid metabolism. Moreover, these findings highlight the need for research to 
probe the role of P2X7 in regulating the differentiation of adipocytes and in bone-fat 
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crosstalk.   
 In terms of clinical implications, patients with metabolic syndrome show 
enhanced expression of P2X7 in adipocytes (Madec et al., 2011). Obese patients have 
elevated P2X7 expression levels, while patients with type II diabetes mellitus show 
reduced levels of P2X7 expression (Glas et al., 2009). Taken together with our results, 
this suggests a link between P2X7 and metabolic syndrome. Moreover, increased marrow 
fat in humans is associated with aging as well as chronic diseases such as diabetes 
mellitus and osteoporosis (Gourine et al., 2009). Thus, our study in mice provides further 
insights into the role of P2X7 in adipose tissues and lipid metabolism, which may be 
clinically relevant in humans with chronic metabolic diseases. 
 
P2 receptors and mechanotransduction in bone — Our lab has previously proposed that 
mechanotransduction in bone is mediated by nucleotide release and subsequent activation 
of P2 receptors in bone cells (Dixon and Sims, 2000). The P2X7 receptor has 
demonstrated roles in bone remodelling (Grol et al., 2009; Grol et al., 2013; Panupinthu 
et al., 2008), cellular metabolism and energy homeostasis (Amoroso et al., 2012; Grol et 
al., 2012), and adiposity (Chapter 3). Moreover, the P2rx7 KO mouse exhibits an 
osteopenic phenotype (Ke et al., 2003) and a reduced osteogenic response to axial 
compressive loading (Li, 2005), implicating P2X7 in mechanotransduction. In Chapter 4, 
we assessed the effects of WBV on wild-type and P2rx7 KO mice, and anticipated 
observing changes whole-body composition in response to vibration (at least in wild-type 
mice). However, our data revealed no significant effects of WBV at the whole-body and 
microarchitectural level using our vibration protocol.  
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Future studies could investigate the effects of different WBV protocols, varying 
frequency, acceleration, duration and/or intervals. WBV remains a promising avenue for 
further research as a potential approach for non-invasive, non-pharmacologic treatment of 
diseases such as osteoporosis.  
 
Anabolic treatment for osteoporosis — A long-term goal is to identify signalling 
pathways underlying mechanotransduction in skeletal tissues. As musculoskeletal 
diseases are extremely prevalent, and the burden becomes of greater concern with an 
aging population, the need for clinical interventions is urgent (Woolf and Pfleger, 2003). 
Currently, there are no non-pharmacological interventions that are effective in counter-
acting the destruction of bone in osteoporotic patients. The limited therapeutic 
interventions available for treatment of osteoporosis are only marginally successful and 
primarily anti-resorptive in their properties (Akesson, 2003). Presently, one anabolic 
(bone building) pharmacological treatment is available (teriparatide, a parathyroid 
hormone peptide). However, due to the extremely high cost of this medication, this 
treatment is currently limited to patients with severe osteoporosis (Maeda and Lazaretti-
Castro, 2014). Thus, it is not difficult to comprehend the allure of WBV, a non-drug-
based (and thus has no drug interactions, a common problem among elderly patients 
taking several medications), non-invasive, relatively affordable and simple-to-use therapy 
for a common, debilitating disease. Therefore, we suggest that future studies should 
continue to investigate the role of WBV, and to determine the therapeutic conditions 
required to mitigate bone loss in osteoporosis.  
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